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ABSTRACT 
Interleukin 5 (IL-5) is an eosinophil differentiation and activating factor and, as a 
consequence has a central role in regulating eosinophilia associated with allergic disease 
and parasitic infections. The biological activities of IL-5 with respect to eosinophils are 
well established, and many intracellular IL-5 receptor-mediated signalling pathways have 
been elucidated. However, these pathways are not exclusively activated by IL-5, but are 
shared by IL-3 and granulocyte macrophage-colony stimulating factor (GM-CSF), which, 
together with IL-5 utilize a common signaling entity, the Be-receptor subunit. 
A functional bipartite nuclear localization signal (NLS) has been identified in IL-5, 
implying that nuclear localization may constitute a novel, ligand-specific pathway through 
which the distinct effects ofIL-5 in eosinophil activation are achieved (Jans et al., 1997ab). 
The present study represents the first elucidation of the detailed mechanisms of nuclear 
localization of IL-5 and its receptor subunits. In vitro nuclear transport assays were applied 
to shed light on the mechanisms of IL-5 nuclear transport, whilst the nuclear translocation 
of both IL-5 and its receptor were verified in the context of a whole living cell, employing 
biochemical techniques including cell fractionation, protein precipitation and Western 
blotting. 
Examination of the IL-5 sequence of both mouse and human revealed that a third short 
cluster of basic amino acid residues ("NLS3 ") is present between the formerly identified 
basic clusters of the bipartite NLS (NLS 1 and NLS2). IL-5 NLS 1- and NLS3- mutant B-Gal 
fusion proteins were found to be excluded from the nucleus, indicating that NLS 1 and 
NLS3 are integral to hIL-5 NLS function. Residues 95-104 of hIL-5 thus appear to 
constitute the hIL-5 NLS, implying that the IL-5 NLS is not a conventional bipartite NLS. 
To investigate the mechanism of uptake of IL-5 into the nucleus, nuclear import of IL-5 and 
a novel single chain IL-5,....,HSA fusion protein (hIL-5sc,....,HSA) was analysed in vitro in 
mechanically perforated rat hepatoma cells. The results of the in vitro assays with hIL-5 
X 
and mIL-5 indicate that their import does not depend on cytosolic factors, ATP or Ran. 
Nuclear import was, however, inhibited by wheat germ agglutin (WGA) and excess 
importin B, suggesting that direct interaction with nuclear pore complexes may play an 
integral part in the nuclear import process of IL-5 . Similar results were obtained for 
hIL-5sc-HSA, which was derived to exclude the possibility that nuclear import of IL-5, 
whose size is below the MW cut-off for passive entry through the NPC is via passive 
diffusion. Nuclear import of hIL-5sc-HSA fusion was independent of cytosolic factors as 
well as of ATP, and was blocked by WGA. Neither IL-5 nor its fusion protein derivatives 
were recognized by the conventional nuclear transport machinery. Thus, consistent with the 
fact that IL-5 does not contain a classical importin a/B recognised bipartite NLS as 
indicated by the mutational studies, this suggests that IL-5 does not utilize a conventional 
nuclear transport pathway. 
The in vivo subcellular fractionation indicated that about 5% of the IL-5 that is internalized 
reaches the nucleus within 12 hours. This implies that IL-5, and any associated molecules 
may localize to the nucleus through a unique pathway that allows exit from the endosomes. 
Previously, piggyback experiments performed with the extracellular domains of the IL-5 
receptor a and B subunits suggested that the IL-5 NLS can specifically cotarget the IL-5 
receptor into the nucleus (Jans et al. , 1997b; Calanni, 1997). Support for the possibility that 
receptor co-localisation may be important for IL-5 nuclear signalling was obtained in the 
cell fractionation studies which verified that full length, membrane-integral IL-5 receptor a 
subunit can be targeted to the nucleus in intact cells, thus verifying results from 
immunofluorescence studies (Jans et al., 1997a; Calanni, 1997). Nuclear import of the IL-5 
receptor a subunit is drastically reduced in the absence of IL-5 , but reaches maximum 
levels within 1 week after re-addition of IL-5 , indicating ligand dependence of the IL-5 
receptor nuclear targeting. Immunoprecipitation experiments using biotinylated IL-5 
showed strong association of IL-5 with its a receptor subunit in the cytosolic fraction, with 
only a small amount of the receptor subunit associated in the nuclear fraction, suggesting 
that the ligand/receptor complex may dissociate once it reaches the nuclear compartment of 
the cell. 
. 
Xl 
Taken together, the results indicate that IL-5 receptor nuclear translocation can occur, in 
IL-5-dependent fashion, and that the IL-5 receptor subunits may therefore play a role in 
nuclear signalling. These results support the hypothesis that IL-5 's specific signaling role 
may be to cotransport its receptor subunits to the nucleus through non-conventional nuclear 
import pathway, where they, either in complex with IL-5 or alone, may affect transcription 
of genes involved in the activation of eosinophils in allergic disease and parasitic 
infections. This nuclear signalling may constitute the basis of the specific role of IL-5 in 
eosinophil differentiation and activation, distinct from IL-3 and GM-CSF, which share 
common receptor components with IL-5. 
.. 
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CHAPTERl INTRODUCTION 
1.1 Interleukin-5 and the IL-3/IL-5/GM-CSF receptor system 
1.1.1 Introduction 
The ability of multicellular organisms to coordinate cell proliferation, survival, and 
differentiation is absolutely dependent on the capacity of different cell types to 
communicate with each other. To enable the large number of cells within an organism 
to interact without direct cell-cell contact, cells produce a vast variety of signalling 
molecules. These include polypeptide regulatory molecules such as cytokines, whose 
primary action is to mediate host defence, and growth factors, whose primary role 
resides in tissue repair through stimulating cell growth and proliferation. Cytokines and 
growth factors have the capacity to relay information from a producer cell to a second, 
responding cell located either in close proximity or at other sites in the body. They do 
this by binding to specific receptors on the surface of the cell. This in turn triggers a 
biochemical cascade inside the cell leading to varied biological responses such as 
motility, adhesion, growth, survival or differentiation (Guthridge, 1998). 
More specifically, cytokines are a diverse group of protein molecules, which mediate 
the effector phases of both innate (non-specific) and adaptive (specific) immunity. 
Cytokines of the Interleukin 3 (IL-3)/lnterleukin 5 (IL-5) and granulocyte/macr~phage 
colony-stimulating factor (GM-CSP) family are important regulators of hematopoiesis 
through modulation of proliferation, differentiation and survival of various 
hematopoietic cell lineages and their precursors (Arai, 1990). Whilst IL-3 and GM-CSP 
act on different blood cells such as granulocytes, macrophages, erythrocytes and early 
hematopoietic progenitors, the inducible cytokine IL-5 is very specific in its action, and 
plays a unique role in the regulation of eosinophils .. IL-5 is produced by T lymphocytes 
following activation and is not only essential for the terminal differentiation of 
eosinophils but is also important for the activation of mature eosinophils (Adachi and 
Alam, 1998). Eosinophils play a crucial role in the killing of helminth parasites 
(Meeusen, 2000) and are the most important effector cells for allergic reactions (Adachi, 
1998; Sanderson et al., 1988). Understanding the specific signalling pathways of this 
cytokine is crucial for the development of therapeutic tools for the treatment of 
conditions like asthma. The identification of the IL-5-specific signalling mechanisms 
- ---
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regulating the function of its target cells is thus of great importance. 
1.1.2 Discovery of IL-5 
Although the existence of eosinophils as a distinct population of leukocytes was noted 
more than a century ago, the molecular basis of their functional regulation has only been 
revealed in the last three decades. Studies examining the role of T cells in the growth 
and activation of B cells reveal that T-cell supematants have the capacity to induce B-
cell proliferation, leading to the designation of a T-cell replacing factor (TRF) (Schimpl 
and Wecker, 1972 ). The B-cell-growth-stimulating activity of T-cell supernatants was 
attributed to a different factor, called B-cell growth factor, later found to be identical 
with TRF (Harada et al., 1985). After another factor, responsible for eosinophil 
differentiation (Sanderson et al., 1985) was co-purified with TRF and the identity of 
their cDNAs revealed, they were renamed Interleukin-5 (IL-5), functioning as a T-cell-
derived cytokine with pleiotropic activities on murine B-cells and human and murine 
eosinophils (Azuma et al., 1986; Campbell et al., 1988; Kinashi et al., 1986; Sanderson, 
1990ab) 
1.1.3 Biological function of IL-5 
IL-5 has pleiotropic activities on multiple cells as summarized in Table 1.1. Within the 
IL-3/IL-5/GM-CSF cytokine family, it is the most specific ligand for the eosinophil 
lineage (Sanderson, 1992). IL-5 plays a central role in determining the number of 
eosinophils in circulation and in tissues through its ability to promote their production, 
proliferation, and differentiation and to enhance their survival by suppressing apoptosis. 
Hematopoietic cytokines are also implicated in the priming of mature eosinophils to a 
range of stimuli that evoke chemotaxis, degranulation, adhesion, and activation of the 
nicotinic adenine dinucleotide phosphate (NADPH) oxidase. It is well established that 
administration of IL-5 to laboratory animals induces blood eosinophilia leading to lung 
inflammation (Iwama et al., 1992), whilst IL-5-overexpressing transgenic mice show 
life-long eosinophilia in many organs without overt pathology, indicating that 
eosinophils require additional factors for activation (Dent et al. , 1990). 
The primary function of eosinophils is believed to be host defense against infection by 
3 
parasitic helminths. This is based on the finding that eosinophil degranulation is 
directed towards killing helminths in vitro resulting in death in the presence of 
antibodies and complement. They move from the blood to aggregate in the locality of 
helminths, large numbers of eosinophils often being closely associated with both intact 
and damaged helminths in vivo. They have also been shown to de granulate in the 
vicinity of helminth surfaces in vivo (Butterworth, 1984). 
IL-5 seems to play a major role in helminth-induced airway hyperresponsiveness (Hall 
et al., 1998). Administration of the anti-IL-5 antibody TRFK-5 to mice inoculated with 
microfilariae of the filarial nematode Onchocerca lienalis reduced the ability of the 
animals to resist reinfection (Folkard et al., 1996). A similar approach has been adopted 
to show that IL-5 is important in driving eosinophilia and reducing the parasite burden 
in mice exposed to Aspergillus fumigatus (Murali et al., 1993; Kurup et al., 1997), 
Toxocara canis (Buijs et al., 1995), and Angiostrongylus cantonesis (Sasaki et al., 
1993). 
Table 1.1. Targets and biological activities of human and murine IL-5 (from Mahanty 
and N utman, 1993) 
Target cells 
Eosinophils 
B cells 
T cells 
Mast cells 
a N.D.- not determined 
Human Mouse 
Biological effect 
Differentiation of precursor cells 
Prolongation of survival and activation 
of effector functions of mature cells 
Role in differentiation and isotype 
switching is controversial 
Induction of IL-2 receptor expression 
Proliferation 
Histamine release 
Secretion of leukotriene C4 
Differentiation 
lg secretion 
Enhancement of IL-4-directed 
class switching from lgM to IgG 1 
and lgE 
Induction of IL-2 receptor 
express10n 
N.D.a 
The importance of IL-5 in allergen-induced tissue eosinophilia in laboratory animals has 
been examined extensively. The exposure of sensitized mice, rats, and guinea pigs to 
allergen generally results in the appearance of IL-5 and eosinophils in the 
Bronchoalveolar Lavage Fluid (BAL) fluid. Pulmonary eosinophilia depends on 
-~ ---
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circulating rather then locally produced IL-5 (Wang et al., 1998) and is associated with 
an increase in airways reactivity to a variety of stimuli, including acetylcholine (ACh), 
arecholine, histamine, and 5-hydroxy-tryptamine (Chand et al., 1992; Gulbenkian et al., 
1992; Nagai et al., 1993, 1996; Bruijnzeel et al., 1993). Similar effects are seen in the 
pleural cavity of antigen-challenged sensitized mice (Bozza et al., 1994). Neutralizing 
IL-5 with antibodies inhibits eosinophil infiltration but has a variable effect on airways 
responsiveness (Gulbenkian et al., 1992; Chand et al., 1992; van Oosterhout et al., 
1993; Nagai et al., 1993, 1996a, 1996b). It thus seems that IL-5-secreting CD4+Th2-
type cells may play a pivotal role in generating blood and airways eosinophilia in mice, 
and in the subsequent development of bronchial hyperreactivity and lung damage that 
occurs in response to aeroallergens (Hogan et al., 1998). Therefore, Il-5 can be seen as a 
major link between activated T cells and eosinophils in both parasitic as well as in 
chronic allergic disease (Kotsimbos, 1997) (Fig. 1.1 ). 
IL-5 also appears to play a role in murine B-cell development, being able to induce 
DNA synthesis in mouse chronic leukemic B cells as well as in dextran-sulfate-
stimulated splenic B cells (Hitoshi et al., 1990; Table 1. 1). Whilst the B-1 cell 
population is markedly increased in IL-5 transgenic mice (Tominaga et al., 1991), the 
number of B-1 cells and peripheral eosinophils in IL-5- and IL-5Ra-deficient mice is 
reduced (Yoshida et al., 1996; Kopf et al., 1996). Thus, there is evidence for both an IL-
5-sensitive developmental pathway for B-1 cells, and a role for IL-5 in the terminal 
differentiation of mature B-1 cells and activated B-2 cells in the murine system (Takatsu 
et al. , 1994; Table 1.1 ). Additionally, a synergistic role for IL-5 in promoting CH gene 
recombination together with IL-4 has been demonstrated in activated mouse B cells 
(Mandler et al. , 1993). IL-5 is thus a potent cytokine able to induce terminal 
differentiation of activated mouse B cells, as well as being a priming factor facilitating 
responsiveness to other cytokines. 
In contrast to its role in mouse B-cell development, IL-5 's role in human B-cell growth 
and differentiation remains controversial (see Table 1.1; Huston et al., 1996; 
Clutterbuck et al. , 1987). No effects on proliferation and lg production were found 
when IL-5 was tested for functional activity on purified human B cells from peripheral 
blood (Clutterbuck et al., 1987). Conversely, another study has reported the potential of 
human B cells to respond to IL-5 (Huston et al., 1996). Detection of mRNA for IL-5Ra 
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in resting B cells upon the stimulation of B cells with the bacteria B-cell mitogen 
produced by Moraxella catarrhalis and lg synthesis of B cells stimulated with mitogen 
and IL-5 have provided direct evidence that human B cells are also able to respond to 
IL-5 (Huston et al., 1996). 
Fig. 1.1. Involvement of IL-5 in allergic reactions. 
Acute Allergic 
Reaction 
Chronic Allergic 
Reaction 
. 
. 
. " " 
While acute allergic reactions are due to the antigen-induced release of histamine and 
lipid mediators from mast cells, chronic allergic reactions involve the production of IL-5 
by activated Th2 cells, causing the recruitment and activation of eosinophils, with 
subsequent liberation of eosinophil products like basic proteins, leukotrienes and platelet-
activating factor. MHC denotes major histocompatibility complex (from Kay, 2001). 
1.1.4 IL-5 gene structure and regulation of gene expression 
The IL-5 gene is mainly induced in activated T lymphocytes that belong to the Th2 
subset-of T cells. The IL-5 gene is part of a cluster of T-helper Th2-type cytokine genes 
located on chromosome 5 in human (5q23-31) and chromosome 11 in mice. It is found 
in the vicinity of the genes for IL-3, IL-4 and GM-CSF. The human IL-5 gene has a 
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length of approximately 4 kb and contains 4 exons and 3 introns, comparable to the 
mIL-5 gene. The 3 introns of the human IL-5 gene are 208, 950 and 105 bp in length, 
those of the mouse IL-5 gene are 829, 187 5 and 79 bp long. A potential TAT A box is 
located 29 bp (human) and 30 bp (mouse) upstream from the start of transcription 
(Sanderson et al., 1988). The chromosomal clustering of the IL-5, IL-4 and GM-CSF 
genes and their inducible expression in T lymphocytes suggests that these genes may 
have been derived from duplication of a common ancestral gene (van Leeuwen et al., 
1989). This potential link raises the possibility of coordinated regulatory mechanisms in 
their regulation (Mahanty and Nutman, 1993). 
Regulation of IL-5 occurs at a number of levels. Its production is thought to result from 
induction of gene transcription by the cytokine IL-2 and/or via the T cell receptor (TCR) 
complex (Van Straaten et al., 1994; Valentine and Sewell, 1997) triggering a signalling 
cascade most probably involving members of the Protein kinase C (PKC) family as well 
as the MAP kinase pathway (Csonga et al., 1998, Baumruker et al., 1999). At the IL-5 
gene level, the proximal regions of the IL-5 promoters seem to be critical for IL-5 
induction. Additionally, the cooperative action between the transcription factors AP-1, 
Ets 1 and GA T A-3 are thought to be essential requirements for IL-5 expression as 
possible parts of a higher transcriptional complex (Wan, 2002; Blumenthal et al., 1999, 
Yamagata et al., 1997). IL-5 also seems to be regulated at the level of rnRNA stability. 
As studies with differentiated human peripheral blood T cells have shown, the IL-5 
mRNA half-life(> 2 h) is longer than that of IL-3 or GM-CSF (Umland et al. , 1998). 
Only IL-5 transcription initiation shows an absolute dependency on de nova protein 
synthesis (Naora et al., 1994a; Umland et al. , 1999). 
1.1.5 Biochemical characteristics of the IL-5 protein 
The IL-5 protein is a homodimer formed by two identical polypeptide chains joined 
together by intermolecular disulfide bonds (Minamitake et al. , 1990). The crystal 
structure of hIL-5 was first resolved for a bacterially expressed form (Milburn et al. , 
1993), followed by the structure of baculovirus-expressed recombinant hIL-5 (Tavernier 
et al., 1995) and Drosophila-expressed rhIL-5 (Johanson et -al. , 1995). The structural 
analysis revealed a novel two-domain structure, with each domain consisting of a four-
a-helix bundle (Figs. 1.2 and 1.3). 
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Fig. 1.2. Three-dimensional structure of hIL-5. 
Tube drawing of IL-5 showing the dimer configuration. Chain 1 is shown in yellow, chain 
2 in white. Light blue and green regions represent the ~-sheets of the respective chain. The 
viewing direction is along the dimer 2-fold axis (from Milburn et al., 1993). 
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Fig. 1.3. Schematic representation of one human IL-5 domain. 
Amino acids are indicated the single-letter code. Each half of the intertwined dimer 
consists of one monomer chain (red; helices A, B, C) and part of the second monomer 
chain (green; helix D'). The colour code for the individual amino acids reflects side-
chain solvent-accessibility: buried residues in orange; intermediate exposed residues in 
yellow, exposed residues in blue (from Milburn et al., 1993). 
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The four-helix bundles in IL-5 are composed of three helices from one subunit, with the 
fourth being provided by the other subunit. These bundles produce an antiparallel 
dimeric organization unique to IL-5 (Chaiken and Williams, 1996). The intermolecular 
disulfide bonds linking the two subunits occur in a head-to-tail fashion where the Cys 44 
residue from each chain forms a disulfide with the Cys86 residue from the other 
(Minamitake et al., 1990; Proudfoot et al., 1991 ). These cysteine residues appear to be 
essential for IL-5 to function, since their removal by site-directed mutagenesis abolished 
biological activity of IL-5 (McKenzie et al., 1991 ). Native IL-5 was initially isolated 
from mouse T-cell supernatants and shown to be a glycoprotein (McKenzie et al., 
1987). 
The protein had an apparent molecular mass of 45 kDa, but the cloning of the cDNA 
sequence revealed that the protein component is composed of two amino acid chains 
with a molecular mass of 13 kDa for each polypeptide monomer (Kinashi et al., 1986). 
So far, the sequence of the IL-5 gene of 14 different species was determined. 
In hIL-5, an O-linked glycosylation appears at residue Thr3 and a N-linked 
glycosylation at Asn28 (Minamitake et al., 1990). Although the carbohydrate 
components do not appear to be essential for IL-5 activity, it was suggested that the N-
linked sugar chains may contribute to the thermostability of the molecule, whilst the O-
linked sugar chains seem to be more effective in suppression of IL-5 activity (Kodama 
et al., 1993). Nevertheless, Escherichia coli-expressed rhIL-5 represents a fully active 
protein, as does that from baculovirus-infected Sf9 cells (Tavernier et al., 1989). 
1.1.6 The IL-5 receptor complex 
Eosinophils and basophils are the primary target cells of IL-5 in humans, whereas in 
mice IL-5 also acts on activated B cells (Murata et al., 1992; Mita et al., 1989a; 
Sanderson et al., 1988; Hitoshi et al., 1990, Tavernier et al., 1991; Chihara et al., 1990; 
Ingley and Young, 1991 ). This selectivity in cell activation is due to the fact that only 
these cells express the receptor system for IL-5. IL-5 has been reported to interact with 
eosinophils with an affinity of between 20 and 400 pM (Tagari et al., 1993; Lopez et al., 
1991; Migita et al., 1991; Ingley and Young, 1991 ). Also, a broad spectrum of 
maximum binding sites per cell (260-1500) has been described for cells including 
primary myeloid cells, eosinophils and basophils, human peripheral blood eosinophils 
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and human promyelocytic HL-60 cells (Migita et al. , 1991; Lopez et al., 1991; Ingley 
and Young, 1991). The high affinity IL-5 receptor consists of two different polypeptide 
chains: a 60 kDa IL-5-specific a subunit (IL-5Ra) and a second subunit, the 130 kDa B 
chain (IL-5RB) (Takaki et al. , 1990; Takaki et al., 1991; Takaki et al., 1993; Tavernier 
et al. , 1991; Murata et al. 1992). While the a subunit is essential for IL-5 low affinity 
binding, the B subunit is necessary for high-affinity binding, although it cannot bind 
IL-5 itself (Fig. 1.4). 
Both mouse and human IL-5Ra can occur in soluble forms (Takaki et al. , 1990; Murata 
et al. , 1992; Tavernier et al., 1991). Although the function of soluble IL-5Ra is not 
clear, these receptor forms may be physiological modulators of their cytokine ligands 
and may alter their effects in hematopoiesis and the immune response (Yamaguchi et 
al. , 1994). It has been suggested that the binding of soluble receptors by cytokines 
might protect them from proteolytic inactivation and prolong their half-lives in vivo 
(Koike et al. , 1994). Recombinant soluble hIL-5Ra (shIL-5Ra) has been shown to 
compete with the membrane-bound form present on eosinophils and their progenitors 
and exert antagonistic properties by capturing of IL-5 in the extracellular space 
(Tavernier et al. , 1990; Kikuchi et al. , 1994; Daser et al. , 2000). shIL-5Ra binds IL-5 
with only 2-3 fold lower affmity than the membrane-bound IL-5Ra, and is able to 
inhibit IL-5-dependent cell proliferation. In contrast, the affmity of soluble mouse IL-
-~ 
5Ra is 10 times lower than the membrane-bound IL-5Ra. Although it can compete for 
IL-5 binding, it seems to be unable to inhibit IL-5-dependent cell proliferation (Kikuchi 
et al., 1994) 
Little is known of the factors that control the transcription and expression of the IL-5 
receptor system (Y asruel et al. , 1997; Zanders et al. , 1994 ). At the gene level, no 
consensus sequences for known transcription factors have been identified in the 
promoter region of the IL-5Ra gene, indicative of unique myeloid cell- and, possibly, 
eosinophil-specific, regulatory elements (Sun et al. , 1996). The existence of a second 
promoter for the human IL-5Ra gene was shown to have an important role in the 
regulation of eosinophil-specific expression of IL-5Ra (Zhang et al. 1997). A recent 
study showed that IL-5 itself could switch IL-SR a expression predominantly to the 
transmembrane form in a mini gene reporter system (Tavernier et al. , 2000). 
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Fig. 1.4. Schematic representation of the IL-5 receptor. 
The extracellular portions of IL-5Ra and IL-5RB are divided into conserved 
fibronectin type-III-like domains (shaded) found in the type I cytokine receptor 
family (Bazan, 1990a). The four conserved cysteines residues are shown as lines, 
the WSXWS1 sequence as thick bar. The conserved, proline rich sequence in the 
cytoplasmic domain of the a chain is shown by a hatched bar. 
1
- amino acids in single-letter code 
Structurally, the a and Be subunits of the 11-5 receptor are members of the Type I 
cytokine receptor superfamily, which contain conserved extracellular domains termed 
cytokine receptor modules (CRM) (Fig. 1.4). Each CRM consists of two repeats of a 
fibronectin type III-like domain. These repeats carry two sets of conserved motifs 
typical of this family of receptors. The first repeat contains four cysteines with 
conserved spacing, while the second repeat contains a WSXWS (single letter amino 
acid code) motif (Bazan, 1990a). 
The extracellular portion of IL-5Ra is composed of three fibronectin type-III-like 
modules (Takaki et al., 1990; Murata et al., 1992). The two membrane proximal 
modules contain the conserved superfamily structures; four conserved cysteines in the 
middle domain and the WSXWS motif (Bazan et al. , 1990a) in the membrane proximal 
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domain. The cytoplasmic domain of IL-5Ra has no significant homology with 
signalling molecules such as kinases, phosphatases, or nucleotide binding proteins, and 
no Src homology (SH) domains. It contains cytoplasmic regions rich in praline (Pro-
Pro-X-Pro) following the transmembrane domain that are well conserved between 
IL-5Ra and the receptors for IL-3, GM-CSP, prolactin, and growth hormone (Takaki et 
al. , 1990). 
The crystal structure of the human Be subunit has recently been resolved (Carr et al. , 
2001 ). The Be subunit appears to be an intertwined dimer in which all subunits consist 
of four domains, each with an approximate fibronectin type III topology. The Be dimer 
structure seems to be analogous to that of the IL-5 dimer, where helix D and strand 2 
appear to have been exchanged as a result of an ancestral domain swapping event that 
has subsequently undergone evolutionary selection, resulting in a short hinge loop 
between helix C and D. The latter prevents helix D from packing close to helices A-C, 
thus precluding the formation of a stable monomeric species (Milburn et al. , 1993). 
IL-5 has significant functional homology with IL-3 and GM-CSP, all of which utilize 
the receptor B subunit (Be), with the ligand specificity preserved by distinct a receptor 
subunits. After ligand-binding, the Be subunit, which is crucial for signal transduction 
(Adachi et al. 1998), forms a high affinity receptor with all three a subunits. 
1.1.7 Transmembrane signalling by the IL-3/IL-5/GM-CSF receptor 
system 
The exact nature of the signalling pathways involved in the activation of hematopoietic 
cells by IL-3/IL-5/GM-CSP is not well established. Nevertheless, these cytokines are 
known to activate at least three common pathways: the Janus kinase family (JAK)/ 
Signal transducer and activators of transcription (STAT) pathway, the ras/Mitogen 
activated protein kinase (MAPK) pathway, and the Phosphatidyl-inositol-3 kinase (PI3-
K) pathway (Fig. 1.5). 
Although the Be receptor subunit of IL-3, IL-5 and GM-CSP lacks intrinsic kinase 
activity, these ligands induce tyrosine phosphorylation of Be as well as a variety of 
cytoplasmic proteins including kinases (Welham et al. , 1994), adaptor proteins (Okuda 
et al. , 1997), guanine nucleotide exchange factors (Matsuguchi et al. , 1995), 
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phosphatases (Welham et al., 1994), and transcription factors (Mui et al., 1995). This 
phosphorylation is mediated mainly by the receptor-associated JAK2. Janus family 
kinases are cytoplasmic tyrosine kinases that are associated with cytokine receptors both 
in vertebrates and invertebrates (Mathey-Prevot et al., 1998). 
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Fig. 1.5. Schematic representation of signal transduction pathways activated 
through IL-3/IL-5/GM-CSF receptors. 
Receptor activation following ligand binding leads to activation of multiple 
cytoplasmic signalling molecules, thought to leads ultimately to proliferation, 
differentiation, survival and activation of cellular functions ( adapted from Adachi 
and Alam, 1998). _ 
STAT - Signal transducers and activators of transcription; JAK - Janus family 
kinase. 
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The membrane proximal region of the ~c subunit contains a conserved proline-rich 
motif termed box 1, which serves as a binding site for JAK.2 (Quelle et al., 1994). Upon 
ligand binding and following receptor dimerization, the JAKs are activated by trans-
phosphorylation of two receptor-bound JAK molecules and subsequently phosphorylate 
a number of substrates including the cytokine receptor itself. 
Following receptor activation and phosphorylation, phosphotyrosine residues within the 
cytoplasmic domain of the ~c receptor function as high affinity binding sites for SH-2 
domain-containing proteins. These proteins include the STATS homologues STAT5A 
and ST AT5B, members of the family of cytoplasmic transcription factors (Ihle, 1996, 
Darnell, 1997). Phosphorylation of STATS by JAK2 then results in STATS activation, 
dimerization and translocation to the nucleus, where it is directly involved in regulating 
gene transcription (Itoh et al., 1998; Mui et al., 1995). The Extracellular signal-
regulated kinases (ERK) 1 and 2 members of the MAPK family have been shown to be 
activated by IL-3, IL-5 and GM-CSF in primary cellular lineages as well as in cell lines 
(Pazdrak et al., 1995b; Coffer et al., 1998). Rapid activation of the guanine nucleotide 
binding protein Ras (p21) induces translocation of Raf- I kinase to the juxtamembranous 
compartment, where the latter is activated by tyrosine kinases, protein 14-3-3, and 
possibly Protein kinase C (PKC) (Stomski et al., 1999). Raf- I regulates ERK, a member 
of the MAPK family, through activation of MEK (MAP or ERK kinase). Activation of 
the raf-1/MAPK pathway eventually results in enhanced transcription of c-Fos and c-
Jun (Satoh et al., 1991; Sato et al., 1993) and might contribute to IL-3, IL-5 and GM-
CSF induced proliferation. 
IL-5 can also activate the serine/threonine protein kinase Jun N-terminal kinase/stress-
activated protein kinase (JNK/SAPK) pathway ( de Groot et al., 1997). Downstream 
targets of this pathway are likely to be transcription factors involved inc-Jun and c-Fos 
regulation such as ternary complex factor (TCF), and activating transcription factor-2 
(ATF2), as well as c-Jun itself ( de Groot et al., 1997). 
Additionally, IL-5 stimulation results in rapid tyrosine phosphorylation of PI3K (Sato et 
al., 1994). The ~c receptor does not contain a consensus motif for PI3K binding, and it 
is likely that other proteins serve as bridging intermediate. Possible candidates are SHP-
2 (Welham et al., 1994) and Tee tyrosine kinase (Takahashi et al., 1997). PI3K 
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transduces signals to a number of serine/threonine kinases such as PKC, protein kinase 
B (PKB or Akt), JNK and p70 S6 kinase ( de Groot et al., 1997). 
1.1.8 Functional role of IL-5/IL-3/GM-CSF signalling pathways 
The functional role of the signalling pathways used by IL-3/IL-5/GM-CSF for 
proliferation, survival and differentiation of different target cells have only recently 
been characterized (Table 1.2). , 
Table 1.2. Role of IL-5 on eosinophils and the intracellular signals involved 1, 
Role ofIL-5 Signalline molecules 
Eosinophilic progenitors 
Proliferation and Differentiation Lyn, JAK2 
Mature eosinophils 
Inhibition of apoptosis 
Priming for degranulation, 
production of leukotriene and 
superoxide 
Direct degranulation and superoxide 
production 
Stimulation of cytokine synthesis 
Upregulation of adhesion molecules 
and induction of adherence 
Stimulation of cytotoxicity 
Expression of MHC class II 
Chemotaxis 
N.D.- not determined 
1 (Adachi and Alam, 1998) 
Lyn, Syk, JAK2, SHP-2, 
Raf-1 
PI3K, Raf-1 
N.D. 
N.D. 
Raf-1 
N.D. 
N.D. 
N.D. 
Most of the work connecting the IL-3/IL-5/GM-CSF signalling pathways to 
physiological function has been performed by analysis of the Be receptor subunit in 
factor-dependent cell lines. Deletion and point mutagenesis of the cytoplasmic domain 
of B c have demonstrated that JAK2, known to bind to the box 1 region, is both 
necessary and sufficient to induce proliferation in mouse Ba/F3 pro-B and CTLL2 
cytotoxic T cells (Itoh et al., 1996; Watanabe et al. , 1996). 
The box 2 region in Be enhances proliferative responses, but is not absolutely required. 
So far, no single tyrosine residue at Be has been found to be crucial for mediating any of 
the known biological activities of IL-3/IL-5/GM-CSF, which implies a high degree of 
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redundancy. When all 8 tyrosine residues in Be were replaced, proliferation was not 
impaired, suggesting that additional pathways might be involved in proliferative 
signalling. IL-3/IL-5/GM-CSF also induce signals leading to prolonged survival and 
inhibition of apoptosis of their respective receptor-bearing cells (Guthridge et al., 1998). 
Although JAK2 activation is required for all known signalling pathways originating 
from Be, its importance in anti-apoptotic signalling remains to be proven. Tyrosine-
phosphorylation does not seem to be essential, as indicated by mutational analysis 
(Okuda et al., 1997; Itoh et al., 1998). 
The recent discovery of a novel PI3-kinase pathway has provided new insights into how 
cytokines can promote survival by the prevention of apoptosis (Franke et al., 1997). In 
the case of IL-3 stimulation of Ba/F3 cells at least, the activation of the PI3-kinase 
ultimately seems to lead to binding of the adapter protein 14-3-3 to BAD (Bcl-2/Bcl-X 
L -Antagonist, causing cell Death). This possibly prevents BAD from exerting its pro-
apoptotic activity, leading to IL-3-mediated survival (Zha et al., 1996; del Peso et al., 
1997). 
In vitro studies with human blood eosinophils have suggested that IL-5 may act by 
altering expression of the anti-apoptotic regulator Bcl-2 and its homologues (Dewson et 
al., 1999; Dibbert et al., 1998), possibly through cross-talk with the PI3-K/Akt and the 
STATS pathways (Santos et al., 2001 ), but this remains controversial. Alternatively, IL-
5 may act by regulating the activation of caspase cell death cascades rather then altering 
the balance of anti-apoptotic and pro-apoptotic Bcl-2 homologues (Zangrilli- et al., 
2000). This model was supported by a recent report demonstrating that caspase-8 and 3 
are the main targets of IL-5 prolonging survival as mediators of Fas-induced eosinophil 
apoptosis (Letuve et al., 2001). Rec~ntly, NF-KB was shown to be involved in TNF-
alpha-enhanced eosinophil survival through the regulation of GM-CSP production by 
eosinophils, with MAPK inhibitors having no effect on this pathway (Temkin and Levi-
Schaffer, 2001). Mutational analysis of Be indicates that, at least in the case of GM-
CSF, an intracellular domain including the box 3 region is essential for GM-CSF-
mediated differentiation of Ml cells (Smith et al. , 1997). It has been demonstrated for 
eosinophils that the tyrosine kinases Lyn and Jak2 play an essential role in IL-5Ra 
signalling, leading to eosinophil differentiation (Stafford et al., 2002). Lyn was directly 
associated with IL-5Ra, and the effect of Lyn appeared to be relatively specific for the 
eosinophilic lineage. To date, however, the critical role of IL-3/IL-5/GM-CSF in 
- ~--
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differentiation cannot be explained on the basis of the current knowledge of signalling 
pathways elucidated for these cytokines. 
Little is known about the effects of above described signalling pathways on rnyeloid cell 
effector function such as cell migration, priming, degranulation or induction of 
adherence. PI3 kinase, but not Ras-MAPK, appears to have a role in superoxide 
production in IL-5-prirned cells (Coffer et al., 1998). Lyn and JAK2 seem not to be 
important for degranulation, whereas Raf-1 kinase has been demonstrated to play a 
central role in regulating not only for eosinophil survival, but also for expression of B2 
integrins as well as for degranulation (Pazdrak et al., 1998). 
1.1.9 Determinants of signalling specificity in the IL-3/IL-5/GM-CSF 
ligand-receptor system 
The sharing of a common receptor subunit (Be) has profound implications for the 
defining of key events that distinguish the signalling pathways between IL-3/IL-5/GM-
CSF. Tan and Kirn (1999) have summarized several proposed models for how particular 
molecular rnechanisrns can achieve signalling specificity in the RTK/Ras/MAP kinase 
signalling pathway, which can reasonably apply to other pathways as well, including 
those activated by the cytokine type I receptor family. 
Model 1: Differential signalling kinetics. Differences in the level of activation of a 
cornrnon signalling pathway might generate different cellular outcomes, either by 
stimulating the same receptor to different degrees, or by activating other receptors ( or 
subunits of the same receptor system) that feed into identical intracellular signalling 
pathways. 
Model 2: Integration of multiple signalling pathways. Signals from separate and 
distinct signalling pathways might be integrated by common proteins, affecting the 
decision of a tissue or cell to execute a particular cell fate. 
Model 3. Cell-type or cell-stage-specific downstream effectors. Cells of different 
types or cells at different developmental stages might express distinct proteins that 
respond to the same upstream pathway to generate different cellular outcomes. 
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The basic principle of how specificity is reached differs between the models. In Model 1 
and 2 signalling specificity is controlled by the levels or types of "instructive" cellular 
signals acting on cells or tissues in a "tissue-extrinsic" fashion, while Model 3 shows 
how the expression of cell or tissue-specific traits can be determined by inherent 
differences in the responding cells or tissues. Here, cellular signals function in a 
"permissive" manner by triggering distinct responses that are pre-programmed in cells 
of different origin or at different developmental stages, and signalling specificity is 
controlled in a "tissue-intrinsic" fashion (Tan and Kim, 1999). It is possible that similar 
mechanisms are responsible to ensure signalling specificity in the IL-3/IL-5/GM-CSF 
system. 
Different cells of the hematopoietic system may express or lack one or several of the 
ligand-specific a receptor subunits at different times during maturation and activation. 
Specifically, the IL-3 receptor is known to be expressed on early hematopoietic 
progenitor cells and certain committed myeloid progenitors, as well as on eosinophils 
and basophiles. The GM-CSF receptor is expressed on most types of myeloid 
progenitors, mature monocytes, neutrophiles, eosinophiles, basophiles and dendritic 
cells. In contrast, the IL-5 receptor seems to be expressed exclusively on eosinophils, 
basophils and murine B cells (Nicola, 1994 ). 
Model 1 suggests that subtle differences in the level of receptor expression could result 
in marked differences in activation of down-stream signalling components. As Rossi et 
al. ( 1996) have demonstrated, the lineage commitment of a hematopoietic precursor cell 
line can be controlled by the level of PKC activity. While the absence of PKC activity 
maintained cells in an undifferentiated state, low PKC activity induced differentiation 
• . 
towards a myelomonocytic phenotype; high PKC activity, in contrast, favored 
eosinophilic differentiation. In addition, the level of ligand concentration at a particular 
time appears to be able to determine the lineage to which a particular progenitor cell 
differentiates. It has been reported for example, that high IL-3 concentrations promote 
the self-renewal of a murine multipotential hematopoietic cell line, whereas low 
concentrations in combination with GM-CSF result in differentiation towards 
granulocytes, macrophages or erythroid cells (Heyworth et al., 1990). 
With ligands like IL-3/IL-5/GM-CSF sharing a receptor subunit thought to be the main 
signalling entity, the specific a receptor subunit may not be important solely for ligand 
recognition and high affinity binding, but might also be involved in ligand-specific 
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signalling and recruitment of specific intracellular adaptor molecules and signalling 
pathways. Experimental evidence is now accumulating that the a receptor subunits of 
the IL-3/IL-5/GM-CSP system may possibly play a role in signalling, despite only 
bearing a 50 amino acids long intracellular domain. Mire-Sluis et al. (1995) claim to 
have demonstrated that IL-5-induced proliferation in the cell line TP-1 is inhibited by 
the phosphatase inhibitor sodium orthovanadate with no effect on IL-3/GM-CSP 
induced proliferation. Similarly, although IL-3/GM-CSP induced proliferation is 
inhibited by the tyrosine kinase inhibitor genistein, IL-5-dependent proliferation seems 
to be unaffected. 
Previously, a GM-CSP receptor a subunit-associated protein (GRAP) was isolated 
using a yeast-2-hybrid system and co-immunoprecipitation studies in mammalian cells 
(Tu et al., 2000). GRAP appears to play an important role in cellular metabolism, and it 
was shown that GRAP does not interact with the IL-3Ra subunit, indicating specificity 
in the interaction of GRAP with the GM-CSPRa, though binding of IL-5Ra was not 
tested. Similarly, JAK2 has been shown to interact with the IL-5Ra Box 1 region, a 
proline-rich domain highly conserved between the IL-3/IL-5/GM-CSP receptor a 
subunits. Interaction with the IL-3 or GM-CSP receptor a subunit, however, has not 
been shown (Ogata et al., 1998). Most recently, a direct association of an adapter 
protein called syntenin with the IL-5Ra subunit was reported (Geijsen et al. , 2001). 
Sytenin was found to be associated exclusively with the cytoplasmic tail of IL-5Ra, and 
did not bind to the IL-3 or GM-CSP subunits. Syntenin directly associated with the 
transcription factor SOX4, whose IL-5-mediated activation followed the binding of 
Syntenin to the IL-5Ra. 
Despite the above studies, the signalling pathways currently defined for IL-5 do not 
account for its specific effect on the activation and differentiation of eosinophils, since 
all of these pathways are also activated by IL-3 and GM-CSP. It is therefore possible 
that the specific actions of IL-5 may either be due to mechanisms ensuring signal 
specificity as described above, or it may be due to the existence of other novel 
signalling pathways specific to IL-5. 
One feature of the IL-5 molecule consistent with the idea that additional signalling 
pathways may be responsible for the specific functions of IL-5 is the fact that both 
human and mouse IL-5 contain a putative nuclear targeting signal (NTS), resembling a 
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bipartite nuclear localization signal (NLS) (Jans, 1994; Jans et al. , 1997a). This suggests 
that IL-5 could be directly involved in signalling in an "instructive" manner. NLSs have 
been identified for a variety of polypeptide ligands, including cytokines and growth 
factors, implying that these ligands can be targeted to the nucleus where they may have 
an important role in signalling. The next sections will summarize the current state of 
knowledge for nuclear transport in eukaryotic cells and review the data currently 
available supporting the concept of nuclear localization of polypeptide hormones, 
growth factors and their receptor systems as an additional mechanisms to achieve 
signalling specificity. 
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1.2 General mechanisms of nuclear transport 
1.2.1 Nuclear-cytoplasmic processes in the eukaryotic cell 
The fact that eukaryotic cells possess a nucleus carries important implications for the 
flow of information between the genome of a cell and its cellular functions, meaning 
that its genetic information, the DNA, is separated from the site of protein synthesis, the 
cytoplasm. Separation is effected by a double membrane structure, the nuclear envelope 
(NE), and as a result, gene transcription and translation take place in different 
subcellular compartments, meaning that specific transport events between the two are 
necessary for the cell to function. mRN A must make its way from the nucleus to the 
cytoplasm in order to be translated into protein, whilst proteins needed in the nucleus, 
including the enzymes required for DNA replication, gene regulation, and transcription, 
have to be transported from their site of synthesis in the cytoplasm to the nucleus. All 
transport goes through the NE-localized nuclear pore complexes (NPC), which have a 
molecular sieve function (see 1.2.2). Molecules smaller than 40-45 kDa can diffuse 
freely between cytoplasm and nucleus, while larger molecules require specific targeting 
signals (NLS's - see Section 1.2.3) in order to enter the nucleus. This provides the cell 
with a means to regulate the process of protein transport to the nucleus and make it 
highly specific. In terms of signal transduction leading to phenotypic changes such as 
differentiation, proliferation, and transformation, the cytosolic signals transduced at the 
level of the membrane through receptor activation upon hormone, growth factor, or 
cytokine binding need to be converted into nuclear signals. Almost without exception, 
this involves protein translocation events from the cytoplasm to the nucleus (Jans and 
Hassan, 1998). 
1.2.2 The nuclear pore complex (NPC) 
Spatial connection between the nucleus and cytoplas1n is provided by a large protein 
assembly termed the NPC, embedded in the NE (Feldherr ·et al. , 1984; Rout et al., 
2000). The number of NPCs per cell appears to depend on the demand for nuclear 
transport, and accordingly varies greatly with cell size and synthetic and proliferative 
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activity. There are approximately 200 NPCs in a yeast cell (Rout and Blobel 1993), 
3000-5000 in a proliferating human cell, and 5 x 107 in a mature Xenopus oocyte 
(Cordes et al 1995). 
The NPC is a large structure, varying in size from 60 MDa in S. cerevisiae to 125 MDa 
in vertebrates, which contains multiple copies of 30 to 50 different proteins called 
nucleoporins (Nups) (Stoffler et al., 1999; Rout et al., 2000) in varying stoichiometries. 
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Fig. 1.6. Model of the nuclear pore complex. 
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The NPC consists of about 3 0 different proteins, forming a basic subunit 
that is repeated 16 times. Additional, filamentous structures are on both 
sides of the pore. On the nuclear side, these link together to form the 
nuclear basket (Blobel and Wozniak, 2001). 
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Although the overall sequence homology between yeast and vertebrate Nups is usually 
not greater than 3 0% identity (Ryan and Wente, 2000), NP Cs are highly conserved in 
both structure and function across eukaryotes implying their central role in the transport 
process (Davis, 1995; Fabre and Hurt, 1997). Nups are classically defined as being 
stably associated with the NPC, although mobile Nups have more recently been 
identified (Nakielny et al., 1999; Zolotukhin and Felber, 1999). 
The basic structural framework of the NPC consists of an 8-fold rotational symmetry 
whereby 8 interconnected spokes surround a central gated channel with attached 
cytoplasmic and nuclear filaments (Fig. 1.6) (Rout et al., 2000; Blobel and Wozniak, 
2001; Dworetzky and Feldherr, 1988; Feldherr et al., 1984; Richardson et al., 1988). 
The nucleoplasmic filaments conjoin to form a basket-like structure while cytoplasmic 
filaments spread into the cytoplasm. The NPC forms aqueous channels through which 
all passage into and out of the nucleus proceeds (Dworetzky and Feldherr, 1988; 
Feldherr et al., 1984). 
As already alluded to, the NPC has a pore-like function whereby molecules less than 40 
kDa are able to diffuse between the nucleus and cytoplasm, while proteins larger than 
40 kDa require an NLS for nuclear entry (Bonner, 1975; Breeuwer and Goldfarb, 1990; 
Jakel et al. , 1999; Paine et al., 1975). It is intriguing that even proteins or RNAs smaller 
than 20-30 kDa, such as histones (Breeuwer and Goldfarb 1990, Jakel et al., 1999) and 
tRNAs (Zasloff 1982) normally cross the NPC in an active and carrier-mediated 
fashion, presumably to ensure that transport occurs in a controlled manner (Gorlich and 
Kutay, 1999). 
1.2.3 Conventional NLS-dependent nuclear protein import 
NLSs are defined as sequences necessary and sufficient for nuclear targeting of their 
respective proteins. Although there is no strict consensus sequence, NLSs are typically 
small regions of basic amino acids (Dingwall and Laskey, 1991) arranged either in a 
single cluster (monopartite) as typified by that of the well-characterized Simian Virus 
(SV 40) large tumor antigen (T-ag) (Kalderon et al. , 1984a/b; -Lanford and Butel, 1984) 
(Table 1.3 A), or situated in two clusters separated by a 10-12 amino acid spacer 
(bipartite) resembling the NLS of the Xenopus laevis phosphoprotein nucleoplasmin 
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(Table 1.3 B) (Chelsky et al., 1989; Robbins et al., 1991). 
In contrast to other transport signals such as those for mitochondrial or ER localization, 
NLSs are not cleaved after transport, as they are required to function several times 
through a number of cell divisions, following the open mitosis of eukaryotic cells. In 
addition, as NLSs are not removed (Agutter and Prochnow, 1994; Nigg, 1997; Stochaj 
and Silver, 1992) nor confined to N- or C-terminal regions of the protein, the only 
restriction regarding the position of an NLS within the protein is that they are 
accessible. 
Two experimental approaches for identification of functional NLS regions are: 
1) Mutagenesis of residues of an NLS results in cytoplasmic localization of the 
NLS-containing protein, indicating that the NLS is necessary for nuclear import. 
2) Coupling of an NLS to a normally cytoplasmic protein either as a fusion protein 
or as a cross-linked peptide, targets the protein to the nucleus, indicating that the 
NLS is sufficient for nuclear import. 
3) 
Two experimental setups are commonly used to investigate the transport properties of 
NLS-bearing proteins; one using transfection, and the other utilizing labelled proteins. 
The transf ection approach does not provide information regarding the rates of nuclear 
protein import, and the high levels of protein that are generally expressed may not 
represent physiological conditions (Jans et al., 1995b ). A different approach uses 
fluorescently labelled proteins, which are microinjected into the cytoplasm of single 
living mammalian cells prior analysis of nuclear import by confocal laser scanning 
microscopy (CLSM). 
CLSM has been used quantitatively in combination with the microinjection of 
fluorescently labelled proteins to resolve the nuclear protein import process temporally. 
The establishment of in vitro or reconstituted nuclear import assays has greatly 
enhanced our knowledge of nuclear transport at the molecular level. These assays have 
been based on permeabilizing the cytoplasmic membrane of mammalian cells (Adam et 
al., 1990, 1992) utilizing digitonin, a detergent that selectively permeabilizes the 
cholesterol-rich plasma membrane without dramatically affecting the nuclear 
membrane. 
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Table 1.3 A. Selected examples ofNLS's resembling the monopartite NLS of T-ag. 
l 
Protein NLS1 References 
Viral Proteins 
T-ag PKKKRKVl32 Kalderon et al. (1984a, b ); 
Lanford and Butel (1984); 
Yoneda et al. (1987) 
Polyoma T-ag VSRKRPRP 196 Chelsky et al. (1989); 
Richardson et al. (1986) 
SV4O VP2/3 PNKKKRK 323 Clever and Kasamatsu (1991) 
Transcription factors 
Dorsal RRKRQR 340 Govind et al. (1996) 
V-J UTI KSRKRKL 253 Chida and Vogt (1992) 
NF-AT CNKRKYSLN 271 Beals et al., (1997) 
NF-kB p5O QRKRQK 372 Blank et al. (1991); 
Henkel et al. (1992) 
Nuclear Proteins 
Lamin LI VRTIKGKRKRIDV 420 Chelsky et al. (1989) 
LaminB2 RSSRGKRRRIE 419 Hennekes et al. (1993) 
yeast Histone 2B GKKRSKAK 36 Moreland et al. (1987) 
Other Proteins 
Basonuclin PKKKSRKSS 541 Iuchi and Green (1997) 
Cofilin PEEVKKRKKAV 36 Abe et al. (1993) 
NLSs are shown m the smgle letter ammo acid code with numbers refernng to the 
residue number in the protein sequence. NF-AT, Nuclear factor of activated T-cells; SV 40 T-ag, Simian 
virus 40 large tumor antigen; SV 40, VP2/3- simian virus 40 (SV 40) structural protein VP2/3; 
Table 1.3 B. Selected examples of NLSs resembling the bipartite NLS of nucleoplasmin. 
l 
Protein NLS1 References 
Nuclear Proteins 
Nucleoplasmin KR -9 aa spacer- KKKKL 171 Chelsky et al. (1989); 
Lanford et al. (1990); 
Robbins et al. (1991) 
Xenopus N038 KR -11 aa spacer- KKTR 153 Peculis and Gall (1992); 
Robbins et al. (1991) 
RB KR -11 aa spacer- KKLR 869 Efthymiadis et al . (1 997) 
hpoly(ADP-ribose) polymerase KRK -10 aa spacer- KKKSKK 226 Schreiber et al. (1 992) 
NlN2 RKKRK -1 2 aa spacer- KKSK 551 Kleinschmidt and Seiter (1988) 
Transcription factors 
human Estrogen receptor RK -11 aa spacer- RKDR 495 Picard et al. (1990); 
Ylikomi et al. (1 992) 
human ARNT RAIKRR-13 aa spacer- KFLR 61 Eguchi et al. ( 1997) 
SWI5 KK -10 aa spacer- RKRGRPRK 655 Jans et al. (1995a); 
Moll et al. (1991) 
NLSs are shown m the smgle letter ammo acid code with numbers refernng to the residue number m the 
protein sequence.RB, retinoblastoma; ARNT, aryl hydrocarbon receptor nuclear translocator; 
The same effect can be achieved by mechanical perforation of the plasma membrane 
(Jans et al. , 1991) to allow the tracking of fluorescent import substrates and the 
monitoring of their nuclear uptake by CLSM. Since the cells are depleted of their 
cytosolic components in this approach, the addition of exogenous cytosolic fractions or 
recombinant proteins provides a means of identifying essential, soluble transport 
factors. 
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NLS-dependent nuclear protein import proceeds by an ordered process dependent on 
numerous cytosolic factors including proteins of the NLS-recognizing importin 
superfamily and the monomeric GTPase Ran. Conventionally, the process can be 
divided into five main steps (Catimel et al., 2001; Gorlich and Mattaj, 1996; Nigg, 
1997; see Fig. 1.7): 
Cytoplasm Nucleus 
(i;\ 
~ 
Fig. 1. 7. Conventional NLS-mediated nuclear protein import. After release of 
the NLS binding site of Impa and subsequent ImpB-binding to the IBB domain 
of Impa, a protein containing an NLS is recognised by the Impa/B complex 
through Impa. ImpB mediates binding to the NPC and the complex is 
translocated into the nucleus. Once in the nucleus, Ran-GTP binding to ImpB 
causes dissociation of the transport complex and the cargo is released into the 
nucleoplasm (adapted from Catimel et al., 2001). 
1) Binding of importin B (Imp B) to an Imp B binding (IBB) domain of importin a 
(Imp a), which removes the auto inhibitory segment from the NLS-binding site. 
2) Recognition of the NLS by the Imp a/B heterodimer whereby Imp a binds the NLS 
directly. 
3) Docking of the Impa/B-NLS complex to the cytoplasmic face of the NPC through 
interaction of Imp B with Nups. 
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4) Translocation of the import substrate from the cytoplasmic side of the NPC to the 
nucleoplasmic side through a series of docking events to different Nups within the 
NPC. 
5) Dissociation of the import substrate and Imp a from Imp B through binding of the 
guanine nucleotide binding protein Ran in a GTP bound form (Ran-GTP) to Imp B-
Through an analogous translocation mechanism occurring in parallel to the above series 
of events, nuclear transport factor-2 (NTF2) transports Ran-GDP to the nucleus where it 
is converted to Ran-GTP by the nucleotide exchanger RCC 1, which is chromatin 
associated and hence concentrated in the nuclear compartment. 
NLS recognition is by Imp a (Adam and Adam, 1994; Adam and Gerace, 1991; Radu et 
al., 1995a), which comprises an NLS-binding domain consisting of ten Armadillo 
repeats (Conti et al., 1998; Fontes et al., 2000; Kobe, 1999), and an Imp B-binding 
(IBB) domain at the amino terminus (Gorlich et al., 1996a; Weis et al., 1996). High 
affinity binding, to the order of 2-40 nM, of Imp a/B to NLS regions has been shown in 
vitro (Catimel et al., 2001; Fanara et al., 2000; Hu and Jans, 1999). In higher eukaryotes 
such as humans and mouse, there are multiple isoforms of Imp a ( 6 in humans) that 
appear to have distinct binding specificities for different NLS-containing substrates 
(Sekimoto et al., 1997; Jans et al., 2000b). 
Docking of the importin-transport complex at the NE is mediated by interactions of Imp 
~ with members of a family of soluble Nups associated with the NPC. These mobile 
Nups contain tandem sequence repeats (FxFG and GLFG) that are based on cores 
containing Phe and .Gly (Rout et al. , 2000; Wente and Blobel, 1994) that are separated 
by variable lengths of hydrophilic residues (Buss et al., 1994; Katahira et al., 1999; 
Kehlenbach et al. , 1999; Radu et al., 1995b ). Nup-specific antibodies have been shown 
to inhibit nuclear transport (Clever and Kasamatsu, 1991; Featherstone et al., 1988; 
Powers et al., 1997), as does the lectin wheat germ agglutin (WGA), which inhibits 
transport through its ability to bind O-linked glycosidic N-acetyl-glucosamine moieties 
on FxFG Nups (Dabauvalle et al. , 1988; Hanover eta/., 1987). The essential role of 
these proteins in nuclear trafficking has also been shown by the fact that depletion of 
WGA-binding Nups inhibits transport, whilst re-addition of the WGA-binding protein 
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fraction restores transport activity (Finlay and Forbes, 1990). 
Detailed interactions between Imp B and Nups have been shown in vitro (Chi and 
Adam, 1997; Radu et al., 1995ab; Rexach and Blobel, 1995; Shah and Forbes, 1998) 
and in vivo (Damelin and Silver, 2000). It is likely that the initial docking step 
represents an interaction between nup358, a component of the cytoplasmic fibrils, and 
Imp B (Y aseen and Blobel, 1999ab; Yokoyama et al., 1995). In contrast, interactions at 
the nuclear basket might represent the last step of import or the first step of export. 
Nup 153 and Tpr are two components of the nuclear basket ring and intranuclear fibers, 
respectively. Whilst the Imp a/B/cargo complex seems to bind Nup153, binding of Imp 
B 1 to Tpr apparently occurs only in the absence of cargo (Shah et al., 1998; 
Balasundaram et al., 1999). For the Imp a/B complex, these interactions may reflect the 
terminal step of protein import and the first steps of Imp recycling. Once the nuclear 
transport complex has been transported to the nuclear site, the Imp a/B/cargo complex 
is dissociated through binding of Ran-GTP by Imp B- Ran-GTP binding induces a 
conformational change in Imp B, causing the release of Imp a and the protein cargo. 
Subsequently, Imp B in complex with Ran-GTP is recycled back into the cytoplasm 
(Gorlich and Kutay, 1999), whereas free Imp a requires the Imp B homologue (see 
Section 1.2.4) CAS for its export into the cytoplasm to be available for a new cycle of 
nuclear import (Kutay, 1997). 
1.2.4 Importin ~ homologue-mediated nuclear protein import 
While conventional nuclear protein import can be dissected into the above series of 
cellular events, import pathways have· been identified that do not require Imp a for NLS 
recognition, with Imp B (Imp Bl) or one of the many Imp B homologues (14 in yeast) 
mediating NLS recognition directly as well as mediating NPC/Nup docking and 
interaction with RanGTP as per its role in importin a/B-mediated nuclear import as 
illustrated in Fig. 1.7. The human immunodeficiency virus (HIV) protein Rev, human T-
cell leukemia virus (HTL V-1) protein Rex, and the parathyroid hormone-related protein 
(PTHrP) all appear to be recognized by ImpB itself, independently of Impa (Truant and 
Culleri, 1999; Palmeri and Malim, 1999; Lam et al., 1999). Many transcriptions factors 
such as AP-1, CREB, Fos and Jun, SRY and TRFl, which are constitutively localized in 
the nucleus, are transported into the nucleus in a similar, Impa independent fashion 
- --~ 
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(Forwood, 2001).) The shuttling heterogenous nuclear ribonucleoprotein (hnRNP) Al 
protein possesses a 3 8-amino acid stretch, called the M9 region, which mediates nuclear 
import as well as nuclear export (Michael et al. 1995; Siomi and Dreyfuss 1995). 
Nuclear import of hnRNP Al occurs via the M9 receptor transportin (Pollard et al. 
1996; Siomi et al. 1997). In mammalian cells nuclear import of ribosomal proteins is 
mediated by the importin B-like proteins RanBP5, RanBP7, transportin, and the 
importin B subunit itself (Jakel and Gorlich 1998). 
1.2.5 Importin/Ran-independent nuclear import 
In addition to conventional importin/Ran mediated, NLS-dependent protein import, 
alternative pathways into the nucleus have been described (Efthymiadis et al., 1998; 
Fagotto et al., 1999; Michael et al., 1997; Schmalz et al., 1998; Sweitzer and Hanover, 
1996). The HIV-1 Tat transactivator protein, for example, is not recognized by either 
importin a or B , but its NLS (GRKKRRQRRRAP59; Siomi et al., 1990) is sufficient 
to target the 476 kDa heterologous protein B-galactosidase into the nucleus in ATP-
dependent but cytosolic factor-independent fashion (Efthymiadis et al., 1998). Binding 
to components within the nucleus is mediated by the NLS. Another protein able to 
localise in the nucleus in the absence of importins is the multifunctional signalling 
protein B-catenin, a member of the Armadillo protein family, which itself is able to dock 
at the NPC (Fagotto et al., 1999). In this case, B-catenin is able to bind to nucleoporins 
of the NPC directly. Like the Tat NLS, K-NLS (YDRRGRPGCRYDGMVGFSADET 
WDSAIDTWSPSEWQMA Y361 ) of the mRNA binding hnRNP K shuttling protein is 
not recognized by importins, and is able to mediate nuclear import in cytosolic factor-
independent, but ATP-dependent fashion (Michael et al., 1997). The NLS of the 
interferon-induced transcription factor IFI 16 (QKRKKSTKEKAGPKGSKVSRDW145) 
also mediates nuclear import in ATP-dependent, cytosolic factor-independent manner 
(Briggs et al., 2001). The IFI 16 NLS is not recognized by importin a/B with high 
affinity and, like the Tat NLS, the IFI 16 NLS mediates binding to nuclear components, 
although, unlike Tat, this is modulated by protein kinase CK2. The 96 amino acid 
human immunodeficiency virus (HIV) protein V pr does not have clearly identifiable 
modular NLSs (Jenkins et al., 1998; Jans et al., 2000); its nuclear import does not 
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require Ran-mediated GTP hydrolysis or ATP (Jenkins et al., 1998). Jans et al. (2000) 
showed that intranuclear binding of Vpr depends on the presence of cytosolic factors, 
but conventional nuclear transport proteins such as importin a/ B and Ran are not 
responsible. 
Schmalz et al. (1998) have shown that nuclear import of PKCa is independent of 
importin B as well as GTP. Since nuclear import cannot be inhibited by WGA, it 
appears to occur by a mechanism distinct from the one used by conventional NLS-
containing proteins. (Beckmann et al., 1994; Schmalz et al., 1998). 20S proteasomes 
have no known NLS and are imported into the nucleus in an importin a/~-independent 
manner (Mayr et al., 1999). Recently, a novel nuclear transport pathway for the 
spliceosomal proteins UlA and U2B has been described, which is ATP-dependent but 
requires neither cytosolic factors nor Ran (Hetzer and Mattaj, 2000). 
Thus, it is clear that importin/Ran independent pathways exist for nuclear transport. The 
cellular factors responsible for mediating nuclear import in these cases remain 
uncharacterised, although the NLS sequences appear to have been defined. 
--- - --
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1.3 Nuclear Import of growth factors, cytokines and their receptor 
systems 
1.3.1 Introduction 
Over the past 3 decades many different laboratories have demonstrated that polypeptide 
hormones and growth factors can associate with the nuclei of target cells, implicating 
the existence of an alternative transport pathway, to deliver endocytosed polypeptide to 
the nucleus instead of to lysosomes and degradation. In the following sections, the 
current state of knowledge about nuclear transport of polypeptide growth factors, 
hormones and their receptors is summarized. 
1.3.2 Discovery 
The first report of an exogenous polypeptide hormone being localized intracellularly 
was published by Stein and Gross (1959), who found that 125I-labelled insulin localized 
in the cell interior after injection into rats. For the first time it was shown that 
intracellular translocation of an endogenously added growth factor can take place under 
physiological conditions, suggesting a direct involvement of polypeptide hormones at 
intracellular level in the regulation of cellular functions. In 1971, Angiotensin II was 
noted to be localized in the nuclear zone of vascular and cardiac muscle cells after being 
injected in the left ventricle of adult rats (Robertson and Khairallah, 1971 ). Other early 
examples of growth factors being localized in the nucleus of cell lines were Lactoferrin 
(Green et al., 1971) and Nerve Growth Factor (NGF) (Andres et al., 1977). 
1.3.3 Nuclear import of growth factors/receptors 
Nuclear association of polypeptide growth factors (GFs) and cytokines has been 
observed for a broad variety of target cells (Table 1.5). Although the idea of nuclear 
GFs is more or less accepted, the exact pathways involved in nuclear localization are far 
from fully understood and their functional significance is still generally debated. This 
section will summarize the experimental evidence for some of the growth factors and 
their receptors for which nuclear targeting has been described. Nuclear transport is 
juxtaposed with the role of the respective ligands in the better-accepted, conventional 
signalling pathways. 
T a b l e  1 . 5 .  N u c l e a r  a c c u m u l a t i o n  o f  p o l y p e p t i d e  l i g a n d s  a n d  t h e i r  r e c e p t o r s  s u b s e q u e n t  t o  r e c e p t o r - m e d i a t e d  e n d o c y t o s i s  
P o l y p e p t i d e  
l i g a n d  
A m p h i r e g u l i n  
A n g i o g e n i n  
A n g i o t e n s i n  I I  
C N T F  
C T G F  
E G F  
F G F - 1  
N u c l e a r  a c c u m u l a t i o n  
o f  
l i g a n d  a f t e r  
e n d o c y t o s i s  
O v a r i a n  e p i t h e l i a l  
c a r c i n o m a  c e l l s  
P u l m o n a r y  a r t e r y  
e n d o t h e l i a l  c e l l s  
S m o o t h  a n d  c a r d i a c  
m u s c l e  
r a t  l i v e r  
r a t  c o r t i c a l  t y p e  I  
a s t r o c y t e s ,  
g l i o m a  C 6  c e l l s ,  
t r a n s f e c t e d  C O S - 7  c e l l s ,  
X e n o p u s  o o c y t e s  
H u m a n  m e s a n g i a l  c e l l s  
P i t u i t a r y ,  c o l o n  
c a r c i n o m a ,  v a s c u l a r  
e n d o t h e l i a l  c e l l s ,  
r e g e n e r a t i n g  l i v e r ,  
h e p a t o c y t e s  
F i b r o b l a s t s ,  v a s c u l a r  
e n d o t h e l i a l  
c e l l s  
N u c l e a r  b i n d i n g  s i t e s  
f o r  l i g a n d  
N u c l e o l i  
C h r o m a t i n  ( l i v e r ,  
t h y m u s )  
C h r o m a t i n  (  c o l o n i c  
c a r c i n o m a )  
N u c l e a r  a c c u m u l a t i o n  o f  
r e c e p t o r  a f t e r  e n d o c y t o s i s  
B r a i n  n e u r o n s  
C o l o n i c  c a r c i n o m a ,  p i t u i t a r y  c e l l s ,  l i v e r ,  
c o r n e a l  e n d o t h e l i a l  a n d  
g r a n u l o s a  c e l l s  
K i d n e y ,  f i b r o b l a s t s ,  p r e g n a n t  r a t  
u t e r u s ,  h e p a t o m a ,  a d r e n a l  m e d u l - l a r y  
c e l l s ,  m y o b l a s t s ,  a s t r o c y t e s  ( F G F - R l a )  
R e f e r e n c e s  
J o h n s o n  e t  a l .  ( 1 9 9 1 )  
L y s i a k  e t  a l .  ( 1 9 9 5 )  
M o r o i a n u  a n d  R i o r d a n  ( 1 9 9 4 b )  
R o b e r t s o n  a n d  K h a i r a l l a h  ( 1 9 7 1  ) ;  
T a n g  e t  a l .  ( 1 9 9 2 ) ;  
J i m e n e z  e t  a l .  ( 1 9 9 4 ) ;  
L u  e t  a l  ( 1 9 9 8 a ,  b  ) ;  
C h e n  e t  a l .  ( 2 0 0 0 ) ;  
P e n g  e t  a l .  ( 2 0 0 1 )  
B a j e t t o  e t  a l .  ( 1 9 9 9 ,  2 0 0 0 )  
W a h a b  ( 2 0 0 1 )  
R a p e r  e t  a l .  ( 1 9 8 7 ) ;  
R a k o w i c z - S z u l c z y n s k a  e t  a l .  ( 1 9 8 9 ) ;  
J i a n g  a n d  S c h i n d l e r  ( 1 9 9 0 ) ;  
S  i b o n  e t  a l .  ( 1 9 9 4 )  
L i n  e t  a l .  ( 2 0 0 1 )  
C a o  e t  a l .  ( 1 9 9 3 )  
W i e d l o c h a  e t  a l .  ( 1 9 9 4 ,  1 9 9 5 ,  1 9 9 6 )  
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Polypeptide 
ligand 
GH 
HDGF 
IFN-B 
IFN-y 
IL-1-a 
IL-1-B 
IL-2 
Insulin 
LEDGF 
PDGF 
PTHrP 
Nuclear accumulation 
of 
ligand after 
endocytosis 
Liver, cardiovascular 
tissues, transfected 
CHO cells 
Vascular smooth 
muscle cells 
Fibroblasts 
Fibroblasts 
Brown adipose tissue, 
fibroblasts 
T cells, brown adipose 
tissue 
Melanoma cells, 
lymphocytes 
Lymphocytes, 
adipocytes, fibroblasts, 
hepatoma cells 
Mouse lens epithelial 
cells 
SSV-transformed 
fibroblasts 
Cultured tumor cells, 
vascular smooth muscle 
cells 
Nuclear binding sites 
for ligand 
Nucleoplasm, and inner 
and outer 
nuclear membranes, as 
well as chromatin 
(transfected CHO cells) 
Nucleus (fibroblasts) 
Nuclear membrane 
(fibroblasts) 
Nuclear membrane 
(liver, thyroid) 
Heterochromatin/nuclear 
membrane 
Nuclear accumulation of 
receptor after endocytosis 
Adenohypophyseal cells, kidney, 
respiratory tissue, transfected CHO 
cells, cardiovascular tissues (GHR 
andGHBP) 
Fibroblasts 
Fibroblasts 
Brown adipose tissue 
T cells, brown adipose tissue 
Hepatocytes 
Antral follicles and oocytes, hepatocytes, 
granulosa cells 
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The EGF receptor and its ligands EGF and SDGF 
Epidermal growth factor (EGF) is a potent mitogen for epidermal cells in vivo and for a 
wide variety of cells in culture (Johnson et al., 1980). EGF is a 5 kDa MW polypeptide 
produced by the submaxillary glands of the mouse. The prevailing mechanism by which 
EGF exerts its proliferative action is thought to be through the activation of mitogenic 
pathways such as the Ras/MAPK cascade. The EGF receptor, together with receptors 
for NGF, PDGF, FGF or insulin, belongs to the receptor tyrosine kinase family (RTK), 
whose members dimerize after ligand binding and undergo activation by 
autophosphorylation at multiple tyrosine residues in their cytoplasmic tails. The 
phosphory lated residues become docking sites for cytosolic and membrane-associated 
effector proteins containing SH2 domains, followed by the formation of second 
messengers and activation of the Ras/MAPK, PLC and PI3-K pathways (Boonstra et al., 
1995). However, it has long been known that several functions of the EGF/R system 
require mechanisms besides those activating early transient responses (Defize et al., 
1986; Wakshull et al., 1985). 
EGF as well as its receptor have been observed in the nucleus of a whole range of cell 
lines, human placenta, regenerating liver, human thyroid and many different cancer 
types (Johnson et al., 1980; Savion et al., 1981; Burwen et al., 1984; Rakowicz-
Szulczynska et al., 1986b; Green et al., 1987; Raper et al., 1987; Marti et al., 2001). 
The first demonstrations of the accumulation of EGF within cell nuclei were performed 
using cell fractionation as well as autoradiography, but seemed to require the use of the 
chemical chloroquine to inhibit lysosomal degradation of endocytosed EGF in cultured 
cells. In regenerating rat livers however, nuclear localization appeared to be 
physiological (Johnson et al., 1980; Savion et al., 1981 ). In normal rat livers, EGF was 
primarily transported to lysosomes and underwent degradation, while in regenerating 
liver cells, a significant part of intact EGF was transported into the hepatocyte nuclei 
instead (Raper et al., 1987). A small percentage of the nuclear EGF was found to be 
transported to the nucleus together with the EGF receptor (Rakowicz-Szulczynska et al., 
1989). Nuclear transport of EGF receptor can be detected as early as 1 min after EGF 
incubation of different cell lines under physiological conditions, with a peak detected 
between 15 to 30 min (Lin et al., 2001 ). 
A common feature in the results of different experimental procedures identifying the 
nuclear EGF and its receptor was the strong correlation between nuclear localization 
and the highly proliferative status of tissues. A recent report provides the first evidence 
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that the EGF receptor might have a potential role as a transcription factor, suggesting 
that activated (i.e. phosphorylated) receptor molecules themselves can enhance gene 
expression by binding to regulatory domains of genes required for mitogenic effects, 
such as genes involved in the regulation of the cell cycle (Lin et al., 2001). It was shown 
that the EGF receptor bound and activated AT-rich consensus-sequence-dependent 
transcription, including the consensus site of the Cyclin D 1 promoter region. It was 
further demonstrated that nuclear EGF receptor was associated with the promoter region 
of Cyclin D 1 in vivo. This observation is supported by previous reports that the EGF 
receptor can bind to chromatin after nuclear localization in target cells (Rakowicz-
Szulczynska et al., 1989). Of related interest is the observation that Schwannoma-
derived growth factor (SDGF), also a ligand for the EGF receptor, requires nuclear 
localization to induce a mitogenic response in target cells (Kimura et al., 1993). 
Additionally, it can bind to AT-rich DNA sequences that match the AT-rich minimal 
consensus sequences recognized by the EGF receptor. At present, it is not known how 
EGF or the EGF receptor are able to escape from the lysosomal degradation pathway. 
The mechanisms by which they are translocated to the nucleus also remain uncertain. 
Fibroblast growth factor family (FGFs) 
Fibroblast growth factors (FGFs) are pleiotropic growth factors that control cell 
proliferation, migration and differentiation. Many of the actions of FGFs have been 
demonstrated to be mediated through activation of high affinity cell surface receptors 
with intrinsic tyrosine kinase activity, ultimately activating different pathways, such as 
MAP kinase and ERK signalling cascades (Boilly et al., 2000). 
The prototypical ligand is basic FGF (FGF-2), a multifunctional cytokine involved in 
the proliferation and differentiation of a broad variety of mesodermal and neuro-
ectodermal cell types (Bikfalvi et al., 1997). Five different isoforms have been 
characterized, representing alternative translation products from a single mRNA (for 
review see Delrieu, 2000). The non-secreted, nuclearly targeted high molecular weight 
isoforms of FGF-2 (21.5, 22, 24, 34 kDa) have an intracrine mode of action, probably 
interacting with intracellular partners in the cytoplasm and/or the nucleus, and regulate 
the expression of specific target genes (Nakanishi et al., 1992; Delrieu et al. , 1998). In 
contrast, the 18 kDa isoform, despite the lack of a classical signal peptide, is exported 
out of the cell through an endoplasmic reticulum/Golgi apparatus independent 
exocytosis pathway (Florkiewicz and Sommer, 1989). When secreted at the cell surface, 
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the 18 kDa FGF-2 can bind to heparan sulfate proteoglycan (HSPG) low affinity 
receptors and the high affinity receptor FGFR to act in an autocrine or paracrine manner 
(Florkiewicz et al., 1998; Filla et al., 1998). Following internalization, nuclear transport 
of 18 kDa FGF-2 has been observed in various cell types (Bouche et al., 1987; Baldin et 
al., 1990; Zhan et al. 1992; Hawker and Granger, 1994). In coronary venular endothelial 
cells, up to 50% of total internalized FGF-2 is rapidly targeted to the nucleus, 
suggesting that some biological activities of the growth factor may be mediated by 
nuclear FGF-2, subsequent to its binding to the cell surface receptors (Hawker and 
Granger, 1994). The nucleolar localization of 18 kDa FGF-2 is indeed correlated with 
the stimulation of ribosomal gene transcription, whose activation is mediated via the 
direct interaction of nuclear FGF-2 with the regulatory subunit of the protein kinase 
CK.2 (Bonnet et al., 1996). It is important to note that the 18 kDa FGF-2 isoform does 
not possess the NLS present in the NH2-terminal extension of the high molecular 
weight FGF-2 forms (Quarto et al., 1991, and see below). 
To date, five genes are known to encode for FGF receptors, with multiple variants due 
to alternative splicing (Powers et al., 2000). One of the receptors, FGF-1, has been 
demonstrated to translocate to the nucleus of several cell types after stimulation with 
FGF-2 (Maher et al., 1996; Stachowiak et al., 1996ab ). When the subcellular location of 
FGF-2 and its high affinity receptor FGFR-1 in the nervous system were investigated, it 
was shown that following the transition of cells to a subconfluent proliferating state, 
FGFR-1 translocated in parallel with FGF-2 to the nucleus, where both accumulated and 
acted to stimulate transition from the G0/G 1 to the S phase of the cell cycle (Stachowiak 
et al. , 1997ab). 
Prolactin and Growth hormone 
Prolactin (PRL) and growth hormone (GH) are members of the somatolactogenic 
hormone family, the pleiotropic actions of which mediate vertebrate growth and 
mammary differentiation. The main functions of PRL and GH are thought to be 
mediated through binding to their respective receptors. The receptors of both are 
members of the same cytokine receptor type I family as that for IL-3/IL-5/GM-CSF 
( Goffin and Kelly, 1996). A characteristic of this receptor faII).ily is the lack of intrinsic 
tyrosine kinase activity (see Section 1.1.6). Instead, these receptors possess short 
homologous, proline-rich motifs involved in the direct binding of JAK protein kinases 
(Ihle et al., 1997; Leonard and Lin, 2000). 
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None of the known signalling events triggered by PRL or GH are uniquely associated 
with any of the receptors. Indeed, the signalling mechanisms leading to specific function 
of PRL and GH have remained uncertain (Rycyzyn et al. 2000). It has been known for a 
number of years that the activation of PRL receptor-associated signalling pathways is 
linked to PRL internalization (Clevenger et al., 1990a). PRL is internalized via an 
endosomal-like pathway, and transported across the ER and NE in an active process 
requiring co-stimulation by additional ligands, such as IL-2 in lymphocytes and EGF in 
breast epithelium (Clevenger et al., 1990b ). Nuclear translocation of PRL is of 
functional consequence, as nuclear PRL provides a necessary co-mitogenic stimulus for 
IL2- driven growth (Clevenger et al., 1991). In addition, prolactin receptors have been 
detected in association with the NE (Clevenger et al., 1990a). It has been proposed that 
PKC is required for nuclear targeting of PRL (Rao et al., 1995). Recently, interaction of 
PRL with the peptidyl prolyl isomerase cyclophilin B (CypB) was revealed in vitro and 
in vivo. Experimental data indicated that CypB could serve as a chaperone, possibly 
mediating the retrotransport of PRL by CypB association with the ER sec61 transporter 
apparatus, and allowing nuclear transport of the PRL/CypB complex due to a putative 
N-terminal NLS in CypB (Rycyzyn et al., 2000). 
Early immunohistochemical studies have established that GH, GH receptor as well as 
the soluble GH receptor-binding protein (GHBP) are associated with the nucleus of a 
variety of target cells (Lobie et al. , 1990, 1994b). Approximately 20% of GH added to 
G H receptor expressing cells were found to be translocated to the nucleus (Lo b_ie et al. , 
1994a). It has been shown that rapid nuclear localization of GH receptor is critically 
dependent on serum starvation. Additionally, using a yeast two hybrid assay, a SYT 
(putative proto-oncogene involved in the transformed phenotype of synovial sarcomas) 
interacting protein (SIP), which possesses a putative NLS, was identified as potential 
GH receptor interacting protein, which may mediate nuclear localization of the GH 
receptor (Waters et al. , 2001). The physiological role of nuclear localized GH receptor 
and ligand is not yet understood, but the above-mentioned results indicate that nuclear 
localization of the GH receptor may be important in modulating cell sensitivity to the 
proliferative action of GH. 
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1.3.4 Nuclear localization sequences in polypeptide hormones and 
growth factors 
The exact means by which polypeptide ligands, growth factor and their respective 
receptors are translocated to the nucleus after internalization are not well understood. 
What is striking though is the existence of regions containing basic amino acid residues 
resembling NLSs in many of the nuclear localized ligands (Table 1.6). 
Evidence for an important role of NLSs in signalling arises from the fact that multiple 
forms of the same ligand, produced by alternative splicing or through the use of 
multiple in-frame start codons, can exhibit different physiological effects. For example, 
the NLS-containing forms of FGF-2 and PDGF-A are more potent in mitogenic 
signalling than their NLS-lacking counterparts (Maher et al. 1989; Quarto et al., 1991; 
Rifkin et al., 1994). A good example of the importance of an NLS for full functionality 
is that within FGF-1. Induction of mi to genesis by FGF-1 a and FGF-1 ~ appears to be 
directly dependent on nuclear localization (Imamura et al., 1990). Deletion of the N-
terminal NLS abolished stimulation of proliferation without interfering with other 
functions, whilst full mitogenic activity could be restored by the inclusion of the histone 
H2B NLS, demonstrating that nuclear targeting is integral to the biological function of 
FGF-1 (Imamura et al., 1990). 
Basic regions, resembling NLSs, have also been noted in IL-5 (Fig.1.8). In particular, 
these regions carry the feature of a bipartite NLS (see Section 1.2.4) with two of the 
three basic segments, separated by a spacer of 12 amino acid residues (Jans et al., 
1997a; see Section 1.4). Mutational analysis of this NLS and its role in IL-5 function is 
in part the subject of Chapter 3. 
39 
Table 1.6 Overview of polypeptide ligands and growth factors containing putative 
or confirmed NLSs. 
Protein Species Putative NLS Reference 
Amphiregulin human KPKRKKKggkngknRRNKKK.43 Johnson et al. (1991) 
Modrell et al. (1992) 
Angiogenin human RRRGL3sa Moroianu and Riordan (1994ab ); 
Lixin et al. (2001) 
CTGF human PFPRRVK.155 Wahab et al. (2001) 
FGF-1 (aFGF) human RQKRQAR-10 a.a. spacer- Shiurba et al. (1991) 
KRRSSPSKDGR38 Cao et al. (1993) 
RKRPVRRR6s 
FGF-3 mouse RLRRdaggrggvyehlggapPRRRK.76147 b Kiefer et al. (1994) 
Kiefer and Dickson (1995) 
Antoine et al. ( 1997) 
IFN-y human NSNKKKR92 Bader and Weitzerbin (1994) 
KTGKRKRS 135 Subramaniam et al. (1999) 
IL-1 a human KVLKKRRL86 Grenfell et al. (1989) 
Wessendorf et al. (1993) 
IL-1 ~ human PKKKMEKRF99 Grenfell et al. (1991) 
LEDGF human RRGRKRK.1s2 Fatma et al. (2000) 
NOVH human KKGKKCLRTKKS Perbal (1999) 
PDGFA human PRESGKKRKRK.R207 Collins et al. (1987) 
PDGFB human RVTIRTVRVRRPPKGKHRK.2231255 Lee et al. (1987) 
Proenkephalin human KRYGGFMRGLKR194 Bottger and Spruce (1995) 
Prothymosin a human TKKQKT107C Palvimo and Linnala-Kankkunen 
(1990); Manrow et al. (1991) 
Rubtsov et al. (1997) 
Shakulov et al. (2000) 
PTHrP human KTPKKKK93 d Henderson et al. (1995) 
Lam et al. (1999; 2001) 
SDGF human KRKKK119 10 a.a. spacer RKKKK.134 Kimura (1993) 
CTGF, connective tissue growth factor; EGF, epidermal growth factor; FGF, fibroblast growth factor; 
IFN, interferon; LEDGF, lens epithelium-derived growth factor; PDGF, platelet derived growth factor; 
PTHrP, parathyroid hormone-related protein; SDGF, schwannoma-derived growth factor. 
a not recognized by Imp a or ~ ; b Imp a/~ recognized; c NLS is recognized by yeast Imp a (Srp 1 p ), but 
Imp a recognition is not sufficient for nuclear targeting; d Imp ~ mediated. 
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It has been proposed that ligands localized in the nucleus by NLS-dependent pathways 
may influence transcription 
1) through binding to chromatin or DNA; 
2) by activating nuclear kinases or other nuclear enzymes; 
3) through association with transcription factors; or 
4) by co-targeting their receptor subunits to the nucleus. 
FGF-2 has been demonstrated to bind histone HI with high affinity (Bouche et al., 
1987), and may be involved in activating rDNA transcription through binding to 
specific sequences in the non-transcribed spacer of ribosomal genes (Amalric et al., 
1994). FGF-2 has also been shown to interact with the protein kinase CK.2, and can 
directly modulate CK2 activity toward nucleolin, a primary CK2 substrate in vitro 
(Bonnet et al., 1996), so that it has been postulated that FGF-2 may target CK.2 to the 
nucleolus to modulate rDNA transcription. 
Ligands such as insulin and PDGF can associate with chromatin, implying that these 
ligands could modulate chromatin structure and thus gene expression (Jans, 1994). 
An additional function of NLS-dependent nuclear targeting of polypeptide ligands may 
be to co-target their associated receptors to the nucleus (Jans, 1994; Jans and Hassan, 
1997). Once in the nucleus, the ligand-receptor-complex or the receptor on its own 
could influence transcription in similar fashion to the proposed action of ligands (see 
above). For example, the NLS-containing forms of FGF-1 and FGF-2 co-target the 
FGF-1 receptor, a tyrosine kinase, to the nucleus in a functional active form, where it 
may activate nuclear transcription factors by phosphorylation (Maher, 1996; Prudovsky 
et al. , 1994; Stachowiak et al., 1996a). As mentioned earlier, it was shown recently that 
the EGF receptor can bind and activate AT-rich consensus-sequence-dependent 
transcription, including the consensus site of the Cyclin DI promoter region (Lin et al. , 
2001 ). Additionally, the GH receptor was shown to activate JAK.2 and PLC leading to 
transcriptional activation of the TF c/EBP (Waters et al. , 1994), whilst the GH-GHBP 
complex appears to activate PKC (Lobie 1991 ). 
The exact mechanisms of how nuclear transport of polypeptide ligands takes place are 
mostly unknown. For a number of polypeptide ligands, recognition by importins (see 
Section 1.2.3) has been reported (see footnote to Table 1.6), implying that these may be 
imported into the nucleus by conventional nuclear import pathways. 
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1.4 Nuclear Import by IL-5 
The elucidation of the main pathways of IL-5 signalling have thus far not led to an 
explanation of its specific role in the differentiation of eosinophils, since IL-3 and GM-
CSF activate the same signalling cascades revealed so far (see Section 1.1.9). 
Specificity may therefore either lie with the IL-5 receptor a subunit or in the IL-5 ligand 
itself. In fact, basic regions, resembling NLSs, have been noted in both human and 
mouse IL-5 (Fig. 1.8). 
----- - --
N A B 
human IL-5 
mouse IL-5 
-C 
NLSl NLS2 
KKYI DGQKKKCGEERRR111 
KKYI DRQKEKCGEERRR110 
SWI 5 KKYENVVIKRS PRKRGRPRK655 
Nl /N2 RKKRKTEEESPLKDKDAKKSK554 
Nucleoplasmin KRPAATKKAGQAKKKLDK174 
Consensus KK -10-12 aa-
RR 
KKK 
RRR 
Fig. 1.8. The NLSs of human and mouse IL-5 compared to the bipartite 
NLSs of SWIS, Nl/N2 and nucleoplasmin. 
Amino acids are are shown in the single-letter code. The proximal and distal 
arm of the bipartite NLSs are in red. The sequence underlined represents the 
putative novel NLS of IL-5 , with basic residues indicated in bold (for 
references, see Table 1.3B). aa, amino acid 
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In particular, these regions carry the feature of a bipartite NLS (see Section 1.2.4) with 
two of the three basic segments, separated by a spacer of 12 amino acid residues. Of the 
three ligands IL-3/IL-5 and GM-CSF, only IL-5 exhibits this feature. 
The nuclear targeting capacity of fluorescently labelled human IL-5 has been visualized 
in intact, hIL-5-receptor-expressing FDCPl mouse myeloid progenitor cells, using in 
vivo and in vitro nuclear transport assays (Jans et al., 1997a). The hypothesis that two 
basic regions at the carboxy-terminus, called NLS 1 and NLS2 (see Fig. 1.8), may be 
responsible for this nuclear targeting activity was tested using IL-5 NLS-containing B-
galactosidase fusion proteins. The IL-5 NLS was demonstrated to target B-galactosidase 
to the nucleus in both microinjected cells and in vitro with mutation of the proximal arm 
of the bipartite NLS abolishing NLS function (Jans et al., 1997a). 
As mentioned in Section 1.3, several polypeptide ligands have been observed to co-
translocate their surface receptors to the nucleus. Using an in vitro nuclear transport 
assay for hIL-5 and soluble IL-5 receptor subunits, hIL-5 was shown to target both a-
and B- receptor subunits to the nucleus (Jans et al., 1997b ), whereby the non-ligand 
binding B receptor subunit could only accumulate in the nucleus when both IL-5 and the 
a receptor subunit were present. This suggested that the IL-5 NLS might be specifically 
required to enable the nuclear entry of the a and B receptor chains. The importance of 
the NLS 1 and NLS2 clusters in piggy-backing of the IL-5 receptor subunits was tested 
by mutating either arm of the putative bipartite NLS, whereby mutation of the proximal 
arm abrogated IL-S's ability to co-target the receptor subunits to the nucleus (Calanni, 
1997). Unexpectedly, mutations in the distal arm (NSL2) had no influence on the 
nuclear targeting of the receptor subunits, indicating that the NLS of IL-5 was not a 
classical bipartite NLS (Calanni, 1997). 
1.5 Aims and scope of the research project 
The above review of IL-5 signal transduction indicates that there are large gaps in our 
knowledge regarding the molecular basis of the specificity of signaling distinct to that 
mediated byIL-3 and GM-CSF. IL-5 clearly plays an important role in the pathogenesis 
of allergic diseases such as asthma. so that it is of considerable interest to identify the 
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signalling mechanisms specific to IL-5. The findings indicating nuclear translocation of 
receptor-internalized IL-5 (Jans et al., 1997a) imply that the ligand may have a direct 
role in signal transduction in the nucleus. This capability would appear not to be 
possessed by IL-3 or GM-CSF, and conceivably represents the basis of the specific 
effects exhibits on the eosinophil lineage. 
In this study, the mouse myeloid progenitor FDC-Pl cell line is used to study the 
pathway of nuclear transport of IL-5 and its receptors. In particular, the main aims are 
1) To define the putative NLS of IL-5 
2) To determine whether nuclear transport of IL-5 occurs via conventional nuclear 
import pathways, and 
4) To investigate the transport of the IL-5 receptor to the nucleus in vivo. 
Various IL-5 NLS-mutant and fusion protein derivatives were analyzed to ascertain the 
functionality and nature of the putative NLS and critical residues thereof. A well-
established in vitro nuclear transport assay was employed in conjunction with CLSM 
and a previously developed ELISA-based binding assay (Efthymiadis et al. , 1997; 
Hubner et al. 1997, Xiao et al., 1997) used to assess the recognition of IL-5 and its NLS 
by importins. 
For receptor binding studies of various NLS mutant derivatives, a flow cytometry-based 
technique was developed. For the in vivo studies, a protein precipitation pr_9cedure 
based on biotinylation of IL-5 and subcellular fractionation of IL-5 receptor-expressing 
FDC-mIL-5R cells was used. 
Through the use of the techniques and assay described above, this study demonstrates 
that IL-5 possesses a novel NLS mediating nuclear import through a pathway 
independent of importins and Ran. This NLS is presumably the basis of its ability to 
cotransport its a receptor subunit to the nucleus subsequent to receptor-mediated 
endocytosis. Thus, it can be hypothesized that receptor targeting to the nucleus is a key 
signalling event in IL-5 specific signal transduction that requires nuclear localizing 
activity on the part of IL-5. 
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CHAPTER2 MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Chemicals and reagents 
All chemicals and enzymes used were of analytical grade or better. 
2.1.2 Buffers, solutions and culture media 
All buffers, solutions, and culture media were prepared with double-distilled water and 
sterilised by autoclaving at 121 °C for 20 min. Media prepared for bacterial and cell culture, 
solutions for DNA manipulations, protein analysis and in vitro assay techniques are 
described in Table 2.1. 
Table 2.1. Buffer, solutions and culture media used in this study (For abbreviations see 
page vii). 
Use Name of Composition Additional 
--
solutions Information 
Bacterial Luria-Bertani per litre: autoclaved; 
Culture (LB) 10 g bacto-tryptone 20 mM glucose (solid) or 
5 g bacto-yeast extract glycerol (liquid) added 
10 g NaCl antibiotics added 
Cell Culture PBS 137 mMNaCl pH to 7.4 with HCl 
6.75 mM Na2HPO3 
2.5 mM NaH2PO3 
RPMI RPMI Powder 10 .44g/L 
24 mM Sodium Bicarbonate 
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Media for FDC- RPMI 
Pl cell line 10% FBS heat inactivated 
10 mMNaCl 
lmM Na Pyruvate 
0.0006% Monothioglycerol 
Penicillin 60 mg/ml 
Streptomycin 100 mg/ml 
Gentamycin 10 mg/ml 
Media for CTLL- RPMI 
2 cell line 10 % FBS (heat inactivated) 
Penicillin 60 mg/ml 
Streptomycin 100 mg/ml 
Gentamycin 10 mg/ml 
0.05mM2ME 
DNA 7x DNA loading 70 mM Tris-HCl 
manipulation buffer 88 mMEDTA 
2.8 % Sarcosyl 
0. 7 mg/ml BPB 
100 mg/ml Fi coll 400 
TAE 0. 04 M Tris-acetate 
0.01 M EDTA, pH 8.0 
TE 10 mM Tris-HCl, pH 8.0 
1 mM EDTA, pH 8.0 
T1 0Eo.1 10 mM Tris-HCl pH to 7.5 with HCI 
0.1 mMEDTA 
Reverse 5 xAMV-RT 250 mM Tris-HCl, pH 8.3 
transcription buffer 250 mMKCl 
50 mMMgC12 
50mMDTT 
2.5 mM Spermidine 
Protein Coomassie Blue 0.25% Coomassie blue 
expression, Staining Solution 45% Methanol 
purification and 7% Acetic acid 
detection 
Destaining Buffer 45% Methanol 
7% Acetic acid 
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Electrophoresis 25 mM Tris-HCl pH to 8.3 with HCl 
Buffer 192 mM glycine 
0.1% SDS 
2x SDS Lysis 0.13 M Tris-HCl, pH 6.8 
Buffer 4%SDS 
( denaturing, 20% glycerol 
reducing) 0.005%BPB 
5% ~-Mercaptoethanol 
6x SDS Lysis 0.13 M Tris-HCl, pH 6.8 
Buffer 4%SDS 
60% glycerol 
0.005%BPB 
5 % ~-Mercaptoethanol 
fl-Gal Fusion Protein 20 mM Tris-HCl, pH 7.4 
Protein Incubation 10 mMMgC12 
Purification Buffer 10 mM ~-Mercaptoethanol 
Equilibration 20 mM Tris-HCl, pH 7.4 
Buffer 1.6 M NaCl 
10 mMMgCl2 
10 mM ~-Mercaptoethanol 
Elution Buffer 100 mM Boric Acid-NaOH, 
pH 10.1 
10 x Injection 48mMK2HPO4 pH to 7.4 
Buffer 14 mM NaH2PO4 
--
45 mMKH2PO4 
Dialysis Buffer 20 mM Tris-HCl, pH 7.4 
10 mMMgCh 
10 mM ~-Mercaptoethanol 
Gel shift Assays TBE 9 mM Tris-HCl 
9 mM boric acid 
0.2mMEDTA 
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Gel shift binding 10 mM Tris 
buffer 1 mMMgCb 
0.1 % NP-40 
l0mMDTT 
0.8mMEDTA 
3 % glycerol 
1.5 % sucrose 
Cell Buffer A- 0.34 M Sucrose added freshly: 
Fractionation (NP-40- lysis 10 mM HEPES, pH 8.0 1.5 mMDTT 
buffer) 60mMKCl 0.5 mM Spermine 
2mMEDTA 0.15 mM Spermidine 
0.5mMEGTA 
Buffer A+ Buffer A-
(NP-40 lysis 0.5% NP-40 
buffer) 
Buffer C 400 mMNaCl added freshly: 
(Nuclei lysis 7.5 mMMgC12 0.5 mMPMSF 
buffer) 0.2mMEDTA 10 mg/ml Aprotinin 
0.1 mMEGTA 5 mg/ml Leupeptin 
1 mMDTT 
Whole Cell RIPA buffer 50 mM Tris-HCl, pH 8.0 added freshly: 
Lysis 150 mMNaCl 1 mMPMSF 
0.2% SDS 0.15 units Aprotinin 10 
0.5%DOC mg/ml Leupeptin 
0.5% NP-40 1 mM Sodium orthovanadate 
Western Blot Transfer buffer 192 mM glycine 
25 mM Tris-HCl pH 8.3 
20 % methanol 
Blocking buffer PBS 
5% (wt/vol) BSA 
0.3 % Tween 20 
Wash buffer PBS 
(PBS-T) 0.3 % Tween 20 
Antibody dilution PBS 
buffer 0.3 % Tween 20 
2% (wt/vol) BSA 
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Stripping buffer 67 mM Tris-HCl pH 6.7 
10 mMDTT 
2%SDS 
EM Fixation Buffer PBS, pH 7.3 
0.1 M Sucrose 
2-4% PFA 
0.25% Glutaraldehyde 
Wash buffer A PBS, pH 7.3 
(S-PBS) 0.1 M Sucrose 
Wash buffer B PBS, pH 7.3 
(SN-PBS) 0.1 M Sucrose 
50mMNH4Cl 
Blocking buffer PBS, pH 7.3 
l¾BSA 
0.1°/o CWFG 
Antibody dilution PBS, pH 7.3 
buffer l¾BSA 
0.5% Tween-20 
In vitro Nuclear Intracellular 110 mMKCl pH to 7.4 with HCl 
Import Assay Buffer 5 mMNaHCO3 autoclaved 
(IB) 5 mMMgCl2 freshly added: 
1 mMEGTA 1 mMDTT 
0.1 mM CaCl2 10 µg/ml leupeptin 
20 mMHepes 
ATP regenerator 1 XIB 
6.25 mg/ml creatine 
phosphokinase 
500 mM creatine-phosphate 
l00mMATP 
ELISA Blocking Buffer PBS 
10% (wt/vol.) skim milk 
powder 
PBS/Tween/ l¾BSA 
BSA Solution 0.3% Tween 20 
50 
Hybridisation 1 XIB 
buffer 1 mMDTI 
1%BSA 
Diethanolamine 10 % diethanolamine 
buffer 0.5 M MgCl2, pH 9.8 
Dot Blot Assembly mix 13.6 µM final concentration 
heterodimer GST-importin 
a/~ 
1 xIB 
1 mMDTI 
2.1.3 Kits 
The molecular biology kits used in this study are listed in Table 2.2. 
Table 2.2. Molecular biology kits used in this study. 
Kit name 
U.S.E Mutagenesis Kit 
QIAEXII Gel Extraction Kit 
Plasmid Midi Kit 
Wizard Plus Mini Plasmid Prep Kit 
Company 
Pharmacia Biotech 
QIAGEN 
QIAGEN 
Promega 
SuperSignal West Pico Western Blot Kit Pierce 
ECL Plus Western Blot Kit Amersham 
AP detection kit Pharmacia 
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2.1.4 Bacterial strains 
The Escherichia coli bacterial strains used in this study are listed in Table 2.3. 
Table 2.3. Bacterial strains used in this study. 
DH5a F-, 080dlacZDM15, D(lacZYA-argF)Ul69, deoR, recAl , endAl, 
hsdRl 7(rk-, mk+), phoA, supE44, 1-, thi-1, gyrA96, relAl 
Top 10 F' F' {laclqTnl-(TetR)} mer A L1(mrr-hsdRMS-mcrBC) <j>80lacZAM15 
AlacX74 deoR recAl araD139 D(ara-leu)7697 galU galK rpsL endAl nupG 
BL21 (DE3) F-, ompT, hsdSB(rB-mB-), gal, dcm (DE3) 
TGl F', traD36, laclq(lacZ)M15, proA+B+/supE (hsdM-mcrB)5 (rk-mk+ 
McrB-), thi (lac-proAB) 
NM522 (MutS) supE, thi-1, D(lac-proAB), D(mcrB-hsdSM)5, (rK-mK-), (F' proAB laclq,D 
(lacZ)M15) 
MC 1060 - - + F hsdR (rx ,mK ) araD139 D(araABC-leu)7679 galU galK DlacX74 
rpsL thi mcrB} 
2.1.5 Restriction endonucleases 
Restriction endonucleases used in this study are listed in Table 2.4. 
Table 2.4. Restriction endonucleases used in this study. 
Restriction endonucleases Source 
Bal I Promega 
Barn HI NEB 
Cla I Bresatec 
Dpnl Fermentas 
Eco RI NEB 
Stu I MBI 
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2.1.6 Cloning and expression vectors 
Plasmids used in this study are listed in Table 2.5. 
Table 2.5. Plasmids used in this study. 
Plasmid 
pPR2hIL5 
pPR2hIL5 
pPR2hNKA 
pPR2mKEK 
Description Encoded protein 
Contains a Tac promoter which directs the expression hIL-5NLSwt ~-gal 
in bacteria of the E. coli ~-galactosidase enzyme 
( coding for amino acids 9-1023), contains the wild 
type NLS region of human IL-5 ( coding for amino 
acids 93-112), inserted into Smal restriction 
endonuclease site of plasmid pPR2 
Derived from pPR2hIL5, contains NLS mutant region hIL-5NLS1 ~-gal 
of human IL-5 (coding for amino acids 93-112), 
mutated at K95T and K96T 
Derived from pPR2hIL5, contains NLS mutant region hIL-5NLS3 ~-gal 
of human IL-5 ( coding for amino acids 93-112), 
mutated at K102N and K104A 
Derived from pPR2hIL5, contains NLS mutant region mIL-5wt ~-gal 
of mouse IL-5 ( coding for amino acids 92-111 ), 
mutated at G98R and Kl0lE 
pBacPak8hIL5scHSA Contains a AcMNPV polyhedrin promoter which hIL5scHSA 
directs expression of the hIL-5 single chain HSA 
pcDEF3mIL5Ra 
fusion protein 1n insect cells, cloned into the 
BamHl/EcoRl site of pBacP AK8 baculovirus 
expression vector 
Contains an human EF-lalpha promoter which directs full length mIL5Ra 
the express10n of the mouse IL-5Ra chain m 
mammalian cells; 
Contains an SV 40 promoter which directs the 
expression of the neomycin resistance gene that 
confers resistance to the antibiotic G418, and 
contains full length mIL-5 receptor alpha subunit 
cDNA cloned into the BamHl/Ncol site of pcDEF3 
expression vector 
2.1. 7 Oligonucleotides 
Oligonucleotides used in this study are listed in Table 2.6. 
Table 2.6. Oligonucleotides used in this study. 
Mutagenesis Primers 
IL-5NLS1 SENSE 
IL-5NLS1 ANTI 
hNLS3NKA 
NLS3 ATT 
NLS3 COMP 
mNLSwt 
mKEKSENSE 
mKEKANTI 
Sequencing Primers 
pPR2SEQ1 
pPR2SEQ2 
PCRPrimers 
hNLSl VERIFY 
NLS3 VERIFY 
mKEKVERIFY 
pPR2HOT1 
Primer Sequence 
5'-CTI GTC CTT AAT AAC GAC ATA CAT TGA CGG C-3' 
5'-GCC GTC AAT GTA TGT CGT TAT TAA GGA CAA G-3' 
5'-TAC ATI GAT GGT CAA AAC AAG GCC TGT GGA GAA G-3' 
5'-ATI GAC GGC CAA AAC AAG GCC TGT GGA GAA GAA AG-3' 
5'-CTI TCT TCT CCA CAG GCC TTG TTT TGG CCG TCA AT-3' 
5'-GAA ATA CAT XGA TCG CCA AAA AGA AAA GTG TGG-3' 
5'-GAA ATA CAT TGA TCG CCA AAA AGA AAA GTG TGG AG-3' 
5'-CTC CAC ACT TTT CTT TTT GGC GAT CAA TGT ATT TC-3' 
5'-CGT CTT TCT TCT CCA CAC TIT TC3' 
Primer Sequence 
5'ACT CCC GTT CTG GAT AAT GT3' 
5'TTC TCC GTG GGA ACA AAC G3' 
Primer Sequence 
5'GTT TIG GCC GTC AAT GTA TGT CG3' 
5' CTC CGT CTT TCT TCT CCA CAG G3' 
5'CGT CTT TCT TCT CCA CAC TIT TC3' 
5'GGT CGT AAA TCA CTG CAT AAT TCG3' 
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2.1.8 Antibodies and Conjugates 
The primary antibody used in this study are listed in Table 2. 7. 
Table 2. 7. Primary antibodies used in this study. 
Primary Antibody a2ainst Type Company 
mouse IL-5 goat polyclonal Cbiotinylated) R&D 
human/mouse IL-5 rabbit polyclonal Santa Cruz 
mouse IL-3 Receptor a CC-terminus) rabbit polyclonal Santa Cruz 
mouse IL-5 Receptor a CC-terminus) rabbit polyclonal Santa Cruz 
mouse GM-CSF Receptor a CC-terminus) rabbit polyclonal Santa Cruz 
mouse Receptor ~c rabbit polyclonal Santa Cruz 
human IL-5 Receptor a CC-terminus) rabbit polyclonal Santa Cruz 
human Receptor ~c mouse monoclonal Santa Cruz 
human Receptor ~c CC-terminus) rabbit polyclonal Santa Cruz 
human Receptor ~c (N-terminus) rabbit polyclonal Santa Cruz 
human/mouse im portin ~ goat polyconal Santa Cruz 
mouse IL-3 goat polyconal Santa Cruz 
The secondary antibody conjugates used in this study are listed in Table 2.8. 
Table 2.8. Secondary antibodies conjugates used in this study. 
Secondary Antibody/Conju2ates Company 
HRP conjugated anti rabbit Ig Arnersham 
HRP conjugated anti mouse Ig DAKO 
HRP conjugated anti goat Ig Pierce 
Gold conjugated anti-rabbit IgG (10nm gold) Arnersham 
HRP conjugated Streptavidin Silenus 
Streptavidin conjugated Dynabeads M-280 Dynal 
55 
2.1.9 Enzymes and markers 
The enzymes and markers used in this study are listed in Table 2.9. 
Table 2.9. Enzymes and markers used in this study. 
Enzymes, markers Application Source 
T4-DNA ligase Ligation Biolabs 
native Pfu DNA Polymerase PCR Stratagene 
Pfu turbo DNA Polymerase PCR Stratagene 
Alkaline phosphatase ( calf intestinal) Dephosphory lation Pharmacia 
Taq polymerase PCR verification F ermentas/Invitrogen 
GeneRuler 1kb DNA Ladder DNA Agarose gels Fermentas 
(500 kb to 10.000 kb) 
pUC19 DNA/MSPI DNA Ladder DNA Agarose gels Fermentas 
(40 kb to 500 kb) 
BenchMark Protein Ladder SDS PAGE/ Coomassie Staining Gibco BRL 
BenchMark Protein Ladder/prestained SDS PAGE/Western Blot Gibco/Invitrogen 
2.1.10 Miscellaneous materials 
For Western Blot procedures, 3MM chromatography paper was used from Whatman Ltd., 
and nitrocellulose membrane was provided by Schleicher and Schuell. 
- ~--
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2.2 Molecular Methods of DNA Manipulation 
I. E.COLI MANIPULATION 
2.2.1 Preparation of competent E. coli cells 
Competent E.coli cells were prepared for DNA transformation using two different methods: 
a) CaCl2 method 
E. coli cells were streaked out onto an agar plate and grown overnight at 3 7°C. A single 
colony was used to inoculate 3 ml of LB and incubated at 3 7°C overnight with agitation. 
400 ml of LB was inoculated with 100 µl of the overnight culture and grown at 3 7°C to an 
OD600 of 0.8-1.0 with vigorous shaking on a Controlled Environment Incubator Shaker 
(New Brunswick Scientific Co. Inc. USA). To harvest the cells, the culture flasks were 
chilled on ice for 15 min, the cell suspension transferred into 500 ml centrifuge tubes and 
centrifuged in a cold GS-3 rotor (Sorvall RC5C, Sorvall Instruments, DuPont) at 4800 rpm 
for 15 min. After removing the supernatant the pellet was resuspended in 50 ml cold, sterile 
CaCl2 (0.1 M) and incubated overnight at 4 °C. After spinning for 5 min at 5000 g, the 
supernatant was discarded and the pellet resuspended in 5 ml cold mix of 0.1 M CaCl2 and 
glycerol (85: 15). The cell suspension was aliquoted into pre-chilled Eppendorf tubes and 
stored at -70 °C until use. 
b) Electrocompetent cells 
Two times 400 ml of LB were each inoculated with 400 µl of a fresh overnight culture. The 
cells were grown at 3 7 °C to an OD600 of 0. 7 with vigorous shaking on a Controlled 
Environment Incubator Shaker (New Brunswick Scientific Co. Inc. USA). To harvest the 
cells, the culture flasks were chilled on ice for 15 min, the cell suspension transferred into 
500 ml centrifuge tubes and centrifuged in a cold GS-3 rotor (Sorvall RC5C, Sorvall 
Instruments, DuPont) at 4800 rpm for 15 min. After removing the supernatant, the pellet 
was carefully resuspended in 1 ml of ice-cold water, topped up with cold water to 1 Land 
centrifuged as above. This procedure was repeated with 500 ml and 20ml of ice-cold water. 
The cells were resuspended in a final volume of 3 ml cold 10% glycerol in water. The cells 
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were subsequently aliquoted into pre-chilled Eppendorf tubes, frozen on dry ice and stored 
at -70 °C until use. 
2.2.2 Transformation of competent E. coli cells 
Transformation of competent bacteria was performed using the heat shock procedure based 
on that of Sambrook et al. (1989). Plasmid (1 µg) or half of a ligation mix was mixed with 
competent cells (200 µl) and incubated on ice for 30 min before a 90 sec heat shock at 
42°C. The culture was then placed on ice for 2 min followed by the addition of 1 ml of LB 
and incubated at 37°C for 1 h. For routine plasmid transformations, 200 µl of the 
transformation culture was plated onto an agar plate containing the requisite selective 
antibiotic(s), while in the case of ligations, 50 µl of the bacterial culture was plated, and the 
remaining culture centrifuged, resuspended in 50 µl of LB and additionally plated out on a 
separate plate. Plates were incubated at 3 7°C overnight and colonies picked and used to 
inoculate 5 ml of LB with antibiotic, incubated at 37°C overnight (shaking 200 rpm) to be 
used for DNA preparation and further analysis. 
2.2.3 Long term storage of E. coli cells 
E. coli strains containing various plasmids were grown up for storage in 5 ml cultures to 
late log phase (OD595 of 1.0). To 1 ml aliquots of culture was added 1ml of 30% sterile 
glycerol-LB mix and the cells gently inverted and then stored at -70°C. 
II. PREPARATION AND ANALYSIS OF DNA 
2.2.4 Plasmid preparation 
Preparations of ,__,5 µg plasmid DNA were carried out using a Kit from Promega (see Table 
2.2), according to the procedure recommended by the manufacturer. Briefly, 4 ml of 
bacteria grown at 37°C for 12 h (shaking at 200 rpm) under the selection of an appropriate 
antibiotic were collected by centrifugation (14.000 rpm, 1 min) and lysed using alkaline 
lysis buffer (included in kit). Following pH neutralization, the cell debris was removed by 
centrifugation (Eppendorf benchtop centrifuge, 14.000 rpm, 1 min) and the supernatant 
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passed through a spin filter. The solution was washed and eluted in 50 µl TE buffer. 
Plasmid amounts of approximately 100 µg were prepared using the QIAGEN Plasmid Midi 
Kit ( see Table 2.2) using essentially the same method and buffers as above. 
2.2.5 Agarose gel electrophoresis 
Separation of DNA fragments of greater than 100 bp was performed by electrophoresis in 
0.8-2.0% agarose gels in TAE buffer (see Table 2.1) using a horizontal slab gel apparatus 
(BioRad) run at 60-100 V for 2-4 h. Agarose gels were stained in 0.5 µg/ml ethidium 
bromide (EtBr) and DNA fragments visualized under fluorescent UV light. 
2.2.6 Quantitation of DNA 
DNA samples were quantitated spectrophotometrically based on absorbances at 260 nm. 
The concentration of DNA in plasmid preparations was calculated on the basis that an OD 
of 1 at 260 nm corresponds to 50 µg/ml of double stranded DNA. 
2.2. 7 Recovery from agarose gels 
Recovery and purification of DNA fragments from agarose gels was performed by gel 
extraction according to the protocol given with the gel extraction kit (Qiagen). Following 
separation by agarose gel electrophoresis (see section 2.2.5), the band of interest was 
located under UV illumination using a Transilluminator (Gel Documentation System, 
N ovaline ), the band removed using a scalpel, placed into an eppendorf tube and the DNA 
recovered using a gel extraction kit (Qiagen, see Table 2.2). 
2.2.8 Phenol/Chloroform extractions 
Phenol was added to half the volume of the DNA solution and mixed by vortexing for 1 
min. The mixture was left at RT for 5 min and then re-vortexed for 1 min. A similar volume 
of chloroform:isoamyl alcohol (24:1) was added to extract the phenol. The mixture was 
vortexed for 1 min and then centrifuged for 5 min at 14.000 rpm. The upper aqueous phase 
was removed and placed in a fresh Eppendorf tube. Ethanol precipitation followed all 
phenol/chloroform extractions. 
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2.2.9 Ethanol precipitation 
Ethanol precipitation was carried out by adding 3 M sodium acetate to 1/10 the volume of 
the DNA solution and twice the total volume of 100% ethanol. The sample was placed at -
20°C for 30 min and the precipitated DNA collected by centrifugation at 14.000 rpm for 5 
min. The supernatant was washed with 100 ml 70% ethanol and air dried for 30 min. The 
pellet was resuspended in TE buffer (see Table 2.1). 
III. ENZYMATIC MANIPULATION OF DNA 
2.2.10 Restriction endonuclease DNA digestion 
Routine digestion of DNA fragments (0.1-5 µg of DNA) were carried out using 2 U of a 
restriction endonuclease per µg DNA in the presence of the appropriate buffer supplied by 
the manufacturer. Reactions were typically incubated for 1-2 h at the recommended 
temperature in a final volume of 20 µl final volume and terminated by heating to a 
temperature ( 65-85°C) sufficient to denature the endonuclease. Digesting DNA samples of 
more than 5 µg involved scaling the reaction appropriately with respect to amount of 
restriction endonuclease and the final volume of the reaction. 
2.2.11 Dephosphorylation of plasmid DNA 
Dephosphory lation of linearized plasmid vector DNA was carried out to prevent religation 
of plasmid ends. Calf intestinal phosphatase (CIP) was added at a final concentration of 0.5 
U/µg plasmid in One-Phor-All buffer (Pharmacia) and incubated at 37°C for 15 min. 
Another 0.5 U/µg plasmid of CIP was added and incubation at 37°C continued for a further 
15 min. Phenol/chloroform extraction (see Sections 2.2.8) followed by ethanol precipitation 
(see Section 2.2.9) removed contam_inating proteins and the DNA resuspended in TE 
buffer. 
2.2.12 Ligation 
Ligation of DNA fragments was performed by combining the DNA components at a molar 
ratio of 10: 1 insert:vector in the presence of Ix T4 DNA ligase buffer and 400 U ligase T4 
DNA ligase in a final volume of 20 µ1. Sticky end ligations were incubated at 22°C for 12 h 
and half the ligation mix used to transform competent E. coli cells (see Section 2.2.2). In all 
-- -- --
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ligations, a negative control was performed by replacing the DNA insert component with an 
equal volume of water to establish background ligation due to vector religation. 
IV. MUTAGENESIS 
2.2.13 U.S.E single strand mutagenesis 
Mutagenesis was performed using the U.S.E Mutagenesis Kit supplied by Pharmacia 
according to the manufacturer to convert the plasmid pPR2hIL5 (see Table 2.5) into 
pPR2hNKA. Briefly, the mutagenic primer hNLS3NKA (see Table 2.6) designed to 
remove a Bal I restriction site and insert an Stu I restriction site was annealed to the 
pPR2hIL5 plasmid and incorporated into a nascent strand by in vitro DNA synthesis, using 
T 4 DNA polymerase. The DNA was then treated with the Bal I restriction enzyme whereby 
plasmid DNA which incorporated the mutagenic primer was resistant to digestion, while wt 
plasmid DNA was linearized. The DNA mixture was then introduced into E. coli strain 
NM522 mutS (see Table 2.3), a strain whose defect in repairing mismatches in duplexed 
DNA helps ensure against repair of the mutations during growth. Since covalently closed 
circular DNA will be taken up by bacteria 100- to 1000-fold more efficiently than linear 
DNA, the majority of the transformants would contain mutant plasmids. Plasmid DNA was 
then isolated from the transformed cells and subjected to a second round of Bal I restriction 
enzyme selection to increase the proportion of mutant plasmids. The mixture was then 
transformed into E. coli strain MC1060 cells (see Table 2.3) and screened for clones 
containing the mutation based on restriction analysis with Bal I and Stu I endonucleases. 
2.2.14 Double-stranded mutagenesis 
Mutagenesis was performed according to the QuikChange Site-Directed Mutagenesis Kit 
protocol supplied by Stratagene according to the manufacturers instructions. Briefly, the 
QuikChange site-directed mutagenesis method was used with double-stranded plasmid 
DNA. The procedure starts with a supercoiled, dsDNA vector with the insert of interest and 
two synthetic oligonucleotide primers containing the desired mutation. The oligonucleotide 
primers, each complementary to opposite strands of the vector, were extended during 
temperature cycling by native PfuTurbo DNA polymerase under the following conditions: 
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Cycle number Time per cycle Temperature 
lcycle 30 sec 9s 0 c 
16 cycles 30 sec 95°c 
1 min ss 0 c 
2 min per kb of plasmid length 68°C 
On incorporation of the oligonucleotide primers, a mutated plasmid containing staggered 
nicks was generated. After temperature cycling, the product was treated with 10 units of the 
restriction endonuclease Dpn I for 1 hour at 3 7°C to digest the parental DNA template and 
select for the synthesized DNA containing mutations. Since DNA isolated from most E. 
coli strains is dam methylated, it is susceptible to Dpn I digestion, which is specific for 
methylated and hemi-methylated DNA. The reaction was stopped by heating the mix for 10 
min at 68°C. The nicked vector DNA incorporating the desired mutations was then 
transformed into the competent E.coli strain Top 10 F' (see Table 2.3). The cells were 
grown overnight on LBA plates and mutant colonies verified by colony PCR (see Section 
2.2.16). 
2.2.15 Polymerase chain reaction 
PCR was carried out to amplify DNA fragments for cloning and to screen for recombinant 
plasmids. For the purpose of construct preparation, the high fidelity Pfu DNA polymerase 
was used while for routine analysis/screening, Taq DNA was utilized accordiug to the 
protocols described in Table 2.10. 
All components were combined on ice and the reactions carried out under the following 
cycling conditions: pre-amplification denaturation was carried out at 94°C for 30 s 
followed by 30 thermal cycles consisting of denaturation (94°C for 30 s), primer annealing 
(for 30 sat temperatures 4-10°C below Tm of the primers) and extension (72°C for 1 min 
(Taq) or 2 min (Pfu) per kb of the product). 10 µl of the PCR product was analysed by 
agarose gel electrophoresis (see Section 2.2.5). 
62 
Table 2.10. PCR reaction components incorporating Pfu or Taq DNA polymerase. 
Pfu reactions 
1 x cloned Pfu buff er 
250 µMeach dNTP 
250 nM each primer 
2.5 units Pfu turbo enzyme 
Taq reactions 
lx Taq buffer 
250 µMeach dNTP 
250 nM each primer 
0.5 units Taq enzyme 
2 ng/µl plasmid template DNA 2 ng/µl plasmid template 
2mMMgCh 
H20 to 20 µl 
2.2.16 Colony PCR 
For screening of mutant E. coli colonies, transformed cells were grown overnight on LBA 
plates. Single colonies were picked with a sterile toothpick and spotted onto a fresh LBA 
master plate before resuspending in 50 µl water, heated for 10 min at 65°C and the lysate 
placed on ice. Each PCR reaction contained 5 µl lysate, lx Taq buffer, 1.5 mM MgCl2, 0.2 
mM dNTP, 0.25 pmol of each primer and 0.55 units Taq polymerase. PCR was performed 
as shown in Table 2. 11. 
Table 2.11. Thermal profile for colony PCR reactions. 
Cycle number Time per cycle Temperature 
1 cycle 1 min 94°c 
30 cycles 30 sec 94°c 
15 sec Tm-2°C 
1 min per kb of plasmid length 12°c 
The DNA samples were amplified using a capillary thermal cycler (FTS-1, Corbett 
Research, Australia). PCR products were separated for analysis on a 1.5% agarose gel with 
subsequent staining in ethidium bromide for 30 min. 
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2.2.17 DNA sequencing 
The fidelity of clones was determined by automated sequencing by combining 500 ng of 
plasmid, 3 .2 pmol sequencing primer, 8 µ1 BigDye Terminator Mix and water in a final 
volume of 20 µ1. The mixture was then subjected to 25 thermal cycles involving 96°C for 
10 s, 50°C for 5 s, and 60°C for 4 min. Unincorporated dye-labelled terminators were 
separated from the mixture by ethanol precipitation by adding 2.0 µ1 3M NaAcetate and 50 
µl 100% EtO H. The mixture was incubated on ice for 7 min and then centrifuged at 14. 000 
rpm for 30 min at RT. The supernatant was discarded and the pellet washed with 500 µ1 
70% EtOH. The pellet was then dried and the sequence determined using the Perkin Elmer 
ABI Prism 377 DNA sequencer in the Biomolecular Research Facility, JCSMR, ANU. 
2.2.18 Mammalian cell transformation 
FDC-Pl cells were grown in RPMI-1640 completed medium with the factor mIL-3 (see 
Table 2.1) and subcultured at 5 x 105 cells/ml the day before transfection. The cells were 
harvested and resuspended in factor-free growth medium described above. 7.5 x 106 cells 
were incubated with 10 µg of the plasmid pcDEF3mIL5Ra (see Table 2.5) in 350 µ1 of 
growth medium supplemented with 20% FCS for 15 minutes at room temperature, and 
subjected to electroporation at 300 V and 500 µF capacitance (Bio-Rad GenePulser). The 
cells were transferred into 10 ml of fresh medium and selected for receptor-expressing cell 
by culturing with the factor mIL-5 over a period of 4 to 8 weeks. 
-· ---
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2.3 Analysis of Proteins 
I. OUANTITATION OF PROTEINS 
2.3.1 Bradford Assay 
The concentration of proteins was determined using the Bio-Rad Bradford assay (Bradford, 
1976) according to manufacturer's specifications. Solutions containing 2-14 µg of the 
protein standard BSA were made up to 0.8 ml in water while 3-5 different dilutions of the 
protein to be assayed were prepared and made up to 0.8 ml. 0.2 ml of the protein binding 
reagent (Bio-Rad) was added and incubated for 10 min at RT. The absorbance at 595 nm 
was measured and the values subtracted from a reagent blank prepared from 0.8 ml distilled 
water and 0.2 ml of the above reagent. The concentration of protein was calculated by 
extrapolating from the standard curve obtained from BSA of known concentration (0.2 
mg/ml). 
II. ELECTROPHORETIC SEPARATION OF PROTEINS 
2.3.2 SDS-P AGE 
Proteins were separated using SDS PAGE. Purity and molecular weight of proteins were 
verified using 10% acry lamide gels. A 10% acry lamide gel consisting of 10% acry lamide 
(29:1 acrylamide:bisacrylamide), 0.375 M Tris-HCl (pH 8.8), 0.1 % SDS, 0.03% AMPS 
and 0.015% TEMED was poured and allowed to set for 1 h at RT. The stacking gel 
containing 4.5% acrylamide, 0.125 M Tris-HCl (pH 6.8), 0.1 % SDS, 0.03% AMPS and 
0.015% TEMED was poured on top of the resolving gel with a comb inserted and allowed 
to set at RT for 1 h. For immunoblotting analysis of proteins, 4-20% gradient gels were 
used (Gradipore ). 
Protein samples were prepared for loading by adding SDS loading buffer (Table 2.1) in a 
1: 1 ratio, followed by boiling for 5 min, vortexing for 1 min, and centrifugation at 14.000 
rpm for 5 min. Electrophoresis was performed in 1 x SDS buffer (Table 2.1) at 70 V until 
the bromophenol blue dye marker reached the bottom of the gel. Gels were either prepared 
for Western blotting procedure or Coomassie staining (see Section 2.3.3). 
III. PROTEIN DETECTION 
2.3.3 Coomassie Staining 
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Gels were stained in Coomassie Blue Solution (Table 2.1) overnight and destained for 2-5 h 
with successive changes of Destaining Buffer (Table 2.1 ). The molecular weight was 
compared to a lane loaded with a standardized prestained molecular weight makers 
(Benchmark, Gibco ). Protein concentration was determined using the Bradford assay (see 
Section 2.3.1). 
IV. PROTEIN LABELLING 
2.3.4 Fluorescent labelling of proteins 
Labelling of purified ~-gal fusion protein was performed by adding 1/10 the volume of 4 
mg/ml 5-iodacetamido-fluorescein (IAF, Molecular Probes, Inc. USA, 200 µl) dissolved in 
1 M Bicine (pH 7.8). The solution was adjusted to pH 7.8 with 1 M KOH and incubated at 
RT for 90 min wrapped in aluminium foil. To remove free dye, 2 ml of labelled protein 
were loaded on to a PD-10 column (Pharmacia) to separate the labelled protein from 
unincorporated dye. The samples were eluted with 3 ml of PBS, and then concentrated and 
purified using centricos (Millipore). To calculate the ratio of label to protein, 1/500 or 
1/250 dilutions of the purified fusion proteins were prepared in 1 ml of H2O, and the 
concentration and extent of labelling of the protein determined based on absorbance 
readings (A) at 495 nm (label) and 280 nm (protein) according to the following equations 
(Rihs and Peters, 1989): 
Concentration (mg/ml)= A280 - (0.35 x A495) x dilution factor 
1.8 
Labelling (mol/mol) = A495 x 1.8 x 0.233 
0.15 x [A280 - ( 0.35 x A495)] 
Baculovirus-expressed cytokines and cytokine receptors were fluorescently labelled using 
the covalent amine-labelling reagent SFX (fluorescein-X succinimidyl ester). 100 µg of 
freshly prepared SFX (5 mg/ml in DMSO) was added to 200 µg of protein PBS and 
66 
incubated at RT for 1.5 h, protected from light. PBS was then added to bring the sample 
volume to 500 µl, and the total volume was loaded on to a NAP-5 column (Pharmacia) to 
separate the labelled protein from unincorporated dye. The samples were eluted with 1 ml 
of PBS, protein samples concentrated using 'Ultrafree-MC' fiher units (Millipore) and 
concentration measured using Bradford assay (see section 2.3.1) 
2.3.5 Biotinylation of proteins 
To biotinylate mIL-3 and mIL-5, a N-hydroxysuccinimide-Biotin (Sulfo-NHS-Biotin) was 
utilized. Sulfo-NHS-Biotin is a water-soluble, membrane-impermeable biotin derivative, 
which reacts with primary amines of proteins. It contains a 22.4 A long, non-cleavable 
spacer for improved complex formation with streptavidin and reduced steric hindrance. 
Biotinylation was performed according to the manufacturers instructions (Pierce). 500 µl of 
baculovirus-expressed mIL-5 and mIL-3 were loaded on to a NAP-5 column (Pharmacia) 
and eluted with 1 ml PBS pH 7.5. The protein samples were concentrated using a lOkD 
MWCO 'Ultrafree-MC' filter units (Millipore) and the protein concentration adjusted to 1 
mg/ml after determining the concentration using the Bradford assay (see Section 2.3.1). 
To 100 µl of 1 mg/ml mIL-5 or mIL-3 were added 40 µl of 4 mg/ml biotin dissolved in 
PBS pH 7.5 and incubated overnight at 4°C. To remove unincorporated biotin, sample 
volumes were adjusted to 500 µl with PBS and samples loaded on to NAP-5 columns and 
eluted with 1ml PBS. The purified protein samples were concentrated using 10 kD MWCO 
'Ultrafree-MC' filter units, the protein concentration determined by Bradford assay and 
adjusted to 1 mg/ml. 
2.4 Expression -and purification of P-gal fusion proteins 
2.4.1 Expression 
Bacteria containing the plasmids encoding the ~-galactosidase fusion proteins used in this 
study were inoculated into 5 nil LB with 100 µg/ml ampicillin and grown at 37°C 
overnight (220 rpm). The culture was transferred into 400 ml LB containing 100 µg/ml 
ampicillin and 1 mM IPTG for fusion protein induction, and grown at 3 7°C overnight with 
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shaking (220 rpm). The bacteria were harvested by centrifugation at 8.000 rpm for 15 
minutes at 4°C (GS-3 rotor) and resuspended in 5 ml of Protein Incubation Buffer (see 
Table 2.1). 
2.4.2 Purification 
Cells were disrupted at 4°C by five 3 minute cycles of ultrasonication at 3-4 output with a 1 
minute break between cycles using a Model W-220F sonicator (Ultrasonics Inc. USA) and 
then transferred into 1.5 ml Eppendorf tubes. After centrifugation (SS34 rotor) for 30 
minutes at 4 ° C at 13. 000 rpm, the supernatant was collected and Na Cl added to a final 
concentration of 1.6 M. The supernatant was then applied to a prewashed Econo-column 
(Bio-Rad) containing 4 ml of p-aminobenzyl-1-thio-B-D-galactopyranoside-agarose 
(Sigma), which contains a covalently attached nonhydrolyzable B-galactosidase substrate. 
The column was then extensively washed with 2 litre of Equilibration Buffer (see Table 
2.1) to remove non-specifically bound material. The fusion protein was eluted using Elution 
Buffer (see Table 2.1 ). 15-20 fractions were collected into Eppendorf tubes containing 250 
µl of 2 M Tris-HCl (pH 7.0) for immediate neutralization of the eluate. Tubes were mixed 
by inversion and stored on ice. 
B-galactosidase activity in fractions was checked by adding 20 µl of orthonitrophenyl-B-D-
galactopyranoside (ONPG, Sigma, 4 mg/ml) to 10 µl of each fraction. Fractions exhibiting 
a yellow colour change were subsequently analysed by SDS-PAGE (see section 2.3.2). The 
gel was stained in Coomassie Blue Solution (Table 2.1) for 1 hour and destainea for 2-3 
hours by repeatedly changing the Destaining Buffer (Table 2.1 ). Column fractions were 
stored at -20°c. 
Based on the results of the gel analysis, peak protein fractions were dialyzed in a 50 kDa 
MWCO dialysis membrane against 2 litres of Dialysis Buffer (Table 2.1) at 4 ° C with 
continuous stirring overnight. Dialysed fusion proteins were transferred into a 100/7 5 (7 5 
kDa MWCO) ultrathimble tube (Schleicher and Schull, Germany) and pressure dialyzed 
against 200 ml of Dialysis Buffer ( see above) using a vacuum pump (Edwards, England) to 
concentrate the protein solution. The protein concentration was determined by measuring 
the absorbance at 280 nm with 1.8 optical density (OD) for 1 mg/ml of protein (Rihs and 
Peters, 1989). 
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2.4.3 Filter-based protein concentration (Centricon, Millipore) 
E.coli expressed ~-gal fusion proteins were concentrated and purified from label at 3,500 
rpm (SS34 rotor) using a 100 kDa MWCO centricon (Amicon, USA). Repeated cycles 
were carried out of washing the centricon with Injection Buffer (Table 2.1). When the 
flowthrough was free of chromophore as indicated by examination under UV (UV 
transilluminator, USA), the labelled protein was collected, its absorbance measured at 280 
and 495 nm and then stored at -70°C until further use. 
2.5 Expression and purification of recombinant cytokines and cytokine 
receptors 
hIL-5, mIL-5 the NLSl and the monomeric mutant derivative of mIL-5 were provided by 
the Cytokine Molecular Biology and Signalling Group, JCSMR. hIL-5, mIL-5 and the NLS 
mutant derivatives of mIL-5 were expressed using the baculovirus system in Sf9 insect 
cells. The proteins were purified by gel filtration followed by ion-exchange 
chromatography and activity measured using a Thymidine incorporation assay as described 
in Section 2.7.3 . 
2.6 Expression and purification of IL-5sc-HSA fusion protein 
The IL-5sc-HSA fusion protein was provided by the Cytokine Molecular Biology and 
Signalling Group, JCSMR. 
The plasmid expressing the hIL-5sc HSA fusion protein was derived by PCR of 3 separate 
fragments with subsequent subcloning into the baculovirus expression vector pBakPak8. 
First, a hIL-5 fragment, including the signal sequence and flanked by Barn H I/Nar I 
restriction sites was derived by PCR and inserted into the MCS of the plasmid pBSKS+. A 
second IL-5 fragment, without the signal sequence and flanked by N ar I/Kpn I sites was 
derived and subcloned in identical fashion. This single-chained IL-5 construct was then 
subcloned into the MCS of the transfer vector pBakPak8. Finally, a PCR product consisting 
of HSA sequence encoding for aa 25-588 (CAA23754.1) flank~d by Kpn I/EcoR I sites was 
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inserted into pBakP AC8. Constructs were screened by restriction analysis and a positive 
clone sequenced to confirm its identity. 
The hIL-5sc-HSA fusion protein was baculovirus-expressed and purified by the Cytokine 
Molecular Biology and Signalling Group, JCSMR as described in Section 2.6 and 
fluorescently labelled as described in section 2.3 .4 of Material and Methods. 
2. 7 Cell culture 
2.7.1 HTC cells 
Cells of the rat hepatoma tissue culture (HTC) line, a derivative of Morris hepatoma 7288C 
cell line, (Flow Laboratories, Bonn, Germany) were cultured in Dulbecco's modified 
Eagle's medium (DMEM, ICN Biomedicals, Inc. USA, (Jans et al., 1991; Rihs et al., 1991) 
supplemented with 10% heat-inactivated foetal calf serum (PCS, CSL) in a humidified 
incubator (Forma Scientific, Inc. USA) with 5% CO2 atmosphere at 37°C. The cells, grown 
in 50 ml flasks (Nunclon, Denmark), were maintained by Lyndall Briggs, Anna John and 
Chenoa Barton (Nuclear Signalling Laboratory, JCSMR). Cells were subcultured every 3-4 
days ( at 90-100% confluence) in a laminar flow hood (Airpure, Email Westinghouse Pty. 
Ltd. Australia) by removing the medium, washing the cells twice with sterile PBS and 
resuspending them by incubating with 2 ml of 0.25% trypsin in EDTA (Sigma) diluted 1 in 
10 in PBS for 3-5 min at 22°C. The trypsinised cell suspension was transferred into a 50 ml 
Falcon tube containing 6 ml fresh DMEM containing 10% PCS and centrifuged at-500 rpm 
(Sorvall Technospin) for 5 min at 22°C. After discarding the supernatant, the pellet was 
resuspended in 5 ml DMEM. For maintenance, 0.2 and 0.5 ml of cells were pipetted into 
fresh culture flasks. 
2. 7 .2 FDC cells 
The mouse myeloid progenitor FDC-Pl factor (IL-3)-dependent cell line was provided by 
Sally Ford (Cytokine Molecular Biology and Signalling Group, JCSMR) for further 
culturing as well as for transformation with the pcDEF3mIL5Ra (see Table 2.5) plasmid to 
obtain the FDC-mIL-5R cell line (see section 2.2.18). These cells were grown in RPMI-
1640 medium as listed in Table 2.1. 
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The mIL-3 and mIL-5 used for culturing was prepared from Sf9 cells infected with a 
baculovirus expressing mouse IL-3 and mouse IL-5 and was provided by S. Ford (JCSMR). 
One unit of factor bioactivity is the amount of IL-2 required to support half-maximal 
proliferation of the corresponding FDC-cells. Every three days cells were diluted 1 in 10 
and the medium was replaced with fresh medium containing the appropriate factor. The 
cells were grown at 37°C, 5% CO2 in air and 95% relative humidity. 
2. 7 .3 Bioassay (3H-Thymidine incorporation) 
For routine determination of bioactivities of baculovirus-expressed factors, a 3H-thymidine 
incorporation assay was performed by Sally Ford, Cytokine Molecular Biology and 
Signalling Group, JCSMR. 
FDC cells, expressing the appropriate receptor, were grown to 4xl 05 cells/ml and washed 4 
times in factor free RPMI-1640 medium to remove any factors and resuspended in RPMI to 
2xl 04 per 50 µ1. 
15 serial dilutions of factor were pipetted in triplicates into 96 well plates, with a starting 
concentration of 300 nM and then 50 µl of cells added. One well was left as blank and cells 
added to factor-free media. 
Cells were incubated for 44 hours at 37°C, 5% CO2 in air and 95% relative humidity. 
Subsequently, cells were pulsed with 0.5 µCi of 3H-thymidine per well, cells harvested 
after 4 hours using a cell harvester (Inotech) and 3H-thymidine incorporation counted using 
a liquid scintillation counterr (Packard, Australia). Data analysis was performed using the 
Kaleida Graph 2.13 software (Macintosh). 
2. 7 .4 Biotinylatioil of cell surface proteins 
FDC cells were washed 3 times with ice-cold PBS (pH 7 .5) to remove any media and to 
adjust the pH to slightly alkaline. Cells were resuspended in PBS to a concentration of 
2x106 cells/ ml and 0.5 mg of Sulfo-NHS-LC-Biotin per ml added. Cells were incubated for 
30 min at RT and then washed 3 times in ice-cold PBS to remove any remaining biotin 
derivative (Altin, 1995). 
71 
2.8 Confocal laser scanning microscopy (CLSM) 
The localisation of fluorescently tagged proteins within the cell was monitored by CLSM. 
This technique is based on fluorescence microscopy whereby a light source is passed 
through two sets of filters - one to ensure that light reaching the tissue specimen is of the 
optimal wavelength to excite the designed fluorescent chromophore, and one to filter the 
light obtained from the specimen to allow only wavelengths specifically emitted when the 
chromophore fluoresces to be collected. CLSM is similar in this regard except a laser is 
used to illuminate the specimen through a pinhole aperture at a single point, and only 
emitted-light from the focal plane is allowed to pass through the same pinhole to reach the 
detector. By scanning the beam of light across the specimen, very sharp two-dimensional 
images of the exact plane of focus can be built up. Rapid scanning (1 scan per second) 
enables experiments to be carried out in real time on living cells. Due to its special optics 
and higher sensitivity digitized image, the CLSM can be used to measure relative amounts 
of fluorescently labelled proteins at the subcellar level in living cells. 
2.9 In vitro nuclear transport assay 
For nuclear transport assays, 0.8 and 1.0 ml of trypsinised cells (Section 2.7.1) were 
pipetted into two fresh tissue culture flasks containing 24 ml fresh DMEM. HTC cells were 
seeded in DMEM on coverslips (15 mm x 15 mm) in 12 well culture plates (Nunclon, 
Denmark) and grown for 36 h to 50-70% confluence. The DMEM was then replaced with 2 
ml of DMEM without phenol red and glutamine (ICN) containing 1 M Hepes with 10% 
FCS prior to use for analysis of nuclear import. Nuclear import was analysed at the single 
cell level using mechanically perforated HTC cells in conjunction with CLSM (see Section 
2.8) (Efthymiadis et al., 1998; Jans et al., 1991; Xiao et al., 1996). Briefly, HTC cells 
grown on glass coverslips were rinsed with lx IB (see Table 2.1). Excess liquid was 
drained followed by adding 3 µl lx IB. A single layer of tissue paper was placed onto the 
cell monolayer and rapidly removed 3 seconds later to mechanically perforate the cells. The 
coverslip with perforated cells was then placed with the cell-bearing surface face down to 
the nuclear import mix, which had been prepipetted into a chamber on a slide created by 
0.1-mm-thick double-sided pressure-sensitive tape (Scotch 3M) into which a hole of 0.8 
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mm in diameter was punched. 
Experiments were performed in a 5 µl volume containing BSA (30 mg/ml) or cytosolic 
extract (untreated reticulocyte lysate, Promega), an ATP-regenerating system (0.125 mg/ml 
creatine kinase, 30 mM creatine phosphate, 2 mM ATP) and transport substrate or a control 
(70-kDa fluorescein isothiocyanate- or Texas-red-labelled dextran; Sigma) to assess nuclear 
integrity. In inhibition experiments, cytosolic extract or the transport substrate was 
preincubated at RT for 15 min with antibody ( 40 µg/ml) specific to Importin B (Santa 
Cruz). The coverslip was finally sealed with nail polish to prevent dehydration during the 
experiment at RT. 
Scanning over time (every 3-4 min over 15-45 min) was performed using a Nikon Optiphot 
or Bio-Rad 2000 microscope, using a 60x magnification oil immersion lens. 
Image analysis and curve fitting was performed as described (Efthymiadis et al., 1997; 
Xiao et al., 1997). Images obtained from CLSM were analysed using the NIH Image 1.62 
public domain software. The ratio (Fn/c) of nuclear (Fn) to cytoplasmic fluorescence (Fe) 
was determined as follows: 
Fn/c = (Fn - Fb) / (Fe - Fb), 
where Fn/c was the nuclear/cytoplasmic ratio, Fn the fluorescence in the nucleus, Fe the 
fluorescence in the cytoplasm, and Fb the background fluorescence due to 
autofluorescence. Experimental data for nuclear import kinetics over time was fitted with 
the following equation : 
Fn1c (t) = Fnlcmax (1 - e-~, 
using the KaleidaGraph 2.13 software (Macintosh). Fn/c (t) represents the nuclear/ 
cytoplasmic ratio at time t, Fn/cmax, the maximal level of nuclear accumulation, and k the 
import rate constant. 
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2.10 ELISA 
The binding of bacterially expressed GST-tagged mouse importins to IL-5NLS ~-gal fusion 
proteins and IL-5sc-HSA fusion protein was assessed using an ELISA-based binding assay 
(Efthymiadis et al., 1998; Efthymiadis et al., 1997; Hubner et al., 1997; Xiao et al., 1997). 
Proteins were coated into the wells of polystyrene microtiter plates (Nunclon) in triplicates 
at 0.5 µg/well using 50 mM NaHCO3 (pH 9.8) for 16 hat 4°C. The wells were blocked by 
adding 400 µl lx IB containing 1 % BSA for 1 hat RT with shaking (Platform rocker; Bio-
Line), and then washed 4 times with lx IB (Table 2.1) with the third wash being incubated 
for 1 h at RT as above. Serial dilutions of importins were then added in Hybridisation 
buffer (Table 2.1) to the microtiter plates and incubated for 16 h at 4 °C. After extensive 
washing with lx IB containing 1 % BSA, goat GST-specific antibody (500 ng/well) was 
added and the plates incubated for 3 h, and non-specifically bound antibody removed by 
washing 10 times with PBS containing 0.3% Tween-20 (Bio-Rad). Alkaline phosphatase-
conjugated rabbit anti-goat IgG (0.025 U of enzyme/well) was added and the plates 
incubated for 1 h at RT and washing performed as described for the primary antibody. 
Binding activity was then determined by adding the chromogenic substrate para-
nitrophenyl phosphate (p-NPP, 1 mg/ml, Sigma) dissolved in 10% diethanolamine and 0.5 
mM MgC12 (pH 9.8) and the change of absorbance at 405 nm followed over 90 min using a 
plate reader (Molecular Devices, Menlo Park, Ca, USA), with values corrected by 
subtracting both the absorbance at O min, and that in wells incubated without importins. 
Data were collected and stored using the Softmax software program (Mac intosh). 
Processing of the ELISA raw data and correction of values were carried out using the 
Microsoft Excel software (Efthymiadis et al., 1997; Hilbner et al., 1997). Binding affinity 
of proteins or peptides to importin subunits were evaluated by plotting the corrected 
absorbance for different importin concentrations against time using the KaleidaGraph 2.13 
software (Macintosh). Data in the linear range were used to obtain the OD change per min 
(OD/min), which was plotted against the concentration of importins. Curves obtained were 
fitted using the function: B(x) = B max (1- e-kx), where x is the concentration of importin, 
and B is the level of importin bound. The Kd, the apparent dissociation constant, 
representing the concentration of importins yielding half-maximal binding, was calculated 
from this equation. 
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2.11 Post-Embedding Immunogold Staining (Electron microscopy) 
Samples for electron microscopy were prepared following a procedure adapted from 
(Dvorak, 1989). Cells in suspension were washed 3 times in PBS and subsequently fixed in 
fixation buffer, containing 4 % PFA and 0.25 % glutaraldehyde (see Table 2.1). After 
fixation for 2 hours at 4°C, cells were washed in S-PBS (see Table 2.1) and then incubated 
for 1 h in SN-PBS containing 50 mM NH4Cl (see Table 2.1). Thin sections were prepared 
by the Electron microscopy unit, JCSMR. 
For immunostaining, thin sections were first incubated in blocking solution (see Table 2.1) 
for 30 min followed by incubation with the primary antibody for 18 hat 4°C. Cells were 
washed 3 times in PBS before incubation with the gold-labelled secondary antibody at 4 ° C 
for 1 h. Cells were washed 3 times in PBS, then contrasted with uranyl acetate and lead 
citrate and subsequently washed 6 x lmin in H20. Samples were viewed and photographed 
using a Philips EM301 electron microscope at 100 KV. 
2.12 Flow cytometry 
2.12.1 Flow cytometric studies of ligand-receptor interactions 
FDC-Pl cells grown to lxl 06 cells/ml, washed 3 times with factor-free RPMI (0.1 ¾BSA), 
and resuspended in cold PBS and aliquoted to 105 cells per sample. The cells were 
incubated with IL-5,...,Sfx for total binding or IL-5,...,Sfx with IL-5 in 100-fold excess for 30 
min on ice to avoid internalisation of the ligand. 
Flow cytometric measurements were performed using a F ACScan flow cytometer (Becton 
Dickinson Immunocytometry Systems, Inc.) with instrumental setting at FLl for 
measurements of fluorescein fluorescence (laser excitation at 488 nm and emission at 530 
nm, bandwidth 30 nm). Live cells were gated by light scattering or by exclusion of 
propidium iodide, and 10 000 events were acquired in each scan. 
The geometrical mean of the fluorescence intensity of gated cells was determined using 
CellQuest software (Becton Dickinson) for Macintosh. Subsequent analysis of data was 
performed using the Kaleida Graph 2.13 software (Macintosh). 
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2.12.2 Cell viability 
Prior to subcellular fractionation, cells were tested for viability using flow cytometry to 
ensure that the percentage of live cells was greater than 95%. 5xl 05 cells were resuspended 
in 500 µl PBS and 10 µl of propidium iodide (150 µg/ml) added and incubated for 10 min 
on ice. The fluorescence of cell nuclei as a measure of cell death was determined using the 
F ACScan flow cytometer with instrumental settings at FL2 for measurements of propidium 
iodide fluorescence (laser excitation at 488 nm and emission at 575 nm, bandwidth 42 nm). 
Data were analysed using the CellQuest software. 
2.13 In vivo fluorescence studies 
For in vivo subcellular localization studies, 107 FDC-mIL-5R cells were subcultured in 
factor free RPMI-1640 medium in 1 µM fluorescently labelled mIL-5-Sfx in the absence or 
presence of a 10-fold excess of unlabelled mIL-5 for various times at 37°C. After different 
times 106 cells were harvested into 15 ml centrifuge tubes, fresh factor free RPMI-1640 
medium added to make a final volume of 15 ml, and the cells centrifuged at 1500 rpm for 5 
min at l 8°C. Following removal of the supernatant, the cells were resuspended in 15 ml of 
medium and the wash repeated three times to remove any remaining factor. 
Cells were resuspended in 5 µl of medium and pipetted into a chamber on a slide created by 
0.2-mm-thick double-sided pressure-sensitive tape (Scotch 3M) into which a hole of 0.8 
mm in diameter was punched. A coverslip was mounted onto the slide and the cells sealed 
with nail polish to prevent dehydration during the experiment at RT. Cells were kept on ice 
until visualisation of fluorescence using CLSM. 
Image analysis of the CLSM files was performed using the NIH Image 1.49 public domain 
software to quantitate the membrane and nuclear fluorescence in the absence ( total binding) 
and presence (non-specific binding) of unlabelled hIL-5, with the latter subtracted from the 
former to give a measure of the fluorescence ( specific binding). 
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2.14 lmmunoblotting 
2.14.1 Western blotting 
Protein samples were transferred from the protein polyacrylamide gels onto nitrocellulose 
membrane (Schleicher & Schuell) using the Mini Trans-Blot Transfer cell (BioRad). 
First, two Whatman paper (Advantec MPS, Japan) and one western blot nitrocellulose 
transfer membrane (Schleicher & Schuell, Germany) were cut to size (9 x 7 cm & 8 x 6 cm 
accordingly) per gel. Membranes and gels were equilibrated in transfer buffer (Table 2.1) 
for 15-30 min, the transfer apparatus assembled according to the manufacturer's 
specifications and then run overnight at 10-30 V constant voltage. 
Transfer efficiency was checked by Coomassie staining the gels, while the membranes 
were incubated in blocking buffer (Table 2.1) for 60 min at RT on an orbital shaker 
(Ewards, Australia). The membranes were incubated in primary antibody for 60 min at RT, 
washed 3x10 min at RT with PBS-T, incubated for 1 h at RT in a secondary HRP-
conjugated antibody and washed again 3xl 0 min at RT with PBS-T. For protein detection 
the ECL Plus™ Western blotting system (Amersham Pharmacia Biotech) was used 
according to the manufacturer's specifications. Digital images were derived using the LAS-
1000 imaging system (Fuji, Japan). 
2.14.2 Stripping and re-probing 
Antibodies were removed from immunoblots using Re-Blot plus Stripping solution 
(Chemicon) according to the manufacturer's specifications. Wet blots were incubated in lx 
stripping solution with gentle mixing for 15 min at room temperature, washed in T-PBS 
and re-probed as described in Section 2.14.1. 
2.14.3 Semiquantitative analysis of immunoblots 
Semiquantitative analysis of immunoblots was carried out using the Image Gauge software 
(Fuji) in conjunction with KaleidaGraph 2.13 software (Macintosh). 
First, digital images of immunoblots were derived using the LAS-1000 imaging system 
(Fuji, Japan). The average signal of specific bands as well as background corresponding to 
each band on the immunoblot was determined and then signal values corrected by 
subtracting background values of protein-free membrane areas.-
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2.14.4 Dot Blot 
To assess the binding of IL-5 to importins under native conditions, dot blots were prepared 
with baculovirus-expressed IL-5 or E. coli expressed IL-5NLS-~-Gal fusion proteins. 8.4 
pmol of IL-5 or 16.8 mol of IL-5 NLS-~-Gal fusion proteins per sample were blotted onto 
nitrocellulose, the blots washed 3 times with PBS/Tween (0.3 % ) and blocked overnight in 
Ix IB/5 % BSA buffer. Blots were washed 4 times 10 min in lx IB/1 % BSA buffer and 
then incubated in pre-assembled Importin-GST mix (Table 2.1) overnight at 4 °C. After 
washing 4 times 10 min in PBS/Tween (0.3 %), blots were incubated in primary anti-GST 
antibody (lx IB/1 % BSA buffer) for 2 hours at RT, then washed 3 times and incubated 
with secondary AP-conjugated anti goat IgG antibody (lx IB/1 % BSA buffer) for 60 min 
at RT. Following 3 washes colouring solution was added and the reaction stopped after 2-
15 min by washing the blots with water. 
2.15 Cell fractionation and Whole cell lysis 
2.15.1 Whole cell lysis 
10 7 cells grown in suspension were washed twice in cold PBS and the pellet resuspended in 
800 µl RIPA buffer containing Protease inhibitors (see Table 2.1). The cell lysate was 
freeze-thawed twice in liquid nitrogen and subsequently passed through a 23-gauge needle 
five times to sheer the DNA in the lysate. The lysate was then centrifuged at 13.000g for 15 
mins at 4 °C (Eppendorf benchtop centrifuge) and the supernatant transferred into a fresh 
eppendorf tube and stored at -20°C until further use. 
2.15.2 Subcellular fractionation 
2 x 10 7 to 108 cells in suspension were harvested, washed twice with cold PBS, centrifuged 
at 1500 rpm for 5 mins at 4°C and then carefully resuspended in 1 ml ofNP-40 lysis buffer 
( see Table 2.1) per 2 x 10 7 cells. Prior to lysis, cell viability vvas checked as described in 
Section 2.12.2. After incubation in lysis buffer for 5 mins, the cells were pelleted by 
centrifugation at 3000 rpm at 4°C. The pellet containing the nuclei was carefully 
resuspended and washed twice in 40 ml lysis buffer lacking the detergent NP-40 and then 
-- ---
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centrifuged at 3000 rpm at 4 °C. The nuclear pellet was resuspended in 150 µl Nuclei lysis 
buffer (see Table 2.1) per 2 x 10 7 cells, centrifuged at 13 .000 g for 5 mins at 4 °C, the 
supernatant transferred into a fresh tube and stored at -20°C until further use. 
For fractionation experiments following incubation of cells with biotinylated ligands, 2 x 
1 0 7 to 108 cells in suspension were first starved for 4 hours in factor-free RPMI-1640 
medium ( see Table 2.1 ), the cell viability monitored as described in Section 12.12.2 and 
then the cells were incubated with the appropriate factor prior to fractionation as described 
above. 
2.15.3 Protein precipitation (Streptavidin-conjugated magnetobeads) 
For protein precipitation, subcellular fractions were incubated with 15 µl of magnetobeads 
(Dynal) per ml lysate. Prior to incubation, beads were washed 3 times with lysis buffer A+_ 
If cells were incubated with biotinylated factors before lysis, cell lysates were mixed with 
beads and incubated overnight with constant rotation at 4 °C. Beads were pulled down using 
a magnetic block holding 5 eppendorf tubes (Dynal), washed gently with PBS, and 
resuspended in 20 µl 2x SDS cracking buffer (Table 2.1 ). Samples were heated to 120°C 
for 10 min and loaded onto 4-20% gradient gels (Gradipore ). 
Electrophoresis was performed in Ix SDS buffer (Table 2.1) at 70 V until the bromophenol 
blue dye marker reached the bottom of the gel. Gels were prepared for Western blotting and 
proteins transferred as described in Section 2.14.1. 
2.16 Protein-Protein Electrophoretic Mobility Shift Assay (EMSA) 
Protein-protein interactions between cytokines and importins were assessed by gel mobility 
shift analysis . 300 nM of IL-5 ,__,biotin was incubated with 3000 nM importins in the 
presence of gel-shift binding buffer (see Table 2.1) for 20 min at RT. The samples were 
then subjected to electrophoretic separation through a non-denaturing TBE polyacrylamide 
gel (4-20%, Gradipore) at 60 V overnight at 4°C. The proteins were subsequently blotted 
onto Nitrocellulose membrane overnight at 30V, stained with Streptavidin-HRP 
(Chemicon, 1: 10.000), developed with ECL Plus (Amersham), and analyzed on the Fuji 
Film LAS 1000 using the Image Gauge software. 
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CHAPTER 3 PATHWAY OF NUCLEAR IMPORT OF IL-5 
3.1 Introduction 
IL-5 is a cytokine that primarily functions as a stimulus for eosinophil differentiation 
and activation. Although several IL-5 dependent signalling pathways have been 
identified, these pathways are shared with IL-3 and GM-CSP and are therefore unlikely 
to account for the specific role of IL-5 in eosinophil differentiation. A putative bipartite 
NLS, characterised by two clusters of basic amino acids separated by a spacer of 10-12 
amino acids, has been identified in both human and mouse IL-5 (Jans et al., 1997a; see 
Section 1.4, Fig. 1.8), raising the possibility that targeting of the IL-5/IL-5 receptor 
complex to the nucleus may play a more direct role in the response of eosinophils to the 
IL-5 signal. 
Mutagenic studies of bipartite NLS such as those of nucleoplasmin (Dingwall et al., 
1987), SWI5 (Moll et al., 1991), N1N2 (Hu and Jans, 1999), and retinoblastoma (Rb) 
protein (Efthymiadis et al., 1997) have established the necessity of both clusters of basic 
amino acids for nuclear targeting (Li and Etkin 1993; Robbins et al., 1991; Schmidt-
Zachmann and Nigg, 1993). 
In in vitro experiments the hIL-5 bipartite NLS region was able to target the 
heterologous E.coli protein B-galactosidase ( 4 76 kDa) to the nucleus. Substitution of 
lysines 95 and 96 in the proximal arm of the putative NLS region (NLS 1) by threonine 
residues abolished nuclear transport of the fusion protein, suggesting that this bipartite 
NLS is indeed responsible for targeting IL-5 to the nucleus, presumably not just in vitro 
but also in intact, receptor expressing·-cells (Jans et al. , 1997a). 
Additionally, it has been shown for IL-5 that it is capable of co-translocating its receptor 
subunits into the nucleus in vitro (Jans et al., 1997b ), with mutation of specific basic 
residues in the proximal arm (NLS 1) abolishing the ability to target its receptor subunits 
to the nucleus (Calanni, 1997). In contrast, mutations in the distal arm (NLS2) had no 
impact on the piggyback capacity of IL-5 (Calanni, 1997). 
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.___ ___ P_u_ta_t_iv_e_l L_-_s_N_IL_S_r_e_g_io_n ____ -1 ~-Gal 
hIL-5 wt LIKK YIDGQ KKK CGEE RRRV112 
hIL-5 NLSl- Litt YIDGQ KKK CGEE RRRV 
NLSl NLS3 NLS2 
Fig. 3.1. The putative NLS-region of hIL-5. The sequences for hIL-5(wt), and the 
hIL-5(NLS 1-) mutant form are indicated in the single letter amino acid code. Basic 
residues are indicated in bold. 
The aim of the investigations described in this chapter was to characterize the 
mechanisms by which IL-5 gains access to the nucleus and to investigate the role of 
putative NLS regions of amino acid residues within the primary sequence of IL-5 in the 
interaction with components of the cellular nuclear import machinery. 
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3.2 Flow cytometric approach for measuring the receptor binding 
capability of IL-5 and its NLS mutant derivatives 
Previous experiments have shown that, in contrast to the wild type form, the NLS 1 
mutant of m.IL-5 shows greatly reduced ability to co-transport its IL-5 receptor subunits 
into the nucleus in an in vitro nuclear transport system (Calanni, 1997). In addition, 
using an in vitro eosinophil differentiation assay (unpublished data, Takamoto, Shinshu 
University School of Medicine, Matsumoto, Japan), it has been shown that while mIL-5 
stimulated the production of eosinophil colonies in bone marrow cultures, the mIL-5 
NLS 1- mutant derivative was unable to do so. To exclude the possibility that the 
described phenomena were due to interference of the mutations in the NLS 1- region 
with high affinity receptor binding, the receptor binding properties of this mIL-5 NLS 
mutant derivative were examined using a flow cytometry based binding assay. 
To establish the feasibility of a flow cytometric approach for measuring the receptor-
binding of IL-5,....,Sfx, the fluorescence flow cytometric profiles of a FDC-mIL-5R cell 
line were compared with those of the original IL-5 receptor lacking cell lines FDC-Pl. 
The FDC-mIL-5R cells were responsive to IL-5 since they were stably transfected and 
expressed the m.IL-5 receptor a chain in addition to the endogenous mIL-5 ~-receptor 
subunit as described in Section 2.2.18 of Materials and Methods. Both cell lines were 
exposed to fluorescently labelled m.IL-5 and m.IL-5 NLS mutant derivatives in the range 
of 0.2-10 nM. At these low ligand concentrations, cytometric analysis discriminates 
between ligands associated with the cells and ligands remaining in solution, making 
removal of unbound ligand unnecessary (Sklar et al., 1984). 
The fluorescence cytometric profiles of FDC-mIL-5R cells incubated with mIL-
5(wt}....,Sfx are shown in Fig 3.2. Panel A shows the total binding of mIL-5(wt}....,Sfx to 
FDC cells expressing the m.IL-5 receptor. In a typical experiment, the geometrical mean 
of the fluorescence of non-treated cells was approximately 3, which arises from cellular 
autofluorescence. At concentrations of 10 nM the geometrical mean of the fluorescence 
typically reached a value 2-times greater than that of cells alone. 
When the cells were exposed to m.IL-5(wt}....,Sfx in the presence of a 100-fold excess of 
unlabelled m.IL-5 (Fig. 3 .2, Panel B), the fluorescence was drastically reduced, with the 
residual fluorescence attributable to non-specific binding. 
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Fig. 3.2. Fluorescence histogram of 
FDC-mIL-5R cells, incubated with 
increasing concentrations of 
mIL-5~Sfx. 
Cells of the mouse myeloid 
progenitor cell line FDC-Pl stably 
transfected with the cDNA 
corresponding to the alpha chain of 
the mIL-5 receptor were incubated 
for 3 0 min at 4 ° C with increasing 
concentrations of (A) 
mIL-5~Sfx (total binding) or (B) 
mIL-5~Sfx 1n the presence of 
unlabelled mIL-5 in 100-fold excess 
(non-specific binding) as described 
in Section 2.12.1 of Materials and 
Methods. For clarity, only four 
sample concentrations of mIL-5~Sfx 
are shown. 
Fig. 3.3. Fluorescence histogram of 
FDC-Pl cells, incubated with 
increasing concentrations of 
mIL-5~Sfx. 
Cells of the mouse myeloid 
progenitor cell line FDC-Pl lacking 
the mIL-5 receptor alpha subunit 
were incubated for 30 min at 4 °C 
with increasing concentrations of 
(A) mIL-5~Sfx (total binding) or (B) 
mIL-5~Sfx in the presence of 
unlabelled mIL-5 in 100-fold excess 
(non-specific binding) at 4 °C as 
described in Section 2.12.1 of 
Materials and Methods. 
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The fluorescence cytometric profiles of IL-5 receptor lacking FDC-Pl cells incubated 
with mIL-5(wt}---Sfx are shown in Fig. 3.3, Panels A and B. The fluorescence in panel A 
increased only slightly with increasing concentrations of mIL-5(wt}--,Sfx, again 
representing unspecific binding. 
Receptor binding curves from these cytometric data were derived by plotting the 
fluorescence versus the concentration of mIL-5,__,Sfx. Fig. 3 .4, Panel A shows the total 
and nonspecific binding of mIL-5,__,Sfx. The fluorescence due to non-specific binding 
was the fluorescence observed in the presence of unlabelled mIL-5 in 100-fold excess 
relative to mIL-5,__,Sfx. 
The specific binding of mIL-5,__,Sfx to FDC-mIL5R cells is shown in Fig 3 .4, Panel B. 
The specific binding is the difference between the total and non-specific binding of 
mIL-5,__,Sfx. The data for the specific binding were fitted for the function 
B(x) =B max (1 - e -kx), where B max is the maximal binding, k is the rate constant, and x 
is the concentration of fluorescently labelled ligand in nM. The kD value obtained from 
the binding curve of mIL-5(wt) to FDC-mIL-5R cells was 0.4 7 nM, which is of the 
same order of magnitude as published values (150 pM Mita et al. , 1989; Koike and 
Takatsu 1994). In comparison, mIL-5 did not show any significant specific binding to 
FDC-Pl cells (Fig. 3.4, Panels C and D). These experiments established that a flow 
cytometric approach could be used to investigate the receptor binding capabilities of the 
mIL-5 NLS 1- mutant derivative. 
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Fig. 3.4. Receptor binding of mlL-5,-..,Sfx using a flow cytometry-based binding assay. 
Typical receptor binding curves are shown for FDC cells expressing the mIL-5 receptor (Panels A and B) and FDC-Pl cells lacking the mIL-5 
receptor system (Panels C and D). The data were obtained from cytometric profiles as shown in Figures 3.2 and 3.3 and plotted as the 
geometrical mean of the fluorescence versus the concentration of mIL-5~Sfx. The curve for total binding was obtained in the presence of 
fluorescently labelled ligand, while the non-specific curve was acquired in the presence of additional unlabelled ligand in 100-fold excess 
(Panels A and C). The data were plotted for specific binding as the difference between the total and non-specific binding (Panels B and D, and 
fitted for the function B(x)=B max (1 - e -kx ), where Bmax is the maximal binding, k is the rate constant, and x is the concentration of ligand in 
nM. 
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3.3 The mIL-5 NLSl- mutant form of mIL-5 exhibits drastically 
reduced binding affinity to its receptor 
Using the flow cytometric approach for measuring the ligand-receptor interaction as 
described above, the binding capability of the mIL-5 NLS 1- mutant derivative was 
examined. Receptor binding of mIL-5 NLS 1 mutant was investigated using FDC-mIL-
5R cells exposed to the fluorescently labelled mIL-5 NLS 1- mutant derivative in the 
range of 0.2-10 nM and analysed by flow cytometry as described in Section 3.2. In 
contrast to wild type mIL-5, the mIL-5(NLS 1-) mutant derivative showed drastically 
reduced specific binding to FDC-mIL5R cells (Figs. 3 .5 and 3 .6), indicating that the 
binding affinity to the mIL-5 receptor system is severely affected by the mutation in the 
proximal arm of the putative NLS region of mIL-5. 
This would explain the results obtained for in vitro receptor piggy back experiments, in 
which the mIL-5(NLS 1-) mutant derivative failed to cotranslocate the soluble mIL-5 
receptor subunits to the nucleus (Calanni, 1997). It also suggests that the inability of this 
IL-5 mutant form to stimulate the production of eosinophil colonies in bone marrow 
cultures may have been due to a deficiency in high affinity binding to the IL-5 receptor, 
rather than specific interference with nuclear targeting of this NLS mutant derivative. 
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Fig. 3.6. Receptor binding of 
mIL-5~Sfx (NLSl-) mutant. 
Typical receptor binding curves are 
shown for FDC-mIL-5R cells. The 
data were obtained from 
cytometric profiles as in Fig. 3.5 
and plotted as the geometrical 
mean of the fluorescence versus 
concentration of the NLS 1-mutant 
derivative of mIL-5~Sfx. 
The curve for total binding was 
obtained in the presence of 
fluorescently labelled ligand, while 
the non-specific curve was 
acquired in the additional presence 
of unlabelled ligand in 100-fold 
excess (Panel A). 
The data were replotted for 
specific binding as the difference 
between the total and non-specific 
binding (Panel B). 
The data were fitted for the 
function B(x)=B max (1 - e -kx ), 
where Bmax is the maximal level 
of specific binding, k is the rate 
constant, and x is the concentration 
of ligand in nM. 
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3.4 Construction of a human IL-5-NLS3- mutant-p-Gal fusion 
Previous investigations of IL-5-mediated piggyback nuclear import of the IL-5 receptor 
subunits indicated that the distal arm of the IL-5 NLS-like region (NLS2) was not 
important for nuclear translocation of the ligand-receptor complex in vitro (Calanni, 
1997). These results implied that the putative NLS region of IL-5 might not be a 
conventional bipartite NLS, defined as two basic clusters linked by a 10 to 12 amino 
acid spacer sequence (Robbins et al., 1991). Therefore, the involvement of a third 
cluster (NLS3) between the distal and proximal cluster (Fig. 3.7.) in nuclear transport of 
IL-5 was investigated. 
One method to assess the functionality of an NLS is to test its ability to target the large 
E. coli ~-galactosidase enzyme (476 kDa) to the nucleus (Silver, 1984; Rihs, 1991). 
Previously, it has been shown that the IL-5wt-NLS was indeed capable of targeting 
B-galactosidase to the nucleus, while the hIL-5NLS1- mutant was unable to do so (Jans 
et al., 1997a). The new hIL-5 NLS3--B-Gal construct was derived from hIL-5wt-NLS-
~-Gal by mutation of the NLS3 region. Lysine 102 was substituted by asparagine, and 
lysine 104 was replaced by alanine to obtain the mutant sequence shown in Fig. 3. 7. 
____ P_u_ta_ti_v_e_l L_-_5_N_L_S_r_e_g_io_n __ -l 13-Gal 
hIL-5 wt LIKK YIDGQ KKK CGEE RRRV112 
hIL-5 NLs3- LIKK YIDGQ nKa CGEE RRRV 
NLSl NLS3 NLS2 
Fig 3.7. The hIL-5-NLS3--P-Gal fusion protein. The sequences for hIL-5(wt), and the 
hIL-5(NLS3-) mutant form are indicated in the single letter amino acid code. Basic 
residues and mutations therein are indicated in bold. 
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The plasmid expressing a hIL-5-NLS3--B-Gal fusion protein was generated by 
oligonucleotide site-directed, single strand mutagenesis of plasmid pPR2hIL5wt (Jans et 
al., 1997a). The primer hNLS3NKA (see Table 2.6) with both mutation and selection 
characteristics was utilised to generate the site-specific mutations, whereby the unique 
restriction site Bal I of the plasmid template was removed to serve as the basis for 
selection against non-mutated plasmids. The plasmid pPR2hIL5wt was heat denatured, 
the primer annealed and T4 DNA polymerase used to synthesise the new strand. The 
mixture was then treated with the restriction enzyme Bal I to linearize all non-mutated 
plasmids. The digested mixture consisting of mutated and wild type DNA was used to 
transform the repair-defective E. coli strain NM522 (mutS) (see Table 2.3) mutated in 
double-stranded DNA repair. Plasmid DNA was then isolated from the transformed 
cells and subjected to a second round of Bal I restriction enzyme selection to increase 
the proportion of mutated plasmids. The mixture was transformed into the E. coli strain 
MC 1060 (see Table 2.3) and plated on LBA plates. Constructs were screened by 
restriction analysis using Stu I, and a positive clone of the plasmid pPR2hNKA (see 
Table 2.5) sequenced to confirm its identity. The hIL-5-NLS3--B-Gal protein was 
expressed in E. coli MC 1060 cells and purified by affinity chromatography as described 
in Section 2.4 of Materials and Methods. It was subsequently labeled with IAF (see 
Section 2.3 .4) for nuclear transport studies. 
3.5 Nuclear import of human IL-5-NLS-~-Gal fusion protein is 
abolished in the NLS3- mutant 
Nuclear import of !AF-labelled IL-5-B-Gal fusion proteins was reconstituted using 
mechanically perforated cells in the presence of an ATP-regenerating system, and 
exogenously added cytosol as described in Section 2.9 of Materials and Methods. 
Fluorescence was visualized using CLSM and quantitation performed by image analysis 
(see Section 2.9). As previously shown, hIL-5wt-NLS-B-Gal accumulated in nuclei to 
levels approximately 3-fold those in the cytoplasm (Table 3.1), with half maximum 
accumulation achieved within c. 9 minutes. Nuclear accumulation hIL-5wt-NLS-B-Gal 
was found to be dependent on both ATP and exogenous cytosol, in identical fashion to 
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the NLS-containing T-ag-B-Gal fusion protein (Fig. 3.8, Table 3.1). Similarly, the non-
hydrolysable GTP analog GTPyS inhibited transport (Fig. 3.8, Table 3.1). The results 
thus implied that hIL-5wt-NLS-~-Gal localizes in the nucleus through an ATP- and 
cytosolic factor-dependent pathway inhibitable by GTP analogs, accumulation thus 
likely to be an NLS-dependent process dependent on importin and Ran/TC4. 
hlL-5-NLS-f:l-Gal T-ag -NLS-f:l-Gal 
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Fig. 3.8. Nuclear transport kinetics of the hlL-5-NLS-~-galactosidase fusion 
protein in vitro. 
Nuclear import was reconstituted in mechanically perforated HTC cells. Experiments 
were carried out in the presence and absence of exogenous cytosol and an ATP-
regenerating system or the non-hydrolysable GTP analog GTPyS (in the presence of 
exogenous cytosol and an ATP-regenerating system), as indicated. Where cytosol was 
not used, an equivalent concentration of BSA was included. Results are compared to 
those for an NLS-containing T-ag-~-galactosidase fusion protein. Data were fitted for 
the function Fn/c = Fn/c max (1-e-k:t), where Fn/c max is the maximal level of nuclear 
accumulation, k is the rate constant, and t is time in minutes. Pooled data are presented 
in Table 3 .1. 
Nuclear exclusion of hIL-5-NLSl--B-Gal (Fn/c max of 0.48) was observed as previously 
described (Jans et al., 1997a), consistent with NLSl (see Fig. 3.7) being integral to NLS 
function. The hIL-5-NLS3--B-Gal fusion protein was also completely excluded from the 
nucleus of mechanically perforated HTC cells, with an Fn/c max of approximately 0.5 
(Fig. 3 .9; Table 3 .1 ). 
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Fig. 3.9. Nuclear import of IL-5-NLS-~galactosidase fusion proteins in vitro. 
Nuclear import was reconstituted in mechanically perforated HTC cells. (A) CLSM images of 
nuclear accumulation of NLS-~-Galactosidase fusion proteins after 40 min in the presence of 
cytosol and an ATP-regenerating system. (B) Nuclear import kinetics from a single typical 
experiment performed as in (A) for NLS-~-Galactosidase fusion proteins in the presence of 
cytosol where each data point represents at least three separate measurements for each of Fn 
(nuclear fluorescence), Fe ( cytoplasmic fluorescence) , and background fluorescence. Data 
were fitted for the function Fn/c = Fn/c max (1-e-kt ), where Fn/c max is the maximal level of 
nuclear accumulation, k is the rate constant, and t is time in minutes. Pooled data are 
presented in Table 3 .1. 
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Table 3.1. Nuclear import kinetics of IL-5 and IL-5-B-galactosidase fusion protein 
derivatives compared to those of SV 40 T-ag-B-galactosidase fusion proteins in 
mechanically perforated HTC cells. 
Nuclear Import Parameter a 
Protein b Fn/c max t112 n 
hIL-5wt-NLS-~-Gal (1 x IB) 0.63 + 0.06 N.D.c 1 
hIL-5wt-NLS-~-Gal (+ATP/+ cytosol) 3.11 + 0.23 d 8.7 + 0.9 7 
hIL-5wt-NLS-~-Gal (+ ATP/ - cytosol) 1.19 + 0.07 d 5.3 + 0.5 1 
hIL-5wt-NLS-~-Gal (-ATP/+ cytosol) 1.24 + 0.11 d 3.5 + 0.6 1 
hIL-5wt-NLS-~-Gal (+ATP/+ cytosol/ 1.96 + 0.12 d 4.6 +0.3 1 
+ GTPyS) 
T-ag-NLS-~-Gal (1 x IB) 1.19 + 0.24 12 + 0.8 2 
T-ag-NLS-~-Gal (+ATP/+ cytosol) 9.67 + 0.32 25 + 0.9 8 
T-ag-NLS-~-Gal (+ ATP/ - cytosol) N.D. N.D. 
T-ag-NLS-~-Gal (~ATP/+ cytosol) 1.07 + 0.16 N.D. C 2 
T-ag-NLS-~-Gal (+ATP/+ cytosol/ 1.89 + 0.4 7.5 + 0.4 3 
+ GTPyS) 
T-ag-NLS-~-Gal (+ATP/+ cytosol 1.14+0.15 N.D. C 2 
+ CHAPS) 
T-ag-NLS-~-Gal (+ATP/+ cytosol 1.34 + 0.07 N.D. C 2 
+ anti Imp~) 
N1N2-NLS-~-Gal (+ATP/+ cytosol) 5.9 + 0.28 17.32+ 0.58 2 
hIL-5-NLSl--~-Gal (+ATP/+ cytosol) 0.48 + 0.29 N.D.c 2 
hIL-5-NLS3--~-Gal (+ATP/+ cytosol) 0.52 + 0.04 N.D.c 2 
mIL-5wt-NLS-~-Gal (+ATP/+ cytosol) 0.26 + 0.04 N.D.c 2 
-
-kt· 
a Results represent the mean± S.E. (n md1cated) from data fitted to the function Fn/c - Fn/cmax (1- e ) , 
where Fn/cmax is the maximal level of accumulation at steady state in the nucleus, k is the rate-
constant, and t is time in min. t 112 represents the time to reach half maximal accumulation and is 
calculated by the equation 0.693/k. 
b All experiments were performed in the presence of factors as indicated; where cytosol was not used, 
BSA ( 45mg/ml) was included 
cN.D., not able to be determined due to low nuclear accumulation; IB- intracellular buffer (see Table 
2.1) 
d SE was determined from the curve fit 
The best-characterised monopartite NLS is that of T-ag (residues 126-132; 
PKKKRKV), while the archetypal bipartite NLS is that of nucleoplasmin (Dingwall et 
al., 1982; Robbins et al., 1991). T-ag and X laevis phosphoprotein N1N2 NLSs are 
potent targeting signals, and B-Gal fusion proteins containing these NLSs were therefore 
used as control molecules. Nuclear levels of 10- and 6-fold those in the cytoplasm were 
observed for T-ag-B-Gal and N1N2-B-Gal respectively (Fig. 3.10; Table 3.1). 
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Fig. 3.10. Nuclear import of different NLS-~-galactosidase fusion proteins in vitro. 
Nuclear import was reconstituted in mechanically perforated HTC cells. Experiments were 
carried out in the presence of exogenous cytosol and an ATP-regenerating system. 
(A) CLSM images of nuclear accumulation ofNLS-~-galactosidase fusion proteins. 
(B) Nuclear import kinetics from a single typical experiment performed as in (A) for NLS-~ 
galactosidase fusion proteins. Pooled data are presented in Table 3 .1. 
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Taken together the effects of the IL-5 NLS 1- and NLS3- mutations, both basic clusters 
appear to be necessary for nuclear translocation of B-galactosidase. 
In order to assess the importance of the hIL-5 NLS3 sequence in IL-5 function, site 
directed mutagenesis was used to alter the hIL-5 sequence to introduce the identical 
mutation to that used in the hIL-5-NLS3--B-Gal fusion protein construct. However, the 
NLS3-deficient hIL-5 could not be expressed in the baculovirus system. It therefore 
proved impossible to assess the nuclear targeting ability on the part of the NLS3-
deficient hIL-5 in vitro, or to examine which IL-5 signalling functions were impaired. 
The basis of the lack of expression of the NLS3-deficient hIL-5 derivative was not 
determined directly, but was probably attributable to the introduced amino acid changes 
resulting in structural instability of the mutated IL-5 molecule. Similar observations 
were made before for an NLS I-deficient hIL-5 derivative (Jans and Young, unpublished 
data). 
3.6 Nuclear import is abolished in a mouse IL-5-NLS(wt)-~-Gal fusion 
protein 
Both the hIL-5 NLS 1 and NLS3 regions appeared to be necessary for targeting by the 
hIL-5 NLS of the heterologous B-Galactosidase protein to the nucleus. However, when 
the hIL-5 NLS is compared with the mIL-5 NLS, a marked difference in the NLS3 
region becomes apparent. Glycine at position 100 is exchanged to arginine, while the 
basic residue lysine 102 is replaced by glutamic acid (Fig. 3.11). 
The fact that the NLS region of human IL-5 was able to target the heterologous protein 
hIL-5-NLS-B-Gal to the nucleus raised the question of whether the mouse sequence was 
also able to translocate B-Gal to the nucleus. To analyze if the changes in the mouse IL-
5-NLS region had an impact on the capability of the region to translocate B-Gal to the 
nucleus, a mouse IL-5-NLS-B-Gal fusion protein construct was designed (see Fig. 3.11). 
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00]_c ___ o_ 
-I B-Gal ___________________ ___. Putative IL-5 NLS region 
hIL-5 wt LIKK YIDGQ KKK CGEE RRRV112 
mIL-5 wt LIKK YIDRQ KEK CGEE RRRV 111 
NLSl NLS3 NLS2 
Fig 3.11. The mIL-5wt-~-Gal fusion protein. The sequences for hIL-5(wt), and the 
mIL-5wt form are indicated in the single letter amino acid code. Basic residues are 
indicated in bold. 
To obtain the wild type sequence for mouse IL-5-NLS, lysine 103 and glycine 100 of 
the hIL-5-NLS(wt) sequence were substituted by glutamic acid and arginine 
respectively, whereby the mIL-5wtNLS-~-Gal construct was derived from hIL-5wt-
NLS-~-Gal by double stranded mutagenesis of the pPR2hIL-5wt plasmid (see Section 
2.2.14 of Materials and Methods). The primers mKEKsense and mKEKanti (see Table 
2.6) were utilized to generate the site-specific mutations, whereby the unique restriction 
site Bal I of the plasmid template was removed to serve as the basis for screening 
against non-mutated plasmids. The two synthetic oligonucleotide primers, each 
complementary to opposite strands of the vector, were extended during temperature 
cycling by native PfuTurbo DNA polymerase under conditions described in Section 
2.2.14 of Materials and Methods. On incorporation of the oligonucleotide primers, a 
mutated plasmid containing staggered nicks was generated. After temperature cycling, 
the product was treated with 10 units of the restriction endonuclease Dpn I for 1 hour at 
3 7°C to digest the parental DNA template and select for the synthesized DNA 
containing mutations. The resulting mix was digested with the restriction enzyme Dpn I, 
which is specific for methylated and hemi-methylated DNA. The nicked vector DNA 
incorporating the desired mutations was then transformed into the competent E.coli 
strain Top 10 F' (see Table 2.3) and cells grown overnight on LBA plates. Constructs 
were verified by colony PCR (see Section 2.2.16) and screened by restriction analysis 
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using Bal I and a positive clone plasmid pPR2mKEK sequenced to confirm its identity. 
The mIL-5wt-B-Gal protein was expressed in E. coli MCl 060 cells and purified by 
affinity chromatography as described for the other B-Gal fusion proteins. 
Nuclear import was assessed in vitro using mechanically perforated HTC cells in the 
presence of an ATP-regenerating system and exogenously added cytosol. The mIL-5wt-
NLS-B-Gal fusion protein was completely excluded from the nucleus of mechanically 
perforated HTC cells. Maximum nuclear accumulation levels were approximately 0.3 
relative to the cytoplasm (Fig 3.9; Table 3.1), comparable to those of hIL-5-NLSl--B-
Gal and hIL-5-NLS3--B-Gal, indicating that the mouse putative NLS region is not 
sufficient to target B-Gal to the nucleus in the in vitro nuclear transport assay. This 
raised the question of the role of the NLS region in nuclear import of IL-5 itself. 
3.7 Expression and labelling of mIL-5 and mutant derivatives 
In order to investigate the mechanistic basis of nuclear transport of IL-5 in the context 
of the entire IL-5 molecule, mIL-5 and NLS mutant derivatives were utilized for in vitro 
nuclear transport studies (Fig. 3.12). 
Beside an NLS 1- mutant, a monomeric form of mIL-5 was generated. In the native form 
of IL-5, the short loop between helices C and D prevents unimolecular folding of helix 
D into a functionally obligate structural motif (see Fig. 1.2 in Section 1.1.5). By 
lengthening this loop, an insertional, monomeric form of IL-5 can be created that shows 
biological activity similar to that of native IL-5 (Dickason and Huston, 1996). The 
introduction of the eight amino acid spacer between K 101 and E 102 separates the two 
lysines K101 and K103 , which makes the monomeric form comparable to the IL-5 NLS3-
mutant. 
mIL-5 and NLS mutant derivatives were expressed and purified by the Cytokine 
Molecular Biology and Signalling Group, JCSMR as described in Section 2.5 and 
fluorescently labelled as described in Section 2.3 .4 of Materials and Methods. 
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wt 
NLSr 
mono 
D 
Putative NLS Region 
SLIKK YIDRQ KEK CGEE RRR11 1 
SLiaa YIDRQ KEK CGEE RRR 
SLIKK YIDRQ KE-Baa spacer-K CGEE RRR 
Fig. 3.12. mIL-5 and its NLS mutant derivatives. The sequences for mIL-5(wt), the 
mIL-5(NLS 1-) mutant form and the monomeric mIL-5 form are indicated in the single 
letter amino acid code. Basic residues proposed to be crucial components of the NLS 
are indicated in bold. aa, amino acids 
3. 8 Nuclear import of IL-5 in vitro does not require cytosolic 
components 
In order to carry out kinetic measurements of IL-5 nuclear transport, baculovirus-
expressed Sfx-labelled IL-5 and NLS mutant derivatives thereof were used. The 
fluorescent derivatives retained biological activity in proliferation assays using mouse 
myeloid progenitor FDC-mIL-5R cells. 
The nuclear import kinetics of these SPX-labelled derivatives was measured in in vitro 
as described in the previous sections. 
In vitro nuclear transport assays with mIL-5 and its NLS mutant derivatives showed that 
wild type IL-5 as well as the NLS derivatives accumulated rapidly and strongly in the 
nucleus of HTC cells (Fig 3.12, Panels A and B; Table 3.2). Specifically, mIL-5wt 
accumulated in the nucleus to levels approximately 2.4-fold those in the cytoplasm, with 
half maximal accumulation achieved within 3 minutes (t 112 3 .15). The level of 
accumulation of the NLS mutants was similar to that of wild type. For the NLS 1 
mutant, nuclear accumulation was 2.4-fold higher than in the cytoplasm, with the half 
maximum accumulation achieved within c. 2 minutes (t112 1 .~2). The monomeric NLS3 
mutant form, showed 2.2-fold nuclear accumulation over cytoplasm, with half-
maximum accumulation attained at 1.5 minutes (Fig. 3.13). 
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Table 3.2. In vitro nuclear import kinetics for mlL-5 and NLS mutant derivatives. 
Nuclear Import Parameter a 
PROTEINb Fn/c max t112 n 
hlL-5-Sfx (1 x IB) 2.31 + 0.06 0.49 + 0.6 4 
hIL-5-Sfx (+ATP/+ cytosol) 2.09 + 0.19 0.39 + 0.36 6 
hIL-5-Sfx (+ATP/+ cytosol/ 1.90 + 0.03 0.63 + 0.5 2 
+ GTPyS) 
mlL-5-Sfx (1 x IB) 2.35 + 0.06 3.15 + 0.28 6 
. mIL-5-Sfx (+ATP/+ cytosol) 2.73 + 0.43 1.9 + 0.5 2 
mIL-5-Sfx (+ ATP/ - cytosol) 2.15 + 0.07 1.3 + 0.5 2 
mIL-5-Sfx (-ATP/+ cytosol) 2.30 + 0.38 d 1.8 + 0.7 1 
mIL-5-Sfx (+ATP/+ cytosol/ 1.90 + 0.10 d 0.76 + 0.4 1 
+ GTPyS) 
mIL-5(NLS1-) 2.40 + 0.12 1.92 + 0.16 3 
mlL-5(mono) 2.20 + 0.21 1.5 + 0.39 3 
mIL-5 +WGA 1.20 + 0.04 N.D. C 3 
mIL-5 + CHAPS 1.0 + 0.24 N.D.c 2 
mIL-5 + importin ~ (full length) 1.17+0.19 N.D.c 2 
mIL-5 + importin ~ (1-380) 2.60 + 0.33 5.78 + 0.47 2 
mIL-5 + importin a 2.26 + 0.09 d 5.47 + 0.14 1 
a 
-
-kt Results represent the mean± S.E. (n md1cated) from data fitted to the function Fn/c - Fnlcmax (1 - e ), 
where Fnlcmax is the maximal level of accumulation at steady state in the nucleus, k is the rate constant, 
and t is time in min. t 112 represents the time to reach half maximal accumulation and is calculated by the 
equation 
0.693/k. 
b All experiments were performed in the presence of factors as indicated; where cytosol was not used, 
BSA ( 45mg/ml) was included 
c N.D., not able to be determined due to low nuclear accumulation; IB- intracellular buffer (see Table 2.1) 
ct SE was determined from the curve fit 
As mentioned in Section 3 .5, NLS-dependent nuclear protein import in vitro 1s 
dependent on ATP. In vitro experiments were performed to investigate the dependence 
of mIL-5 nuclear import on ATP and cytosolic factors (Fig 3.14; Table 3.2). Maximal 
nuclear accumulation of mIL-5 was -dependent of neither ATP nor exogenous cytosol, 
although the rate of nuclear import was increased by about 2-fold (Table 3 .2), implying 
that nuclear import was accelerated by both ATP and cytosolic factors. GTPyS appeared 
to have little effect on nuclear import of mIL-5, in contrast to its strong inhibition of 
nuclear import of the NLS-containing T-ag B-Gal fusion protein (Fig.3.8; Table 3.1). 
A clear difference was thus observed in the dependence of the mIL-5 nuclear import on 
ATP and cytosolic factors compared to hIL-5 NLS-B-gal dependent on both ATP and 
exogenous cytosol (Table 3 .1; Fig. 3. 8), in identical fashion to conventional NLS-
containing B-Gal fusion proteins. 
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Fig. 3.13. Nuclear import of mIL-5 mutant derivatives in vitro. 
Nuclear import was reconstituted in mechanically perforated HTC cells. (A) CLSM images of 
nuclear accumulation of mIL-5-Sfx and derivatives after 30 min in the absence of exogenous 
cytosol or ATP. (B) Nuclear import kinetics from a single typical experiment performed as in 
(A) for mIL-Sfx and derivatives in the absence of cytosol where each data point represents at 
least three separate measurements for each of Fn (nuclear fluorescence), Fe (cytoplasmic 
fluorescence), and background fluorescence. Data were fitted for the function Fn/c = Fn/c max 
(1-e-kt ), where Fn/c max is the maximal level of nuclear accumulation, k is the rate constant, 
and tis time in minutes. Pooled data are presented in Table 3 .2. 
Similarly to mIL-5, maximal nuclear accumulation of hIL-5 was not dependent of ATP or 
exogenous cytosol, and the rate of nuclear import was similar with and without transport 
factors (Fig. 3 .14; Table 3 .2). Besides, GTPyS appeared to have no effect on nuclear import 
of hIL-5. 
3 
Fn/c 
2.5 
2 
1.5 
1 
0.5 
0 
3 
Fn/c 
2.5 
2 
1.5 
1 
0.5 
mIL-5 
• 
0 10 
hIL-5 
• 
6. 
• 
20 
Time (min) 
+ATP+ cytosol • 
• i 
:+- AT]l- cytosol 
+ATP+ cytosol 
+ GTPyS 
30 
- ATP - cytosol O 
40 
e+ATP+c 
• 6. • 
+ATP+ cytosol 6. 
+ GTPyS 
0 ,... __ ..... _____ .,...._...,...,___....,. _________ _ 
0 10 20 
Time (min) 
Fig. 3.14. Nuclear import of hIL-5 and mIL-5 in vitro. 
30 40 
Nuclear import was reconstituted in mechanically perforated HTC cells. Experiments 
were carried out in the presence and absence of exogenous cytosol and an ATP-
regenerating system or the non-hydrolysable GTP analog GTPyS (in the presence of 
exogenous cytosol and an ATP-regenerating system), as indicated. Data were fitted for 
the function Fn/c = Fn/c max (1-e-kt ), where Fn/c max is the maximal level of nuclear 
accumulation, k is the rate constant, and t is time in minutes. Pooled data are presented 
in Table 3 .2. 
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Thus, whereas hIL-5-NLS-B-Gal localizes in the nucleus through an ATP- and cytosolic 
factor-dependent pathway, baculovirus-expressed IL-5 and its NLS mutants do not 
require exogenously added cytosolic factors or ATP to accumulate in the nucleus, 
indicating that different mechanisms are responsible for nuclear transport of IL-5 itself 
and the IL-5-NLS-B-Gal fusion protein. 
3.9 Nuclear import of IL-5 in vitro is inhibited by WGA and CHAPS 
The recombinant protein mIL-5 and its NLS mutant derivatives used to investigate the 
nuclear targeting capability of IL-5 ( ,_,30 kDa) are smaller than the molecular weight 
cut-off (50 kDa) requirement for an NLS for nuclear targeting (Jans and Hilbner, 1996). 
It would the ref ore be expected that IL-5 may enter the nucleus by passive diffusion, 
with the nuclear accumulation observed in the previous experiment attributable to 
binding of mIL-5 and its NLS mutant derivatives to nuclear proteins or to DNA. To 
clarify this question, the nuclear translocation of mIL-5 and its NLS mutant derivatives 
was analysed following either the addition of WGA to the in vitro nuclear transport mix 
or the permeabilisation of the nuclear membrane with CHAPS as described in Section 
2.9 in Materials and Methods. 
To test whether nuclear accumulation of mIL-5 was due to diffusion through the NPC 
into the nucleus and binding of nuclear components, the nuclear envelope was 
permeabilized using the detergent CHAPS (Efthymiadis et al. , 1997). Under these 
conditions, nuclear accumulation can only occur through binding to nuclear 
components. Nuclear accumulation of mIL-5 in the nucleus of CHAPS-treated cells was 
abolished (Fn/c 1, Fig. 3 .15 Panel B; Table 3 .2), implying that the nuclear accumulation 
of mIL-5 evident" in Fig.3.12 occurred through an active transport process and not 
through binding to nuclear components. 
The lectin WGA is known to block nuclear transport of nuclear proteins through its 
ability to bind O-linked glycoside N-acetyl-glucosamine moieties on FxFG 
nucleoporins (see Section 1.2.3 ) . The essential role of these proteins in nuclear 
trafficking has been shown by the fact that depletion of WGA-binding nucleoporins 
from nuclei inhibits transport, with restoration of transport activity being achieved by 
readdition of the WGA-binding protein fraction (Finlay and Forbes 1990). 
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Fig. 3.15. Nuclear import of mIL-5-Sfx in vitro. 
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Nuclear import was reconstituted in mechanically perforated HTC cells. (A) CLSM images of 
nuclear accumulation of mIL-5-Sfx after 30 min in the absence or presence of CHAPS or 
WGA as indicated. (B) Nuclear import kinetics from a single typical experiment performed as 
in (A) for mIL-5-Sfx in the absence of cytosol with the additions as indicated where each data 
point represents at least three separate measurements for each ofFn (nuclear fluorescence), Fe 
( cytoplasmic fluorescence), and background fluorescence. Data were fitted for the function 
Fn/c = Fn/c max (1---e-kt ), where Fn/c max is the maximal level of nuclear accumulation, k is 
the rate constant, and tis time in minutes. Pooled data are presented in Table 3.2. 
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WGA drastically reduced nuclear accumulation of mIL-5, from original nuclear levels 
approximately 2.5-fold higher than in the cytoplasm to equal levels in the nucleus and 
cytoplasm (Fn/c 1.2, Fig. 3 .15), indicating that nucleoporins were required for IL-5 
nuclear transport which clearly therefore occurred through the NPC. 
3.10 Nuclear import of IL-5 in vitro is inhibited by full length importin 
~' but not by a C-terminally truncated importin ~ form (1-380) 
It is known that a number of proteins can translocate to the nucleus in an importin-
independent fashion. Examples are B-catenin (Fagotto et al., 1998), the human 
immunodeficiency virus accessory protein Tat (Efthymiadis et al. , 1998) or IFN-
induced nuclear factor IFI 16 (Briggs et al. , 2001; see Section 1.2.5). Furthermore, the 
nuclear transport of B-catenin in vitro is inhibited by the addition of importin B (Fagotto 
et al., 1998), believed to be due to competition with importin B for binding sites at 
nucleoporins. Detailed interactions between importin B and nucleoporins have been 
shown in vitro (Chi and Adam, 1997; Radu et al. , 1995; Rexach, 1995; Shah and 
Forbes, 1998) and in vivo (Damelin and Silver, 2000), with the interaction between 
nup3 5 8 and importin B possibly representing the initial docking step (Damelin and 
Silver, 2000; Rout et al., 2000; Ryan and Wente, 2000). 
In order to investigate the effect of exogenously added importin B on the nuclear 
transport of mIL-5 in vitro, full length human importin B was compared in its ability to 
inhibit nuclear transport of IL-5 with a truncated form spanning residues 1-380. Full 
length importin B was able to drastically reduce nuclear accumulation of mIL-5 to levels 
equal that of cytoplasm (Fn/c 1.17, Fig. 3 .16), implying that importin ~ does compete 
with IL-5 for binding sites at the nuclear pore complex. In contrast, neither importin a 
nor the truncated version of importin B had an effect on the nuclear accumulation of 
mIL-5 (Fig. 3 .16), suggesting that this truncated form may not compete for the same 
NPC-sites as importin ~. 
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Fig. 3.16. Inhibition of nuclear import of mIL-5-Sfx by importin ~ in vitro. 
Nuclear import was reconstituted in mechanically perforated HTC cells. (A) CLSM images of 
nuclear accumulation of mIL-5-Sfx after 30 min in the absence or presence of full length, C-
terminally truncated importin ~ (100 pM) or importin a (100 pM) as indicated. (B) Nuclear 
import kinetics from a single typical experiment performed as in (A) for mIL-5 in the absence of 
cytosol with the additions as indicated where each data point represents at least three separate 
measurements for each of Fn (nuclear fluorescence), Fe (cytoplasmic fluorescence), and 
background fluorescence Data were fitted for the function Fn/c = Fn/cmax (1-e-kt ), where 
Fn/cmax is the maximal level of nuclear accumulation, k is the rate constant, and t is time in 
minutes. Pooled data are presented in Table 3 .2. 
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3.11 Construction, expression and labelling of an IL-5-HSA fusion 
protein 
The experimental results for the IL-5 NLS B-galactosidase fusion proteins are in clear 
contrast to those for baculovirus-expressed IL-5 with respect to the requirement for ATP 
and cytosolic components for nuclear accumulation. Nuclear transport of the B-gal 
fusion proteins seems to depend on the addition of exogenously added ATP, cytosolic 
factors as well as on the functionality of the putative NLS region of IL-5. By contrast, 
baculovirus-expressed IL-5 as well as its NLS mutant derivatives are transported into 
the nucleus independently of those factors, with no marked differences shown between 
wild type and NLS mutants with regards to the kinetics of nuclear translocation. 
Clearly, baculovirus expressed IL-5 is approximately 30 kDa in MW and therefore 
below the "cut-off' value of 50 kDa for passive diffusion through the NPC, while the 
IL-5 NLS B-galactosidase fusion protein is a very large molecule of 476 kDa, by far 
exceeding the "cut-off' value of the NPC. The IL-5 NLS B-galactosidase fusion protein 
thus is not a very physiological model in terms of investigating the nuclear transport 
properties of IL-5 or sequences thereof. In order to assess the nuclear transport 
capabilities of IL-5 in a system better approximating the physiological situation, a single 
chained hIL-5 dimer construct was designed by David Mann, Cytokine Molecular 
Biology and Signalling Group, JCSMR (Fig. 3 .17). 
The hIL-5sc-HSA fusion protein has several advantages compared to the B-galactosidase 
fusion protein construct. First, it contains the complete sequence of hIL-5, which in the 
single chain form has been shown to be fully functional (Li et al., 1996). Secondly, the 
molecular weight of the HSA fusion protein is above the cut off value for passive 
diffusion through the NPC, but, by comparison with the IL-5 NLS B-gal fusion protein, 
does not exceed the size of a possible ligand-receptor complex (approx. 350 kDa), 
bearing in mind the observation that IL-5 is capable of piggybacking its soluble receptor 
subunits to the nucleus in vitro (Jans et al., 1997b ). 
0~01 SLIKK YIDGQ KKK GGEE RRR · 10 
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Fig. 3.17. Schematic representation of the human IL-5 single chain HSA fusion 
protein construct (hlL-Ssc-HSA). A gene encoding a single chain form of hIL-5 dim.er 
fused to HSA was constructed by linking the two hIL-5 chain coding regions with a 
Gly-Gly linker, and linking the hIL-5sc to HSA with a Gly-Thr-Gly linker. Expression 
of this gene using a baculovirus system. in Sf9 insect cells yielded a biologically active 
hIL-5 single chain HSA fusion protein (hIL-5sc-HSA). 
3.12 Nuclear import of the 93kDa hILSsc-HSA fusion protein in vitro 
does not require ATP or exogenously added cytosolic factors 
Nuclear import of the hIL-5 8 c-HSA fusion protein was assessed in vitro using 
mechanically perforated HTC cells. In vitro nuclear transport assays with hIL-5 8c-HSA 
showed that it accumulated rapidly in the nucleus of HTC cells (Fig 3.18, Table 3.3), to 
levels approximately 2.5-fold higher than those in the cytoplasm. (Fn/c 2.72). 
Half maxim.al accumulation was achieved within 3 minutes (t112 3.3), which is slower 
than that of hIL-5 (30 kDa) alone (see Fig. 3.13, Table 3.2), likely because the 
molecular weight of IL-5 8c-HSA fusion protein (93 kDa) is 3 times greater. In contrast, 
HSA-Sfx was completely excluded from. the nucleus (Fn/c 0.59), indicating that nuclear 
accumulation of hIL-5 8c-HSA was not due to the HSA moiety itself (Fig. 3 .18, Panel 
B). A control 70kDa Dextran molecule was unable to diffuse into the nucleus (Fig. 3.18, 
Panel A), showing that the nuclear m.em.brane was intact. 
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Fig. 3.18. Nuclear import of IL-5 -HSA in vitro. 
SC 
30 40 
Nuclear import was reconstituted in mechanically perforated HTC cells. (A) CLSM images of 
nuclear accumulation of IL-5sc-HSA-Sfx compared to HSA-Sfx after 30 min in the absence 
of exogenous cytosol or ATP. (B) Nuclear import kinetics from a single typical experiment 
performed as in (A) for HSA in the absence of cytosol where each data point represents at 
least three separate measurements for each of Fn (nuclear fluorescence), Fe (cytoplasmic 
fluorescence), and background fluorescence. Data were fitted for the function Fn/c = Fn/c max 
(1--e-kt ), where Fn/c max is the maximal level of nuclear accumulation, k is the rate constant, 
and tis time in minutes. Pooled data are presented in Table 3.3. 
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In vitro experiments were also performed to investigate the dependence of hIL-58c-HSA 
nuclear import on ATP and cytosolic factors (Fig. 3.19, Panel B; Table 3.3). Maximal 
nuclear accumulation of hIL-5 8c-HSA was independent of both ATP and exogenous 
cytosol, although the rate was slightly increased in their presence (t112 1.26), indicating 
that the nuclear import was accelerated to some extent by both ATP and cytosolic 
components. 
Table 3.3. In vitro nuclear import kinetics for hIL-5 sc-HSA. 
Nuclear Import Parameter a 
Protein Fn/c max t112 n 
hIL-5scHSA 2.7 + 0.07 3.46 + 0.48 6 
HSA 0.59 + 0.05 N.D. b 6 
1.58 + 0.11 b 3 hIL-5scHSA + CHAPS N.D. 
-
HSA+CHAPS 1.36 + 0.08 N.D. b 3 
hIL-5scHSA + cytosol/ATP 2.6 + 0.15 1.26 + 0.16 2 
HSA + cytosol/ATP 1.4+ 0.16 0.65 + 0.22 2 
-
hIL-5 sc HSA + anti-Imp B antibody 2.2+0.12 0.65 + 0.28 2 
-
a Results represent the mean± S.E. (n indicated) from data (see Figs. 3.18, 3.19) from 
distinct experiments fitted to the function Fn/c = Fnlcmax (1 - e-kt) , where Fnlcmax is the 
maximal level of accumulation at steady state in the nucleus, k is the rate constant, and t 
is time in min. t 112 represents the time to reach half maximal accumulation. 
bN .D. - not able to be determined. 
To test whether this accumulation was due to an active transport process, the nuclear 
envelope was permeabilised using the detergent CHAPS (Efthymiadis et al. , 1997). 
Under these conditions, nuclear accumulation of hIL-5 8c-HSA was drastically reduced, 
nuclear levels being only 1.6-fold higher than in the cytoplasm, compared to 1.4-fold for 
HSA (Fig. 3.19, Panel C; Table 3.3). The conventional NLS-containing T-ag-NLS-B-
Gal fusion protein showed comparable levels (Fn/c 1.2; Table 3 .1 ). The results implied 
that hIL-5 8c-HSA was unable to bind to nuclear components, implying that nuclear 
accumulation of hIL-5 8c-HSA in the presence of an intact nuclear membrane as seen in 
Fig 3.15 (Panel A) occurs through an active transport process. 
108 
A No addition + Cytosol +CHAPS 
B 3 
• No addition Fn/c 0 Fig. 3.19. Nuclear import of 
2.5 Cytosol o IL-S-HSA in vitro. 
Nuclear import was reconstituted in 
2 
mechanically perforated HTC cells. 
(A) CLSM 1.m.ages of nuclear 1.5 
accumulation of IL-5-HSA~Sfx 
1 after 30 mm ill the absence or 
presence of cytosol, CHAPS or anti-
0.5 i.mportin ~ antibody ( 40 µg /ml) as 
indicated. (B-D) Nuclear import 
0 kinetics from a single typical 0 10 20 30 40 
Time (min) experiment performed as in (A) for 
IL-5-HSA~Sfx ill the absence or 
C 3 + Chaps presence of cytosol (B), for IL-5-
Fn/c HSA-Sfx or HSA~Sfx ill the 
2.5 
presence of CHAPS (C) or for IL-5-
2 HSA~Sfx in the presence of anti-
I L-5 -HSA-Sfx i.mportin ~ antibody (D) as • SC • 
1.5 
• 
.. 0 indicated. Each data point represents 
00 HSA-Sfx at least three separate measurements 
1 for each of Fn (nuclear 
0.5 fluorescence), Fe ( cytoplasmic 
fluorescence), and background 
0 fluorescence. Data were fitted for 
0 10 20 30 40 the function Fn/c = Fn/c max (1-e-~, 
Time (min) 
where Fn/c max is the maximal level 
D 3 of nuclear accumulation, k is the Fn/c • 
• No addition rate constant, and t IS ti.me ill 2.5 
• • minutes. Pooled data are presented 0 in Table 3.3. 
2 anti-lmportin ~ 
antibody 
1.5 
1 
0.5 
0 
0 10 20 30 40 
Time (min) 
109 
3.13 Anti-importin p antibody does not prevent nuclear accumulation 
of IL-5sc-HSA 
The observation that hIL-58c-HSA can translocate into the nucleus of mechanically 
perforated HTC cells in the absence of cytosolic factors suggests that IL-58c-HSA 
import is independent of conventional importin and Ran-dependent pathways. However, 
cytosolic factors may not be completely depleted after cell permeabilization, with a 
small pool of importin B known to remain associated with the NPC (Gorlich et al. , 
1995; Fagotto et al., 1998; Schedlich et al., 2000), able to mediate nuclear import of 
factors such as insulin growth factor binding protein (IGFBP) 3. To exclude the 
involvement of importin B in the nuclear accumulation of hIL-58c-HSA, a specific 
antibody (Hubner et al., 1999) was used in the in vitro nuclear transport assay as 
described in Section 2.9 of Materials and Methods. 
Nuclear accumulation was not significantly reduced in the presence of anti-importin B 
antibody (Fn/c 2.2; Fig. 3.19, Panel D; Table 3.3), implying that importin B appears not 
to be involved in nuclear translocation of the IL-5 8c-HSA fusion protein. 
The same anti-importin B antibody was active in inhibiting nuclear accumulation of the 
importin a/B-recognised NLS-containing T-ag-NLS-B-galactosidase fusion protein (see 
Table 3 .1) as well as that of the importin B-recognised transcription factor CREB 
(Hubner et al. , 1991; Forwood, 2001) and IGFBP-3 (Schedlich et al. , 2000). 
3.14 IL-5 is not recognized by the conventional NLS-binding importin 
alp heterodimer 
Whilst nuclear transport of the hIL-5wt-NLS-B-Gal fusion protein is dependent on cytosolic 
factors, the baculovirus-expressed IL-5 forms as well as the hIL-5 8c-HSA fusion protein did 
not require exogenous factors to translocate into the nucleus, implying that importins do not 
play a role in their nuclear localization. A previously established enzyme-linked 
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immunosorbent assay (ELISA)-based importin binding assay was used (Efthymiadis et al., 
1997) to investigate whether importin a!B recognizes the IL-5 NLS. IL-5-NLS-B-Gal fusion 
proteins were coated onto microtiter plates, incubated with increasing amounts of importin 
a-GST, importin B-GST or pre-dimerized importin a/B-GST complex, and binding was 
quantitated using antibodies specific to GST and an alkaline phosphatase-labelled secondary 
antibody as described in Section 2.10 of Materials and Methods. In comparable fashion to 
previous measurements (Efthymiadis et al., 1998), the positive control T-ag-NLS B-Gal 
fusion protein was recognized by the importin a/B-GST complex with high affinity, 
showing an apparent dissociation constant (ko) of 10 nM (Fig. 3 .20). 
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Fig. 3.20. The NLS regions of mIL-Swt, hIL-5wt and mutant derivatives and 
hIL-Ssc~HS.A are not recognized by importins as quantitated using an ELISA-based 
binding assay. T-ag-NLS-~-Gal, mIL-5wt-NLS-~-Gal and mutant derivatives were 
expressed in E.coli as described in section 2.4. of Material and Methods. hIL-5-HSA was 
expressed in baculovirus system. Microtiter plates were coated with either T-Ag-NLS-~-
Gal, mIL-5wt-NLS-~-Gal, hIL-5wt-NLS-~-Gal, or hIL-5wt-~-Gal and derivatives and 
incubated with increasing concentrations of importin subunits. Data were fitted for the 
function B(x) B max (1 - e -k.x ), where xis the concentration of importin, and B the level of 
importin bound, with the apparent dissociation constants indicated. 
In contrast, the mouse and human wildtype IL-5-NLS-B-Gal fusion proteins as well as 
their NLS mutant derivatives exhibited no significant binding of the importin a/B-GST 
complex above that of B-galactosidase alone (Fig. 3 .20). 
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To exclude the possibility that this result was a consequence of the fact that the 
IL-5-NLS region is out of context in the tetrameric B-Gal fusion protein, even though it 
is functional in terms of NLS activity, an ELISA was used to investigate whether 
importin a!B would recognize the IL-5sc-HSA fusion protein. IL-5sc-HSA showed no 
detectable recognition of the importin a/B-GST complex above that of HSA alone (Fig. 
3.20). This lack of binding of the IL-5sc-HSA fusion protein by the conventional 
importin a!B NLS receptor was consistent with the in vitro nuclear transport results in 
that nuclear accumulation of the IL-5sc-HSA fusion protein does not require cytosolic 
factors. 
3.15 Discussion 
In this chapter, the mechanism of nuclear transport of IL-5 was investigated using an 
established in vitro nuclear import assay, representing the first quantitative analysis of 
nuclear transport of several mouse and human IL-5 NLS mutant derivatives and a 
human 
IL-5 8c-HSA fusion protein. Initial experiments (Jans et al., 1997a) had implied that 
human IL-5 contained a conventional bipartite NLS, but other studies (Calanni, 1997) 
and those presented here indicate that NLS3 rather than NLS2 (see Fig. 3.7) is a critical 
component of the functional NLS of hIL-5. Whilst the hIL-5wt-NLS was able to 
cotarget B-galactosidase into the nucleus, the hIL-5 NLS3- mutant fusion protein was 
completely excluded, implying an involvement of this basic region in nuclear transport 
of IL-5. It therefore seems reasonable to conclude that the hIL-5 NLS is not a classical 
bipartite NLS, but rather comprises a single cluster of lysine residues - KK YIDGQ 
KKK104, which is not recognized by the conventional importin a /B heterodimer. This 
NLS, however, appears to be functional in targeting B-galactosidase to the nucleus in an 
in vitro nuclear transport system. Ostensibly, nuclear import of this fusion protein seems 
to be through a conventional nuclear import pathway, in that it is dependent on ATP and 
cytosolic factors, and is inhibited by the non-hydrolysable GTP analogue GTPyS. Since 
the hIL-5-NLS-B-Gal protein is not recognized by importin a / B, however, it would 
-- ---
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seem that it does not enter the nucleus through a conventional importin a/B-mediated 
pathway. Additionally, the NLS region of mIL-5, in contrast to the hIL-5 NLS, was not 
able to target B-galactosidase to the nucleus, despite the presence of cytosolic factors 
and ATP. Clearly, under in vitro conditions the NLS of mouse IL-5 (KK YIDRQ 
KEK103) is not sufficient for nuclear targeting of such a large heterologous protein. 
In contrast to hIL-5-NLS-B-Gal, hIL-5, mIL-5 as well as hIL-5-HSA are transported 
into the nucleus without a requirement for exogenously added ATP or cytosolic factors. 
Additionally, nuclear transport of IL-5 was not blocked by GTPyS, indicating that Ran 
may not play a role in this process. Even though the size of baculovirus-expressed IL-5 
is below the molecular weight cut-off of the nuclear pore, it is clear from the CHAPS 
experiments described here that nuclear accumulation of hIL-5 and mIL-5 observed in 
vitro is achieved by active transport, rather than passive diffusion and subsequent 
binding to nuclear components. Further, since IL-S's in vivo role (see Chapter 5) may be 
to cotransport receptor molecules to the nucleus, examination of its nuclear import in 
isolation may not be fully comparable to the in vivo nuclear transport of a large IL-5 
receptor complex. 
Clearly, a significant difference was observed in the nuclear import characteristics of 
the B-Gal fusion protein compared to the IL-5-HSA fusion construct. This discrepancy 
may be explained by the distinct features of the molecules used. First of all, the IL-5-B-
Gal protein only contained the NLS region of IL-5 and forms a large, tetrameric 
complex, whilst the HSA protein was fused to the complete IL-5 sequence, consisting of 
a single-chained dimer. 
In accordance with the above findings, different experimental approaches suggest that 
IL-5 in its baculovirus-expressed form, or as a B-galactosidase or HSA fusion protein, is 
not recognized by the conventional importin a/B proteins, indicating that these do not 
mediate IL-5-NLS-dependent nuclear import. The possibility cannot be excluded that 
other importins or indeed other novel proteins factors are responsible for nuclear 
translocation of IL-5, since it has been observed that importins are not always 
completely removed during the perforation process in the in vitro nuclear transport 
assay (Schedlich et al., 2000; Forwood et al., 2001). Whatever the case in this regard, it 
seems clear that importin a/B is not involved. 
Since the HSA fusion protein contains the entire IL-5 sequence, novel importins or 
factors others than those involved in the conventional nuclear import may potentially 
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recognize regions of IL-5 other than the proposed NLS cluster and contribute to nuclear 
transport in an ATP and Ran-independent fashion as shown for a variety of other 
nuclear proteins (see Sections 1.2.5 and 6.2). 
The distinct requirements for in vitro nuclear transport of hIL-5wt-NLS-B-Gal and 
hIL-5 indicate that the B-galactosidase fusion protein is not an appropriate model to 
investigate IL-5 nuclear transport. This especially seems to be the case for mIL-5. 
Whilst mIL-5 nuclear transport is comparable to that of hIL-5 in all respects, mIL-5wt-
NLS-B-Gal, in contrast to hIL-5wt-NLS-B-Gal, was completely excluded from the 
nucleus. Thus, the construction of a mIL-5-HSA fusion protein instead of mIL-5-NLS-
B-Gal would allow further insight into the nature of the IL-5 NLS. Specifically, the 
features of the IL-5 NLS responsible for IL-5 nuclear translocation need to be further 
investigated. The HSA fusion protein would be most suitable as it contains the entire 
IL-5 molecule, shows comparable nuclear transport properties in terms of requirement 
for exogenously added cytosolic factors and ATP, and its size exceeds the molecular 
weight cut-off (50 kDa) of the NPC. Whether these requirements for the hIL-5sc-HSA 
nuclear import reflect those for a putative IL-5,....,IL-5 receptor complex remains to be 
determined. 
IL-5 seems to be able to interact directly with the nuclear envelope, implied by 
inhibition experiments with WGA and importin B, which presumably is the basis of the 
lack of a requirement for interaction with importin a/B for nuclear import. The 
competition by importin B suggests that either common or closely adjacent docking sites 
at the NPC for IL-5 and importin B may be involved. Analysis of the ability of IL-5 to 
bind nucleoporins would clarify this question. 
A problem of concern for future in vivo studies is the fact that amino acids within the 
putative NLS region of IL-5 are important for receptor binding, making mutagenic 
studies difficult. As shown here for the mIL-5 NLS 1- mutant derivative, NLS mutations 
can abolish high affinity binding to the IL-5 receptor, making conclusions about the 
physiological role of these NLS regions in vivo difficult. It is therefore an absolute 
requirement to verify receptor binding for NLS mutant derivatives, and the flow 
cytometry technique established here will undoubtedly be invaluable in such studies. 
- ---
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CHAPTER 4 SUBCELLULAR LOCALIZATION OF IL-5 
INV/VO 
4.1 Introduction 
That IL-5 has the ability to translocate into the nucleus has been documented using 
several different experimental systems, including in vitro (see Chapter 3) and in vivo 
(Jans et al., 1997a) nuclear transport assays, and transfected hIL-5 receptor expressing 
FDC-Pl mouse myeloid progenitor cells (which express the ~c receptor endogenously), 
treated with fluorescently labelled human IL-5 (Jans et al., 1997a). All of these systems 
revolve around the use of fluorescence microscopy, as do other indirect 
immunofluorescence studies, indicating that IL-5 can be targeted into the nucleus of an 
IL-5 receptor expressing human myeloid cell line AML14.3D10 (Calanni, 1997). This 
cell line can partially differentiate into eosinophils in the presence of IL-5 combined 
with GM-CSF (Paul et al., 1993). 
The aim of the work presented in this chapter was to use approaches other than 
fluorescence microscopy to confirm the ability of IL-5 to localise in the nucleus 
subsequent to receptor-mediated endocytosis (Jans et al., 1997a), where IL-5 , in 
contrast to the in vitro nuclear import assay described in the previous chapter, has to 
gain access to the nucleus by passing two consecutive, intact membrane systems, i.e., 
the cell membrane as well as the nuclear membrane of receptor-expressing cells. 
Three different approaches were utilized in order to assess the subcellular localization of 
IL-5 in a recently derived FDC-Pl cell line (FDC-mIL-5R) expressing the mouse IL-5a 
·-
receptor subunit from the high expression pEFBOS vector (pcDEF3mIL5Ra; see Table 
2.5 in Materials and Methods). 
Firstly, baculovirus-expressed IL-5 was fluorescently labelled and internalisation and 
subcellular localization of mIL-5-Sfx in IL-5 receptor expressing cells was investigated 
by means of confocal laser scan microscopy (CLSM) as previously done for hIL-5 (Jans 
et al., 1997a). Secondly, an immunogold labelling approach was used in which thin 
sections of IL-5 receptor bearing cells were immunostained with IL-5 specific 
antibodies and subsequently analysed by electron microscopy (Post-Embedding 
Immunogold Electron Microscopy). Thirdly, a novel, biochemical approach was 
developed, in which IL-5 receptor-expressing cells were incubated with biotinylated 
-- ---
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non-specific fluorescence gave a measure of the specific fluorescence due to binding of 
mIL-5 to the IL-5 receptor at 3 7°C. The 10-fold excess of unlabelled IL-5 was able to 
compete for binding, demonstrating that the process of binding was indeed receptor-
mediated. The membrane binding of IL-5 was rapid and reached maximum levels 
within the first 10 min. Over the time course of 400 min, the level of membrane binding 
did not drop markedly, implying that a steady state equilibrium between internalisation 
of the ligand-receptor complex and receptor recycling movement was reached. Specific 
nuclear fluorescence was detectable approximately 30 min after the addition of IL-
5,...,Sfx, reaching maximum levels at around 120 min, with approx. 20 % of the 
membrane bound amount of IL-5, the kinetics being comparable to the previous study 
with hIL-5 (Jans et al., 1997a). At 4°C the level of specific fluorescence at the 
membrane after 90 min was comparable to that at 3 7°C, but no nuclear mIL-5 was 
detectable. 
30 
25 
a> g .-- 20 
a.> 2 (.) ·-(/) C 
a> ::l 
o c.: 15 
::l co 
i+= l:; 
(.) ·-
·- ..c ~ ~ 10 
a> ---0. 
Cl) 
5 
10 30 60 120 
Time (min) 
240 400 4°c 
' 90 min 
Fig. 4.1. Nuclear localization of mIL-5-Sfx in vivo. 
Specific membrane and nuclear fluorescence due to membrane binding and internalisation of 
fluorescently labelled mIL-5 mouse by FDC-mIL-SR cells. Cells were incubated for various 
times at 37°C with 1 µM mIL-S(wt)~SFX in the absence and presence of a 10-fold excess of 
unlabelled mIL-5, prior to mounting and visualisation of fluorescence using CLSM as 
described in Section 2.13 of Materials and Methods. Image analysis was performed to 
quantitate membrane and nuclear fluorescence in the absence (total binding) and presence 
(non-specific binding) of unlabelled hIL-5, with the latter subtracted from the former to give a 
measure of the fluorescence due to specific binding (see Jans et al., 1997a). 
118 
The intrinsic difficulties of the quantitation procedure used in this approach, mainly due 
to the very high noise to signal ratio meant that alternative experimental approaches 
were necessary to verify the nuclear localization of IL-5 in intact cells. 
4.3 Electron microscopic study of nuclear import of IL-5 
The second approach to investigate nuclear localization of IL-5 in vivo used a post-
embedding immunogold technique as described in Section 2.11 of Materials and 
Methods. Thin sections were prepared of cells cultured either with or without IL-5 as 
well as of cells either expressing or lacking the IL-5 a receptor. Sections were 
subsequently stained with primary anti-IL-5 antibody following incubation with 10 nm 
colloidal gold conjugated secondary antibodies. Analysis of these sections revealed no 
detectable signal at the membrane, in the cytoplasm or in the nucleus of FDC-mIL-5R 
cells cultured in IL-5, suggesting that the approach was not suitable for the purpose of 
IL-5 detection, presumably due to the low numbers of receptor-bound and internalised 
IL-5 molecules. 
4.4 Cell fractionation studies of nuclear import of IL-5 
Cellular fractionation is a powerful tool in the analysis of subcellular distribution of 
proteins. It has been successfully employed to show the nuclear localization of several 
growth factors like NGF (Yankner and Shooter, 1979), EGF (Johnson, 1980; Savion et 
al., 1981), insulin (Goldfine et al., 1977), PDGF (Rakowicz-Szulczynska et al., 1986b) 
and others (for review see Burwen and Jones, 1987). 
Prior to fractionation experiments, the sensitivity of immunoblotting of anti IL-5 
antibodies ( see Table 2. 7) was determined using various recombinant human and mouse 
IL-5 variants. Fig. 4.2 shows the sensitivity of immunoblotting for the ligands tested, 
performed as described in Section 2.14 of Materials and Methods. 
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mIL-5 wt 111111 15 kDa 
500 250 120 60 30 ng 
mIL5 mono 11111 15 kDa 
400 300 200 ng 
hIL5 11111 20 kDa 
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Fig. 4.2. Sensitivity of immanoblotting of recombinant mIL-5, hIL-5, mIL-3 and 
derivates thereof. Proteins were expressed using the baculovirus system in Sf9 cells and 
purified by gel filtration followed by ion-exchange chromatography. Samples were 
prepared for SDS-PAGE and immunoblotted with the respective antibodies (see Table 2.7) 
as described in Section 2.14 of Materials and Methods. 
The detection limit for mouse IL-5 was very high. Specifically, 100 ng of mIL-5(wt) 
were needed for reliable detection, 200 ng of mIL-5(mono ), and 100 ng of mIL-3. In 
contrast, immunoblotting of human IL-5 was 10- to 100-fold more sensitive, where as 
little as 10 ng ofhIL-5(wt) and 1 ng of hIL-5scHSA could be detected. Since the IL-5sc 
HSA fusion protein could be detected with the highest sensitivity, it was chosen for 
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subsequent cell fractionation experiments. The cells used were FDC-hIL-5R cells, 
which are stable transfectants of the hIL-5 receptor a chain in addition to the 
endogenous mIL-5 ~-receptor subunit. 4x107 FDC-hIL-5R cells (see Jans et al., 1997a) 
were pre-incubated with 5 nM IL-5sc-HSA overnight and prepared for immunoblotting 
as described in Section 2.15 of Materials and Methods. 
Whilst IL-5sc-HSA was detectable in the media, nothing was detectable in the cytosolic 
or nuclear fractions (Fig. 4.3). Consistent with this, immunoblotting of a whole cell 
lysate did not reveal any signal for IL-5sc-HSA either, indicating that IL-5sc-HSA was 
internalised in FDC-hIL-5R cells to only negligible levels. 
1 2 3 4 5 
hIL-5 sc HSA fusion protein 
Lane 1: 400 ng hIL-5 HSA 
Lane 2: supernatant ( c. 4 ng hIL-5 HSA) 
Lane 3: lysate FDC-hRa 
Lane 4: cytosolic fraction FDC- hRa 
Lane 5: nuclear fraction FDC- hRa 
Fig. 4.3. Internalization of the human IL-5 sc HSA fusion protein. 
FDC-P 1 cells stably transfected with the cDNA corresponding to the alpha chain of the 
human IL-5 receptor, were lysed or fractionated as described in Sections 2.15 .1 and 
2.15.2. Samples were prepared for SDS-PAGE and immunoblotted with anti hIL-5 
antibody (see Table 2. 7) as described in Section 2.14. 
To investigate whether this lack of any detectable signal was due to interference with 
receptor-binding of the IL-5sc-HSA fusion protein, the receptor binding properties of the 
IL-5sc-HSA were examined using flow cytometry (see Section 2.12.1 of Materials and 
Methods). The receptor binding to the hIL-5sc-HSA fusion protein was compared to that 
of hIL-5(wt) using FDC-hIL-5R cells. Cells were exposed to the fluorescently labelled 
hIL-5 in the range of 0.2-10 nM and analysed as described in Section 3 .2. 
Fig. 4.4 shows the total binding of hIL-5(wt}--,Sfx to FDC-hIL-5R cells. Typical binding 
curves from the cytometric data were derived by plotting the relative fluorescence 
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versus the concentration of hlL-5(wt}__,Sfx (Fig. 4.5). Panel A shows the total and non-
specific binding of hlL-5(wt}__,Sfx. The specific binding of hIL-5(wt)~Sfx to FDC-
hlL5R cells is shown in panel B. The KD value obtained from this typical binding curve 
of hlL-5(wt) to FDC-hlL-5R cells was 1.2 nM, which is of the same order of magnitude 
as published values (Ingley and Young, 1991). 
In Fig. 4.6, the total binding of hIL-5 8c-HSA~Sfx to FDC-hlL-5R cells is shown. 
Typical binding curves were derived from the cytometric data by plotting the 
fluorescence versus the concentration of hlL-5 8c-HSA~Sfx (Fig. 4.7). The hlL-5 8c-
HSA~Sfx fusion protein showed drastically reduced specific binding to FDC-hIL5R 
cells (Fig. 4. 7 panel B ), indicating that binding to the IL-5 receptor is of very low 
affinity. This result suggests that the lack of detection of this hIL-5 form in the 
immunoblotting experiments are likely to be caused by a deficiency in high affinity 
binding to the IL-5 receptor, rendering attempts to localize hlL-5sc-HSA in the nucleus 
of FDC-mIL-5R cells impossible. 
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Fig. 4.4. Fluorescence histogram of FDC-hIL-5R cells incubated with increasing concen-
trations of human IL-5,-Sfx. 
FDC-Pl cells stably transfected with the cDNA for hIL-5Ra were incubated with increasing 
concentrations of hIL-5~Sfx at 4 °C and subjected to flow cytometry as described in Section 
2.12.1 of Materials and Methods. 
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Fig. 4.5. Receptor binding of 
hIL-5,--,S fx. 
Typical receptor binding curves are 
shown. The data were obtained 
from cytometric profiles as in Fig. 
4.4 and plotted as the geometrical 
mean of the fluorescence versus 
the concentration ofhIL-5~Sfx. 
The curve for total binding was 
obtained in the presence of 
fluorescently labelled ligand, while 
the non-specific curve was 
acquired in the presence of 
additional unlabelled ligand 1n 
100-fold excess (Panel A). 
The data were replotted for 
specific binding as the difference 
between the total and non-specific 
binding (Panel B). 
The data were fitted for the 
function B(x) =B max (1 - e -kx), 
where B max is maximal binding, k 
is the rate constant, and x is 
concentration of labelled hIL-5 in 
nM. 
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Fig. 4.6. Fluorescence histogram of FDC-hIL-5R cells, incubated with increasing concen-
trations of hlL-5sc-HSA~Sfx. 
FDC-Pl cells stably transfected with the cDNA for hIL-5Ra were incubated with increasing 
concentrations of hIL-5 -HSA~Sfx at 4 °C and subjected to flow cytometry as described in 
SC 
Section 2 .12 .1 of Materials and Methods. 
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Fig. 4.7. Receptor binding of 
hIL-5 sc -HSA ~Sfx. 
Typical receptor binding curves are 
shown. The data were obtained 
from cytometric profiles as in Fig. 
4.6 and plotted as the geometrical 
mean of the relative fluorescence 
versus the concentration of 
hIL-5sc-HSA~Sfx. 
The curve for total binding was 
obtained 1n the presence of 
fluorescently labelled hIL-5 -SC 
HSA, while the non-specific curve 
was acquired in the presence of 
unlabelled ligand 1n 100-fold 
excess (Panel A). 
The data were replotted for 
specific binding as the difference 
between the total and non-specific 
binding (Panel B). 
The data were fitted for the 
function B(x) =B max (1 - e -kx), 
where B max is maximum binding, 
k is the rate constant, and x is 
concentration of labelled ligand in 
nM. 
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4.5 Establishment of an immunoprecipitation procedure based on 
biotinylation of IL-5 and streptavidin-conjugated magneto beads 
As described in the Section 4.4, the sensitivity of immunoblotting of all recombinant 
ligands and their derivatives used was very low except for hIL-5 8c-HSA, which could 
not be used because of low receptor binding affinity. Another problem with the 
fractionation procedure was the fact that the large volumes of the nuclear fractions ( 500-
1000 µl) made additional concentration steps such as Trichloroacetic acid (TCA) 
precipitation or use of centricons necessary, potentially leading to a loss of protein. This 
fact, together with the expected low amounts of IL-5 in the nucleus of IL-5 receptor-
expressing cells subsequent to incubation at 3 7°C rendered successful detection of IL-5 
in the nucleus of FDC-mIL-5R cells unlikely. 
In order to overcome these problems and to circumvent the reliance on ligand-specific 
antibodies, an immunoprecipitation strategy was developed based on the incubation of 
IL-5 receptor-expressing cells with biotinylated mIL-5 and the utilization of 
streptavidin-conjugated magnetic beads for protein precipitation following cell lysis and 
fractionation of FDC-mIL-5R cells. 
Biotinylation of proteins takes advantage of the strong association between the bacterial 
protein streptavidin from Streptomyces spec. and the vitamin biotin, one of the strongest 
non-covalent interactions known (10- 15 M). The biotin derivative used here was the 
water-soluble Sulfo-NHS-LC-Biotin, which reacts with primary amines. Sulfo-NHS-
LC-Biotin is unable to permeate membranes and contains a 22.4 A long, non-cleavable 
spacer (Pierce, product information). This derivative has been used extensively for 
biotinylation of cell surface proteins (Altin et al., 1995) as well as biotinylation of 
antibodies and recombinant proteins. Ligands were biotinylated as described in Section 
2.3.5. To exclude the possibility that biotinylation of these ligands interfered with 
binding to their respective receptors proliferation assays were carried out with FDC-
mIL-5R cells as described in Section 2.7.3. of Materials and Methods. The biotinylated 
derivatives retained their biological activity (Table 4.2). 
Table 4.2. Biological activities of mIL-5 and mIL-3 and their biotinylated forms 
Biological activity 
Protein in units/mg 
mIL-5(wt) 2.7xl06 
mIL-5(wt}-biotin 2.7x 106 
mIL-3(wt) 4.4 X 10 7 
mIL-3 ( wt }-,biotin 2 X 106 
a Biological activities varied from batch to batch; representative samples were chosen, 
with labelled and unlabelled forms for any one derivative compared for the same batch. 
Activities were determined as described in Section 2.7.3 of Materials and Methods. 
mIL-5,-..Jbiotin 
60 30 15 7.5 4 2 1 0.5 ng 
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- 19kD 
mIL-5,-..Jbiotin L.... ------------ - - ----------
200 50 25 12 6 3 1.5 0.75 ng --
mIL-3,-..Jbiotin 
100 50 25 12 6 3 1.5 0.75 0.3 ng 
Fig. 4.8. Sensitivity of immunoblotting of biotinylated recombinant proteins mIL-5, 
monomeric mIL-5 and mIL-3. 
mIL-5, mIL-5 (monomeric form) and mIL-3 were labelled with biotin, samples prepared 
for SDS-P AGE and immunoblotted with HRP-conjugated streptavidin as described in 
Section 2.14 of Materials and Methods. 
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In Fig. 4.8 the detection limits of various biotinylated ligands are shown. After 
biotinylation, the sensitivity of immunoblotting increased dramatically compared to 
immunoblotting using ligand-specific antibodies. Specifically, as little as 1 ng of mIL-
5( wt }-..,biotin, 1.5 ng of mIL-5(mono}--biotin, and 0.75 ng of mIL-3,--..,biotin could be 
detected. 
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lane 1: 500 µl fraction + 10 µl beads 
lane 2: 1000 µl fraction + 20 µl beads 
lane 3: 1500 µl fraction+ 50 µl beads 
lane 4: 20 µl beads only 
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I I 
after precipitation of mIL-5,....,biotin 
~ .. with 15 µI streptavidin-conjugated 
_ _
magnetobeads 
25 50 100 200 ng 
Fig. 4.9. mIL-5 precipitation using Streptavidin-coupled Dynabeads. 
Dynabeads were tested for their ability to pull down biotinylated mouse IL-5. FDC-Plcells 
stably transfected with the cDNA corresponding to the alpha chain of the mouse IL-5 
receptor, were lysed and fractionated and biotinylated mIL-5 added to the cytoplasmic 
fraction. Different volumes of cytoplasmic fraction were incubated with different amounts 
of Dynabeads overnight at 4°C (A). Different amounts of mIL-5~biotin were incubated 
with 15µ1 Dynabeads overnight at 4°C (B). Samples were prepared for SDS-PAGE and 
immunoblotted with HRP-conjugated Streptavidin as described in Section 2.14 of 
Materials and Methods. 
The main advantage of ligand biotinylation is the possibility of precipitating IL-5 from 
large volumes using streptavidin-conjugated magnetic beads (Dynabeads, Dynal, Oslo, 
Sweden). To test the precipitation capabilities of this system, cytosolic fraction of FDC-
mIL-5R cells pre-incubated with 5 nM mIL-5,--..,biotin as described in section 2.15 of 
Materials and Methods were incubated with increasing amounts of beads. As shown in 
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panel A (Fig 4.9), 10 µl of Dynabeads were sufficient to pull down biotinylated mIL-5 
from 500 µl cytosolic fraction of FDC-mIL-5R. When 15 µl of beads were incubated 
with increasing amounts of IL-5,....,biotin, approximately 50 ng could be recovered (Fig. 
4.9, panel B). 
4.6 IL-5,....,biotin, but not IL-3,....,biotin is associated with the nuclear 
fraction of receptor expressing FDC cells 
In order to assess whether mIL-5,....,biotin can be translocated into the nucleus of intact 
IL-5-receptor expressing cells, 4xl 0 7 FDC-mIL-5R cells were grown and subsequently 
starved for 4 hours in factor-free media. Cells were then incubated overnight in 5 nM 
mIL-5,....,biotin under standard cell culture conditions and prepared for immunoblotting as 
described in Sections 2.14 and 2.15. Cell viability was verified before and after 
incubation with biotinylated factors as described in Section 2.12.2 of Materials and 
Methods. The percentage of dead cells was confirmed by flow cytometry, and only cell 
cultures with a vitality of 95 % or higher were used for further experimental procedures. 
A typical immunoblot for nuclear fractions is shown in Fig. 4.10. mIL-5,....,biotin was 
associated only with the nuclear fraction of FDC-mIL-5R cells, expressing both IL-5 
receptor subunits (Lane 3). In FDC-Pl cells lacking the a receptor subunit for mIL-5, 
no signal for mL-5,....,biotin could be detected (Lane 2). Likewise, when FDC-Pl cells, 
expressing both a and B subunits of the mIL-3 receptor endogenously, were incubated 
overnight in 5 nM mIL-3,....,biotin and prepared for immunoblotting, no signal for mIL-
3,....,biotin could be detected in the nuclear fraction of these cells. In the negative control, 
where Dynabeads were incubated in the nuclear fraction of FDC-mIL-5R cells not pre-
incubated with mIL-5,....,biotin, no signal was detected in the region of 15 to 25 kDa (lane 
7), indicating that the signal for mIL-5 in the nuclear fraction of FDC-mIL-5R cells was 
specific for mIL-5,....,biotin. 
These results suggest that mIL-5 is translocated to the nucleus in intact, IL-5-receptor-
expressing cells. This is specific to IL-5, in that, even though the IL-3 receptor is 
expressed in the FDC-Pl cells, it does not occur for IL-3. 
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20kDa 
Lane Cell type Receptor for Ligand 
1 positive control mIL-5~biotin 15 ng 
2 FDC-Pl mIL-3 mIL-5~biotin 
3 FDC-mIL-5Ra mIL-3 mIL-5 
' 
mIL-5~biotin 
4 FDC-Pl mIL-3 mIL-3~biotin 
5 FDC-mIL-5Ra mIL-3 mIL-5 
' 
mIL-3~biotin 
6 positive control mIL-3~biotin 15 ng 
7 negative control beads alone 20 µl 
Fig. 4.10. mlL-5, but not mIL-3, is associated with the nuclear fraction of myeloid 
progenitor cells FDC-mIL-SRa. 
FDC-Pl cells, stably transfected with the cDNA corresponding to the alpha chain of the 
mouse IL-5 receptor, were incubated with biotinylated mIL-5 or mIL-3 overnight. Nuclear 
fractions were prepared and subsequently precipitated with Streptavidin-conjugated 
Dynabeads overnight at 4 °C. Samples were prepared for SDS-PAGE and immunoblotted 
with HRP-conjugated Streptavidin as described in Section 2.14 of Materials and Methods. 
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In order to estimate the relative amount of IL-5 localized in the nuclear fraction in 
comparison to the cytosolic fraction, both fractions were directly compared by 
immunoblotting. 
A 1 2C 2N 3C 3N 4 
Lane Cell type Fraction Ligand 
1 positive control mlL-5~biotin 15ng 
2C FDC-mIL-5Ra cytosol mIL-5~biotin 
2N FDC-mIL-5Ra nuclear mIL-5~biotin 
3C FDC-Pl cytosol mIL-3~biotin 
3N FDC-Pl nuclear mIL-3~biotin 
4 positive control mIL-3~biotin 15ng 
5 negative control beads alone 20µ1 
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Fig. 4.11. The cytosolic and nuclear distribution of mIL-S~biotin and 
mIL-3~biotin in FDC-Pl/mIL-5Ra cells. 
FDC-Pl cells, stably transfected with the cDNA corresponding to the alpha chain of the 
mouse IL-5 receptor, were incubated with biotinylated mIL-5 or mIL-3 over night. 
Cytoplasmic ( c) and nuclear (N) fractions were prepared and subsequently precipitated with 
Streptavidin-conjugated Dynabeads overnight at 4°C. Samples were prepared for SDS-
PAGE and immunoblotted with HRP-conjugated Streptavidin (A). Protein levels in the 
_cytoplasm (B) and in the nucleus (C) were quantitated as described in Section 2.14.3 of 
Materials and Methods. 
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Panel A (Fig. 4.11) shows that mIL-5,....,biotin could be detected in the cytosolic fraction 
as well as in the nuclear fraction of FDC-mIL-5Rcells. 
In contrast, mIL-3,....,biotin was associated exclusively with the cytosolic fraction, and 
could not be detected in the nuclear portion of mIL-3 receptor-expressing cells. The 
immunoblots were subjected to quantitative analysis using Image Gauge software (Fuji, 
Japan) as described in Section 2.14.3. Compared to the amount of mIL-5,....,biotin 
associated with the cytosolic fraction of FDC-mIL-5R cells, almost 8% was present in 
the nucleus. In comparison, only a faint signal was detected in the nucleus of FDC-Pl 
cells incubated in mIL-3,....,biotin (Fig. 4.11 A and B). These results indicated that only a 
small fraction of IL-5 was translocated to the nucleus of IL-5 receptor expressing cells, 
the greater part of receptor-bound ligand presumably remaining at the membrane or 
traffics through the lysosomal pathway. The low cytosolic amount of IL-3 complicates a 
comparison with IL-5 since the numbers of expressed cell surface receptors for IL-3 is 
greatly reduced compared to that for IL-5. 
To exclude the possibility that the mIL-5,....,biotin signal detected in the nucleus of FDC-
mIL-5R cells was caused by contamination during the lysis and fractionation procedure, 
a control fractionation was performed. This control was comparable in all respects to the 
experimental procedure involving FDC-mIL-5R cells with the exception that the cells 
were not pre-incubated with mIL-5 overnight, but instead were treated with cell lysis 
buffer spiked with mIL-5,....,biotin. 
When immunoblots of both procedures were compared, only the FDC-mIL-5R cells 
pre-incubated with IL-5 showed a detectable signal in the nucleus, but not the spiked 
control (Fig. 4.12). This difference appeared despite comparable amounts of IL-5 in the 
cytosolic fractions, indicating that the signal in the nuclear fraction of FDC-mIL-5R 
cells was indeed specific and not due to an experimental artefact. 
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Lane 1: 15 ng mIL-5,....,biotin 
Lane 2: cytoplasmic fraction FDC-mIL-5Ra (C) 
Lane 3: nuclear fraction FDC-mIL-5Ra (N) 
Lane 4: supernatant cell culture (SIN) 
Lane 5: wash between C and N (W) 
Fig. 4.12. Control for cytoplasmic contamination of the nuclear 
fraction. 
FDC-Pl cells, stably transfected with the cDNA corresponding to the alpha chain of 
the mouse IL-5 receptor, were incubated with mIL-5~biotin (A) or nonbiotinylated 
mIL-5 (B) overnight. Cytoplasmic (C) and nuclear (N) fractions were prepared as 
described in Section 2.15. To verify that the nuclear fraction was not contaminated 
with cytoplasmic proteins during the fractionation procedure, a control (B), 
comparable in all respects but not incubated with mIL-5~biotin was spiked with 
biotinylated mIL-5 immediately prior to lysis for fractionation. Subsequently mIL-
5~biotin was precipitated by incubation of all fractions with Streptavidin-conjugated 
Dynabeads overnight at 4°C. Samples were prepared for SDS-PAGE and 
immunoblotted with HRP-conjugated Streptavidin as described in Section 2.14. 
4. 7 Discussion 
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This chapter reports the first biochemical evidence that IL-5 can be translocated into the 
nucleus of an IL-5 receptor expressing cell line subsequent to receptor-mediated 
endocytosis. Cell fractionation experiments using a biotinylated form of mIL-5 showed 
that nuclear translocation is specific for IL-5, with the control experiments in Fig. 4.12 
demonstrating that the results are not attributable to cross-contamination of cytosolic 
and nuclear fractions. 
The biochemical approach developed here required the use of sufficiently high cell 
numbers to ensure that the number of IL-5 molecules per sample was higher than the 
-- -·--
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detection limit. Subsequent SDS PAGE and immunoblotting permitted the 
discrimination between background noise and specific signal for IL-5. 
Importantly, biotiny lation of the ligands had the advantage of making their detection in 
the cell fractions independent of ligand-specific antibodies, facilitating direct 
comparison between the IL-3 and IL-5 ligands. 
By comparison, the electron microscopy approach was unsuccessful, presumably 
because the small amount of native antigen on the surface of the sections is beyond 
reliable detection. This result is consistent with previously published immunogold 
staining of eosinophils (Dubucquoi et al., 1994) and mast cells (Wilson et al., 2000), 
where no IL-5 was detected in the nucleus of those cells. 
Direct immunofluorescence studies, in contrast, did detect an increase over time of 
specific signal in the nucleus of cells exposed to IL-5, but had the problem of 
background signal accounting for much of the overall signal, which made validation 
difficult (see however Jans et al., 1997). Additionally, the amount of IL-5 used in the 
biochemical approach presumably is with 5 nM much closer to physiological 
concentrations than the amount used in the immunofluorescence studies ( c. 1 µM). 
Further investigations should of course include primary cells like eosinophils to clarify 
whether nuclear transport of IL-5 can also occur in primary target cells under 
physiological conditions. 
CHAPTERS 
5.1 Introduction 
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SUBCELLULAR LOCALIZATION OF 
THE IL-5 RECEPTOR IN INTACT CELLS 
Over the past three decades much evidence has been accumulated to support the 
hypothesis that membrane receptors of growth factors and cytokines can also be 
localized in the nucleus, implying that these receptors may have a direct role in 
intracellular and nuclear signalling in addition to their well-established role of 
mediating signal transduction at the cell membrane. Well-studied examples for 
nuclearly localized receptors are those for NGF (Rakowicz-Szulczynska, 1986), EGF 
(Rakowicz-Szulczynska, 1989), FGF-1 (Prudovsky, 1994), FGF-2 (Maher, 1996), IL-1 
(Curtis, 1990) and GH (Lobie, 1994; Waters, 1994). 
In previous investigations using an in vitro nuclear transport assay, mIL-5 appeared to 
be able of cotargeting the extracellular domains of the IL-5 receptor as a receptor 
complex to the nucleus of rat hepatoma HTC cells (Jans et al., 1997ab). Additionally, 
indirect immunofluorescence studies with intact, IL-5 receptor expressing cells also 
indicated nuclear localization of the full-length, membrane bound IL-5 receptor a and~ 
subunit (Calanni, 1997). Immunofluorescence results, however, need to be treated 
carefully, especially when the background to signal ratio is very high. Confirmation of 
observations using biochemical or other approaches is clearly desirable. 
Cell fractionation has the advantage of permitting the separation of proteins by size 
before immunoblotting. Additionally, immunofluorescence studies with antibodies 
specific to one particular region of the antigen do not answer the question of whether 
the protein is present in its complete or partially degraded form. 
The aim of this chapter was to provide evidence for the nuclear localization of the IL-5 
receptor in intact cells by using subcellular fractionation, and to assess whether the 
receptor is co-localized in the nucleus with IL-5. To this end, biochemical analysis was 
performed, in which IL-5 receptor-expressing cells were subjected to cell lysis and 
fractionation with subsequent immunoblotting procedure. 
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5.2 Immunoblotting of the receptor subunits of the IL-3/IL-5/GM-
CSF receptor system using subunit-specific antibodies 
To establish whether nuclear localization is specific for the IL-5 receptor system and 
does not occur for the IL-3 or GM-CSF specific a receptor subunits, commercially 
available antibodies specifically recognizing the IL3, IL-5 or GM-CSF receptor a 
chains were tested for their ability to detect their antigens. 
Mouse myeloid progenitor FDC-P 1 cells, expressing the receptor systems for all three 
ligands were cultured in the presence of one of the three baculovirus-expressed IL-3, IL-
5 or GM-CSF for 4 weeks and then subjected to a whole cell lysis procedure as 
described in Section 2.15.1. Lysates were then prepared for SDS Page and 
immunoblotting with the respective primary antibodies (see Table 2. 7) and the 
appropriate horseradish-peroxidase (HRP)-conjugated secondary antibodies (see Table 
2.8), prior to analysis using the LAS-1000 system and Image Gauge software. 
A 1 
70k.D 
C 
70 k.Da_ " _ 
2 B 
mIL-5Ra 
Lane 1: FDC-Pl 
Lane 2: FDC-mIL5Ra 
-
mIL-3Ra 
FDC-Pl, + mIL-3 
D 
170 k.Da mR~common 
FDC-mIL5Ra 
70k.Da 
.. 
mGM-CSFRa 
FDC-Pl, + mGM-CSF 
~- 70k.Da 
Fig. 5.1. Immunoblotting of receptor subunits for mouse IL-5, IL-3 and GM-CSF. 
Cells of the myeloid progenitor cell line FDC-Pl, stably transfected with the mouse IL-5 
receptor a subunit, were lysed as described in Section 2.15.1. Samples were prepared 
for SDS-PAGE and immunoblotted with the respective antibodies (see Table 2.7). 
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As shown in Fig. 5.1, a single specific, approx. 70 kDa band was detected for the mIL-5 
receptor a subunit of FDC-mIL-5R cells, which did not appear in the lysate of FDC-Pl 
cells lacking the IL-5 receptor a chain (panel A). No signal could be detected for the 
mBc subunit (panel B). For mIL-3 receptor a, one specific band was visible at c. 70 
kDa, and one additional band appeared above 100 kDa (panel C). No signal was 
detectable for the mGM-CSF receptor a chain (panel D). The lack of signal for Be and 
GM-CSP Ra chain presumably is due to the low quality of the commercial antibody. 
5.3 Subcellular localization of the mIL-5 receptor a chain in mIL-5 
receptor expressing FDC cells 
The evaluation of the capability of the receptor-specific antibodies to recognize their 
respective receptor subunits indicated that immunoblotting using anti-IL-5 receptor a 
antibody was sufficiently sensitive to detect the IL-SR a subunit in whole cell lysates. 
In order to assess the subcellular localization of the mIL-5 receptor, FDC-P 1 cells as 
well as FDC-mIL-5R cells were grown in IL-3 or IL-5 respectively, prior to subcellular 
fractionation (Section 2.15). 
Cells with a vitality of 95 % or higher were used for further experimental procedures, 
--
and before nuclear lysis, the integrity of the nuclei was confirmed by light microscopy. 
To avoid contamination of the nuclear fraction with cytosolic components, nuclei were 
washed twice before nuclear lysis (Section 2.15.2). 
As shown in Fig. 5 .2, the mIL-5 · receptor a subunit could be detected in both the 
cytosolic as well as in the nuclear fraction of FDC-mIL-5R cells cultured in mIL-5 
(lanes 3 and 4). The immunoblotting revealed that the endocytosed mIL-5 receptor a 
associated with the nuclear fraction was intact, and no breakdown products were 
detected on the immunoblot, indicating that the receptor reached the nucleus in its full-
length form. In contrast, no receptor was detected in the fractions of FDC-Pl cells 
lacking the mIL-5 receptor a subunit, indicating the specificity of the result. 
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Fig. 5.2. Nuclear localization of the mouse IL-5 receptor alpha subunit is dependent 
on mIL-5. 
Cytosolic and nuclear extracts were prepared from FDC-mIL-5Ra cells (see Section 
2.15 .2). Extracts were prepared for SDS-PAGE, and immunoblotted with anti-IL-5Ra 
antibody (A). Protein levels in the cytoplasm and in the nucleus (B) were quantitated by 
densitometry (ECL Plus, Amersham) using Image Gauge software, and values normalized 
to amount protein/I 06 cells. 
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5.4 Nuclear localization of mIL-5 receptor a is dependent on IL-5 
If the in vitro observations regarding IL-5 cotargeting its receptor subunits to the 
nucleus (Jans et al., 1997b; Calanni, 1997) are physiologically relevant, than nuclear 
localization of the IL-5 receptor would be predicted to occur in an IL-5-dependent 
fashion in intact cells expressing the full length, membrane bound receptor. To 
investigate the IL-5 dependence of the receptor nuclear transport, FDC-mIL-5Ra cells 
were cultured without mIL-5 for a period of four weeks in the presence of mIL-3 and 
subcellular localization of the IL-5 receptor compared to FDC-mIL-5Ra cells 
constantly cultured in mIL-5. 
Subsequently cells were subjected to subcellular fractionation prior to SDS-P AGE and 
immunoblotting with an IL-5 receptor a specific antibody (see Sections 2.14 and 2.15). 
Equal amounts of proteins were loaded for the cytosolic fractions ( corresponding to 
approx. 1 x 106 cells) as well as nuclear fractions ( corresponding to approx. 2.5 x 10 7 
cells). While the amount of IL-5 receptor a subunit in the cytoplasmic fractions of cells 
growing with and without IL-5 were similar, the IL-5Ra signals in the two nuclear 
fractions differed significantly (Fig 5.2, lanes 4 and 6 respectively). Quantitative 
analysis using the Image Gauge software (Fuji, Japan) indicated that the nuclear fraction 
of FDC-mIL-5R cells growing in medium depleted of IL-5 only showed approx. 15 % 
signal compared to that of cells grown continuously in IL-5. 
To assess the time frame in which this change takes place, a time course experiment was 
performed, where FDC-mIL-5R cells were grown in either the presence or absence of 
IL-5 from 5 min up to 4 weeks. Following cell harvest and wash steps, cells were lysed 
and fractionated as described in Section 2.14. Samples of cytosolic fraction ( approx. 
1 x 106 cells) and nuclear fraction (approx. 1 x 107 cells) were prepared for SDS-PAGE 
and immunoblotted with anti mIL-5Ra antibody. 
In agreement with Fig. 5.2, the amount of cytosolic IL-5 receptor a remained constant 
over the entire period of the experiment (Fig. 5.3, panel A-C), which was expected since 
the receptor was constitutively expressed in FDC-mIL-5R cells. The analysis of the 
immunoblots proved that the signal difference for IL-5 receptor a in the cytosolic 
fractions at all time points was no bigger than 6 %, indicating that the depletion of IL-5 
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in the medium over a longer period had no significant influence on the level of 
m.IL-5Ra expression and therefore on the proportion of cells stably expressing the IL-5 
receptor a in the entire cell population. 
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Fig. 5.3. Time course of IL-5 induced nuclear localization of the mouse IL-5 receptor 
a subunit. 
FDC-mIL-5Ra cells were incubated with baculovirus-expressed mIL-5 for various 
amounts of time. Cytosolic and nuclear extracts were prepared for SDS-PAGE and 
immunoblotting with anti-IL-5Ra antibody (A). Protein levels in the cytoplasm (B) and in 
the nucleus (C) were quantitated by densitometry (ECL Plus, Amersham). Values were 
normalized to the respective cytosolic and nuclear values for cells cultured constantly in 
mIL-5. 
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In contrast, the nuclear fractions showed marked differences in the levels of IL-5Ra 
signals (Fig. 5.3, panel A-N). Analysis of the immunoblots of the nuclear fractions 
showed that with increasing time of IL-5 depletion the amount of nuclear IL-5 a 
receptor is reduced to about 25 % after 4 weeks (see Fig. 5.3). Specifically, the decline 
is most drastic within the first 60 min (to approx 50 %), with the lowest point of nuclear 
IL-5 receptor a after about 4 weeks (Fig. 5.3, panel C). This reduction in nuclearly 
localized IL-5 receptor a could be reverted by adding IL-5 to the cell culture, but only 
over the course of one week the original level was reached, implying that the nuclear 
accumulation of the mIL-5 receptor a subunit is directly dependent on the presence of 
IL-5. 
5.5 mIL-5 receptor a can be co-precipitated with mIL-5,_,biotin from 
the cytosolic fraction of FDC-mIL-5R cells 
The experimental data thus far had indicated that both IL-5 (Chapter 4) and the IL-5 
receptor a subunit (this Chapter) are associated with the cytosolic and the nuclear 
fractions of FDC-mIL-5R cells. The experimental data were obtained independently for 
IL-5 as well as for its receptor a chain in the presence of IL-5. The question remains as 
to whether IL-5 and the IL-5 receptor a subunit remain associated within the nucleus, 
assuming that the two are co transported to the nucleus as has been shown in vitro (Jans 
et al., 1997b; Calanni, 1997). 
Co-immunoprecipitation experiments were performed utilizing a biotinylated derivative 
of baculovirus-expressed mIL-5 (Chapter 4). To this end, FDC-mIL-5R cells were 
incubated overnight with 5 nM IL-5,.__,biotin prior lysis and subcellular fractionation as 
described in Section 2.14. Cytosolic and nuclear fractions were subjected to protein 
precipitation using streptavidin-conjugated magnetobeads overnight, samples prepared 
for SDS-PAGE and subsequently immunoblotted. After staining for IL-5,.__,biotin, the 
immunoblots were stripped and re-stained for detection of co-immunoprecipitated mIL-
5 receptor a (see Section 2.14). While IL-5 was present in both cytosolic and nuclear 
fraction (Fig. 5 .4 ), the IL-5 receptor a subunit was detected in the cytosolic fraction, but 
in the nuclear fraction only a faint band was observed, suggesting that IL-5 and its a 
receptor subunit may dissociate in the course of their nuclear import. 
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Fig. 5.4. Co-immunoprecipitation of the mIL-5 Receptor a subunit. 
A 
B 
FDC-mIL-5Ra cells were incubated with baculovirus-expressed mIL-5~biotin overnight. 
Cytosolic and nuclear fractions were prepared, fractions co-immunoprecipitated with 
strepavidin-conjugated magnetobeads and samples prepared for SDS-PAGE before 
immunoblotting with streptavidin~HRP (A). Immunoblots were stripped and reprobed with 
anti-IL-5Ra antibody (B). 
5.6 Discussion 
The studies reported here demonstrate the nuclear localization of the full-length IL-5 
receptor a subunit using a biochemical approach. Furthermore, the experimental results 
suggest that this nuclear localization is directly dependent on the presence of IL-5 with 
changes in nuclear accumulation of the receptor after IL-5 depletion able to be observed 
within 60 min. 
Even though nuclear localization of the receptor had been shown before, no information 
was available as to whether the nuclear form of the receptor was intact or not since the 
antibodies used in the previous studies only recognized the intracellular portion of the 
receptor (Calanni, 1997). The results presented here clearly indicate for the first time 
that full length receptor can be found in the nucleus, dependent on the presence of IL-5. 
In IP experiments, the IL-5R a subunit was co-immunoprecipitated with IL-5. Whilst a 
clear signal was detected in the cytosolic fraction, the extremely low signal in the 
nucleus indicates a low amount of IL-5 associated with the receptor, suggesting that 
after passage into the nucleus, dissociation of the ligand-receptor complex may take 
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place. This has been shown to be the case before for IL-1, which is not found to be 
associated with its receptor subsequent to nuclear translocation (Solari et al., 1994). 
Interestingly in this context, indirect immunofluorescence studies with the myeloid 
eosinophil differentiating, AML 14.3D 10 cell line had indicated that when incubated 
with the mIL-5 NLS 1- form, the amount of IL-5 receptor a subunit in the nucleus 
decreased substantially by about 40-60% (Calanni, 1997). Bearing in mind the flow 
cytometric analysis of the receptor binding capacity of this NLS mutant, which binds 
the receptor with only low affinity, this is further evidence that nuclear localization of 
the receptor is directly dependent on its ligand. 
Further analysis is needed to clarify the question of the physiological role of nuclear 
localization of the IL-5 receptor a subunit. It is also important to address the question of 
whether the observed nuclear transport is indeed IL-5Ra-specific or whether it can be 
observed for IL-3 and GM-CSP receptor subunits as well. 
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CHAPTER6 GENERAL DISCUSSION 
IL-5 is an eosinophil differentiation and activating factor. Because eosinophils play a 
central role in the pathogenesis of asthma and allergic diseases, an understanding of the 
signal transduction mechanisms specific for IL-5 is of paramount importance. Although 
the biological activities of IL-5 with respect to eosinophils are well established, the 
relationship between IL-5 signalling and function is only now starting to emerge. Many 
intracellular IL-5 receptor-mediated signalling pathways have been elucidated. 
However, these pathways are not exclusively activated by IL-5, but are shared by IL-3 
and GM-CSF, which, together with IL-5 utilize a common signaling entity, the 
~c-receptor subunit. 
IL-5 appears to possess a functional NLS, indicating that nuclear localization may 
constitute a novel, ligand-specific pathway through which the distinct effects of IL-5 in 
eosinophil activation are achieved (Jans et al. , 1997ab). This emerging model of a signal 
transduction mechanism by which specificity is ensured has not received much attention 
in the field of IL-5 signalling. 
Thus, the present study represents the first elucidation of the detailed mechanisms of 
nuclear localization of IL-5 and its receptor subunits. In vitro nuclear transport assays 
have been utilized to shed light on the mechanisms of IL-5 nuclear transport, whilst the 
nuclear translocation of both IL-5 and its receptor has been verified in the context of a 
whole living cell. 
The present study revealed that: 
1. In addition to the previously identified NLS 1 region a newly defined NLS3 region 
appears to be functional in nuclear transport of hIL-5; IL-5 would appear not to 
possess a classical bipartite NLS a.11.d is not recognized by importin a/~, 
2. Nuclear transport of IL-5 itself can occur independently of the conventional nuclear 
transport machinery, 
3. A number of new approaches were developed and used to demonstrate nuclear 
localization of IL-5, 
4. Nuclear localization of intact IL-5 receptor a subunit was shown for the first time 
to occur in living cells, with nuclear receptor localization dependent on the 
presence of IL-5. 
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6.1 The IL-5 Nuclear Localisation Signal 
NLSs are defined as sequences necessary and sufficient for nuclear targeting of their 
respective proteins. Although there is no strict consensus sequence, conventional NLSs 
typically comprise predominantly basic amino acids (Dingwall and Laskey, 1991) 
arranged either in a single cluster (monopartite) or in two clusters separated by a spacer 
of approximately 10-12 amino acids (bipartite). Several studies of "classical type" 
bipartite NLS have indicated the role of particular residues necessary for nuclear nuclear 
targeting functionality (Robbins et al., 1991; Hu and Jans, 1999; Efthymiadis et al., 
1997). 
It has previously been shown that the human IL-5 NLS region is able to target a 
heterologous protein to the nucleus, with mutations within the proximal arm of the NLS 
region (NLSl) abolishing the nuclear targeting activity (Jans et al., 1997a). Intriguingly, 
subsequent experiments with an NLS2 mutant form, in which Arg 108 and Arg 110 of 
the distal arm were mutated, showed that this region is not essential for co targeting of 
the IL-5 receptor subunits to the nucleus mediated by IL-5 (Calanni, 1997). 
These results imply that the IL-5 NLS does not represent a conventional bipartite NLS. 
Analysis of the IL-5 sequence of both mouse and human revealed that a third short 
cluster of basic amino acid residues (NLS3) is present between the formerly identified 
NLS 1 and NLS2 sequences. The nuclear exclusion of both the IL-5 NLS 1 and NLS3 
mutant B-Gal fusion proteins as demonstrated in Chapter 3 indicate that NLS3 is 
integral to hIL-5 NLS function. It is therefore hypothesized that the residues 95-104 in 
hIL-5 constitute the hIL-5 NLS, implying that the IL-5 NLS may not describe a 
conventional class of NLS. 
Previously, a number of non-conventional NLS have been identified (see Table 6.1). An 
apparently novel NLS is that of the HIV-1 Tat transactivator protein 
(GRKKRRQRRRAP5 9; Siomi et al., 1990), which is sufficient to target B-
galactosidase ( 4 7 6 kDa) to the nucleus (Efthymiadis et al., 1998). The interferon-
induced transcription factor IFI-16 NLS (QKRKKSTKEKAGPKGSKVSRDW145) 
confers nuclear transport that requires ATP, but is Ran- and importin a/B-independent 
(Briggs et al., 2001 ). 
The K-NLS (YDRRGRPGCRYDGMVGFSADETWDSAIDTWSPSEWQMA Y361) of 
the mRNA binding hnRNP K shuttling protein is able to mediate nuclear import in 
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cytosolic factor-independent, but ATP-dependent fashion (Michael et al. ) 1997). 
Clearly, IL-5 is not unique in possessing a signal-dependent nuclear import pathway 
that does not utilise importin a/~ or Ran. The lack of homology between the IL-5 NLS 
and the other NLSs listed in Table 6.1, however, implies that the respective NLSs are 
likely to mediate nuclear import through distinct pathways. 
In contrast to the IL-5 wild type form, the NLS 1- mutant of mIL-5 was previously found 
to show greatly reduced ability to co-transport the soluble IL-5 receptor subunits into 
the nucleus in vitro (Calanni, 1997). Furthermore, in vitro eosinophil differentiation 
assays indicated that the mIL-5 NLS 1- mutant derivative was unable to stimulate the 
production of eosinophil colonies in bone marrow cultures (unpublished data, 
Takamoto, Shinshu University School of Medicine, Matsumoto, Japan). The basis of 
this observation was thought to be that the proximal arm of the IL-5 bipartite NLS was 
indeed essential for full function through the NLS. The flow cytometric receptor 
binding experiments performed with the mIL-5 NLS 1- mutant derivative described in 
Chapter 3 indicate that a more likely reason for this observation is that the reduced 
binding affinity of the NLS 1 mutant to the mIL-5 receptor abolishes receptor 
cotransport. This of course does not mean that NLS 1 does not play a role in nuclear 
transport; clearly, the experiments with IL-5-NLS-~-Gal support the idea that it does. 
However, the fact that the NLS 1 mutation impairs receptor binding renders general 
conclusions about its physiological role impossible. For future analysis of receptor 
binding of IL-5 mutant derivatives prior functional studies, the flow cytometric 
approach described here utilizing fluorescently labelled ligands represents a simple, 
reliable and safe alternative to more traditional methods such as binding studies with 
radiolabelled ligands. 
6.2 Pathway of IL-5 NLS conferred nuclear accumulation 
Classical NLS-dependent nuclear transport is a multistep process dependent on 
numerous cytosolic factors including importin a/~ and the monomeric GTP-binding 
protein Ran (see Chapter 1.2.3). The results of the in vitro nuclear transport assays with 
hIL-5 and mIL-5 indicate that their import does not depend on cytosolic factors , ATP or 
Ran (see Section 3.8). Nuclear import was, however, inhibited by WGA and excess 
importin ~, suggesting that direct interaction with O-glycosylated nucleoporins may 
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play integral part in the translocation process of IL-5 (see Section 3.9). Similar results 
were obtained for the hIL-5sc-HSA fusion protein, which was created to exclude the 
possibility that nuclear import of IL-5, whose size is below the MW cut-off of an NPC, 
is due to passive diffusion. Nuclear import of the hIL-5 5c-HSA fusion protein was 
independent of cytosolic factors as well as of ATP, and was blocked by WGA. The IL-5 
NLS was not recognised by importin a/B in the ELISA assay, indicating that it is not a 
classical bipartite NLS, consistent with the idea that IL-5 does not utilize a conventional 
importin a/B-mediated nuclear import pathway. 
As mentioned, signal-dependent but importin/Ran independent nuclear import pathways 
are purported to exist based on results for a diverse group of proteins (Efthymiadis et 
al., 1998; Fagotto et al., 1999; Michael et al., 1997; Schmalz et al., 1998; Sweitzer and 
Hanover, 1996), including HIV-1 Tat, B-catenin, hnRNP K, IFI-16 and PKC-a (see 
Table 6.1). 
Clearly, IL-5 is by no means unique in possessing a signal-dependent nuclear import 
pathway that does not utilise importin a/B or Ran; since the different proteins listed in 
Table 6.1 are not identical in terms of their nuclear import properties, it seems clear that 
these are multiple importin-independent nuclear transport pathways awaiting molecular 
delineation. 
So far, little is know about the mechanisms by which other polypeptides and growth 
factor ligands/receptors are being translocated into the nucleus. Two recent reports for 
insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 (Schedlich et al., 
2000), and fibroblast growth factor receptor (FGFR)l (Reilly and Maher, 2001), 
provided first evidence that nuclear transport of polypeptide hormone and growth factor 
ligands/receptors can be facilitated by importin-mediated mechanisms. 
Nuclear translocation in T47D breast cancer cells of IGFBP-3, carrying a putative NLSs 
within the C-terminal domain, appeared to occur by a nuclear localization sequence 
(NLS)-dependent pathway mediated by the importin B nuclear transport factor and 
requiring both ATP and GTP hydrolysis. Both IGFBP-3 and IGFBP-5 were shown to be 
recognized by importin B and the a/B heterodimer but only poorly by importin a 
(Schedlich et af.., 2000). 
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Table 6.1. Examples of proteins utilizing novel nuclear import pathways. 
Protein Nuclear import properties* Reference(s) 
~catenin direct binding to nuclear envelope independent of importins; requires Fagotto et al. (1998); 
no ATP/GTP; Ran-independent Y okoya et al. (1999) 
hnRNPK NLS:(YDRRGRPGCRYDGMVGFSADETWDSAIDTWSPSEWQMAY361) Michael et al. (1997) 
not recognized by importins; nuclear transport ATP-dependent, but 
does not require Ran 
IFI-16 NLS: (QKRKKSTKEKAGPKGSKVSRDW145); transport requires ATP, Briggs et al. (2001) 
but is Ran-independent; importin a/~ does not recognize IFI-16 with 
high affinity; binding to nuclear components mediated by NLS, 
regulated by CK2 phosphorylation 
IL-5 hIL-5 NLS: KKYIDGQKKK105 not recognized by importin a or ~; This study 
nuclear transport independent of ATP or GTP; WGA and importin ~ 
inhibit nuclear accumulation 
PKC-a NLS peptides, nonhydrolysable GTP analogues, WGA and antibodies Beckmann et al. 
to importin ~ do not inhibit nuclear transport; cytoskeleton integrity (1994); Schmalz et 
important al. (1998) 
HIV-1 Tat NLS: GRKKRRQRRRAP59 sufficient to target ~-Gal into nucleus in Efthymiades et al. 
ATP-dependent manner; not recognized by either importin a or ~; (1998); 
non-hydrolysable GTP analogues prevent nuclear import; Siomi et al. (1990) 
HIV-1 Vpr does not require Ran-mediated GTP hydrolysis or ATP; transport Jenkins et al. (1998); 
independent of importin a /~; intranuclear binding depends on Subbramanian et al. 
cytosolic factors (1998);Jans et al. 
(2000); 
"' Conventional signal-dependent nuclear protein import (see Section 1.2.3) is mediated by 
importins/Ran/nucleoporins/ ATP and therefore inhibited by antibodies to importins, nonhydrolysable 
GTP analogues as well as WGA, which binds to nucleoporins. Exogenous cytosol is normally required in 
vitro to supply importins and Ran. Binding to nuclear components is not conferred by conventional NLSs. 
FGF-2 (18 kD) is known to induce nuclear translocation of the membrane-bound form 
of FGFRl, despite the lack of an NLS in either the ligand or the receptor (Maher, 1996; 
see Section 1.3.3). Recently, Reilly and Maher (2001) have shown that nuclear 
translocation FGFRl occurs via a mechanism distinct from classical nuclear import but 
dependent on importin ~' apparently in an energy-independent manner. 
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6.3 Importance of the IL-5 NLS for signalling 
Various studies have indicated that polypeptide ligands and growth factors such as FGF 
(Imamura et al., 1990, Wiedlocha et al., 1994), PDGF (Collins et al., 1987) and IFNy 
(Zu and Jay, 1991; Bader and Weitzerbin, 1994) have significant signalling roles 
mediated by their functional NLS. The identification of a functional NLS within IL-5 
thus suggests that its nuclear transport may contribute to signalling. IL-5 may mediate 
its action by cotransporting signalling molecules to the nucleus where they may interact 
with chromatin or modulate transcriptional activities by interacting with nuclear 
transcription factors. 
The precise mechanisms by which polypeptide ligands and their receptors traffic from 
the extracellular space to the interior of a cell after internalization is still not well 
established. To reach the cytosol and the nucleus from the extracellular space, 
polypeptide ligands and growth factors must translocate across a cellular membrane, 
either at the cell surface or across the membrane of an intracellular organelle. The same 
challenge of crossing a membrane barrier is shared by many protein toxins that bind to 
cell-surface receptors and exert their effect in the cytosol (Wesche et al., 2000). 
Diphtheria toxin, for example, binds to the uncleaved precursor of heparin-binding EGF 
(HB-EGF) at the cell surface and is subsequently endocytosed. Upon exposure to the 
low pH obtained in endosomes, the A-fragment of the toxin is translocated to the 
cytosol where it enzymatically modifies elongation factor 2 and thereby inhibits protein 
synthesis (N aglich et al., 1992ab ). 
The present study has not addressed the question of how IL-5/IL-5 receptor can escape 
the lysosomal degradation pathway. Nevertheless, the in vivo studies ( see Chapter 4) 
indicate that at least 8% of the IL-5 that is internalized reaches the nucleus within 12 
hours. This implies that IL-5, and any associated molecules may localize to the nucleus 
through a unique pathway that allows exit from the endosomes. This pathway may be 
inefficient as most of IL-5 is being degraded in lysosomes, but it seems likely that the 
relatively small amount of ligand in the nucleus is functionally significant. 
There is clear evidence that the receptors of many growth factors and cytokines can 
colocalize in the nucleus after endocytosis (see Table L-5). This implies that the 
receptor, alone or in complex with their respective ligands, may have a direct role in 
nuclear signalling. Previously, piggyback experiments performed with the extracellular 
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domains of the IL-5 receptor a and ~ subunits suggested that the IL-5 NLS can 
specifically cotarget the IL-5 receptor into the nucleus (Jans et al., 1997b; Calanni, 
1997). Support for the possibility that receptor co-localisation may be important for IL-
5 nuclear signalling was obtained in the cell fractionation studies here which verified 
that full length, membrane-integral IL-5 receptor a subunit is targeted to the nucleus in 
intact cells (see Chapter 5). IL-5 and the IL-5 receptor a-subunit not only localized in 
the cytosolic fraction, but also in the nucleus. These results verify the data from 
immunofluorescence studies (Jans et al., 1997a; Calanni, 1997), where IL-5 as well as 
the IL-5 receptor subunits could be detected in both cytoplasm and nucleus. Subcellular 
localization in the cytoplasm presumably represents both membrane-bound ligand 
receptor complex as well as complex internalized after endocytosis. Nuclear 
localization, however, would not be anticipated according to the conventional model of 
receptor and ligand being degraded in the lysosomal pathway after internalization. That 
nuclear import of the IL-5 receptor a subunit is drastically reduced in the absence of IL-
5, but reaches maximum levels within 1 week after re-addition of IL-5 (see Section 5.4) 
is clear evidence for ligand dependence of IL-5 receptor nuclear targeting. 
Immunoprecipitation experiments using biotinylated IL-5 showed strong association of 
IL-5 with its a receptor subunit in the cytosolic fraction, but only a small amount of the 
receptor subunit in the nuclear fraction, suggesting that the ligand/receptor complex 
may dissociate once it reaches the nuclear compartment of the cell. 
In order to verify the importance of the IL-5 NLS regions in piggybackinR_ the IL-5 
receptor subunits to the nucleus, it is crucial to perform these fractionation and 
immunoprecipitation experiments with IL-5 NLS mutant derivatives; the latter, of 
course, must be completely functional in receptor binding. 
The lack of sensitivity of the anti-~c antibody available meant that it was not possible to 
assess the nuclear import of this receptor subunit. Since it is shared with IL-3 and GM-
CSF, it can be speculated that ~c may not play a role in nuclear signalling of IL-5, 
though there is no evidence for this as yet. Consistent with this idea, however, Martinez-
Moczygemba and Huston (2001) recently showed that agonistic ligation of the IL-3/IL-
5/GM-CSF a and ~c receptor subunits rapidly induces proteasomal degradation of the 
cytoplasmic domain of ~c, but not Ra, although these experiments do not discount the 
possibility that a small number of receptor molecules might be able to escape 
degradation. One way to verify nuclear localization of ~c would be to label cell surf ace 
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proteins before subfractionation and protein precipitation by biotinylating the cell 
surfaces of receptor-expressing cells. Taken together the results indicate that IL-5 
receptor nuclear translocation can occur, apparently in IL-5-dependent fashion, and that 
the IL-5 receptor subunits may therefore play a role in nuclear signalling. 
6.4 Mechanisms of Nuclear Signalling by IL-5 and its receptor 
Specificity can arise from multiple points in a signalling pathway, such as at the level of 
the receptor, through the modulation of signalling kinetics, through cross-talk between 
different signalling pathways, or through ligand-specific downstream signalling events. 
Nuclear localization of polypeptide ligands, as well as their receptors, may represent a 
more direct, "instructive" signalling mechanism (see Section 1.1.9), guaranteeing the 
specificity of the response to the particular ligand in the respective target cells. 
Within the nucleus, the ligand or ligand/receptor complex may induce changes by 
binding to DNA or chromatin, activating nuclear kinases or acting as/associating with 
transcription factors. Chromatin binding properties have been observed for a number of 
growth factors as well as their receptors, such as Angiotensin II (Re et al., 1984ab ), 
NGF (Rakowicz-Szulczynska et al., 1986b), EGF (Lin et al., 2001; Rakowicz-
Szulczynska et al., 1986b ), PDGF (Rakowicz-Szulczynska et al., 1986b ), SDGF 
(Kimura, 1993) and GH (Lobie et al., 1991) (see Table 1.5). 
It was previously shown that the removal of a putative NLS in the N terminus of 
cyclophilin B (CypB), a peptidylprolyl isomerase (PPI) found in the endoplasmic 
reticulum, extracellular space as well as in the nucleus, abrogated the potentiation in 
prolactin (PRL)-induced proliferation of PRL-dependent cell lines and the enhancement 
of PRL nuclear transport, implying a necessary role for CypB in these functions 
(Rycyzyn et al., 2000). Most recently, a report by Rycyzyn and Clevenger (2002) 
indicated that the intranuclear PRL/CypB complex could act as a transcriptional inducer 
by directly interacting with the trancriptional activator Stat5. The enhancement of Stat5-
mediated gene trancription by the PRL/CypB protein complex was associated with 
increased Stat5 DNA-binding activity, resulting from the release of the repressor protein 
PIAS3 (protein inhibitor of activated Stat3), demonstrating how an intranuclear 
polypeptide hormone can potentiate its own signal and possibly contribute to its own 
signalling specificitiy (Rycyzyn and Clevenger, 2002). 
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The binding of angiotensin II to chromatin was found to enhance the susceptibility of 
chromatin to nuclease digestion, implying induction of transcriptional activity (Re et al., 
1984ab ), whilst chromatin binding of NGF resulted in a decrease in transcriptional 
activity (Rakowicz-Szulczynska et al., 1986b ). The EGF receptor also binds chromatin 
after nuclear localization in target cells (Rakowicz-Szulczynska et al. , 1989), and it has 
recently been demonstrated to bind and activate AT-rich consensus-sequence-dependent 
transcription, including the consensus site of the cyclin D 1 promoter region, thus acting 
as a potential transcription factor (Lin et al., 2001 ). SDGF, which requires nuclear 
localization to induce a mitogenic response in target cells, has also been shown to bind 
to AT-rich DNA sequences (Kimura et al., 1993). Rao et al. (1995b) have shown that 
the PRL receptor associates with purified nuclear chromatin, whilst chromatin 
accumulation has also been observed for IFN-a and -~ in vitro (Kushnaryov et al., 
1985; MacDonald et al., 1986). 
In showing piggyback localisation of the IL-5 receptors through IL-5, Calanni (1997) 
concluded that the IL-5 receptor complex is unlikely to directly interact with chromatin 
or DNA, as nuclear accumulation does not appear to occur through binding to nuclear 
components. In contrast, there appeared to be some evidence that IL-5 itself, 
independent of receptor subunits, may accumulate in the nucleus through binding to 
nuclear components (Calanni, 1997), although the present study does not support this 
idea (see Section 3.9). 
Tavernier et al. (2000) recently showed that IL-5, but not IL-3 or GM-CSP can regulate 
the isoform expression of the IL-5 receptor a subunit. Interestingly, in the context of the 
role of IL-5 in the nucleus, the kinetics of switching from soluble to transmembrane 
IL-5Ra was very slow, with a maximal effect after approximately 2 weeks. The 
molecular mechanisms of this specific action have not been investigated, but it was 
argued that direct DNA binding of IL-5 could explain this IL-5-specific action. An 
alternative explanation could be that, while IL-5 is co-translocating its receptor subunits 
into the nucleus, this could allow the a receptor itself to interact, either directly or 
indirectly, with its own promoter regions. These sites have been defined (Sun et al. , 
1996; Zhang et al. , 1997), but the factors controlling the transcription of IL-5Ra remain 
to be established. The present study indicates that the time frame for maximal nuclear 
accumulation of IL-5Ra after IL-5 stimulation (see Fig. 5.3) is comparable to that of the 
switch between the two receptor types, thus consistent with the idea that the a receptor 
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may play a more direct role within the nucleus in this process of reversible switching 
between membrane-anchored and soluble isoform ofIL-5Ra. 
Phosphorylation has been reported for FGF-1 receptor after binding of FGF-2 in the 
nucleus, an event involved in the regulation of the nuclear matrix environment, possibly 
leading to modulation of transcription, replication and RNA processing (Stachowiak et 
al., 1996b ). Nuclear FGF-2 has been shown to interact directly with Casein kinase 2 
(CK2), a serine-threonine kinase (Bonnet et al., 1996), and to stimulate CK2 activity 
toward nucleolin, a major non-histone nucleolar protein (Bouche et al., 1987; Bonnet et 
al., 1996). 
In a similar manner, insulin seems to stimulate phosphorylation of nucleolin, resulting 
in RNA efflux from isolated nuclei (Csermely et al., 1993); dephosphorylation of a 30-
kDa DNA-binding protein upon incubation of nuclei with activated insulin receptor has 
also been reported (Gletsu et al., 1999). Possible targets for cytokine receptor action 
include proteins such as STATs or Grb2 (Mertanie et al., 1999). 
An interesting new hypothesis to explain nuclear transport of NLS-containing cytokines 
as an important part of intracellular signalling networks is that they may act as 
chaperones to facilitate the nuclear transport of non-NLS-containing proteins associated 
with the cytokine ligand/receptor complex such as STATs and JAKs (see Section 1.1.7). 
Subramaniam et al. (2000) showed that the NLS of IFNy, which is required for full 
biological activity, plays an integral intracellular role in the nuclear translocation of the 
transcription factor STATla activated by IFNy. Treatment of IFNy with antibodies to 
the C-terminal region (95-133) containing the NLS prevented the induction of STAT la 
nuclear translocation. A deletion mutant of human IFNy, lacking the C-terminal NLS 
region was found to be biologically inactive and, though still able to bind to the IFNy 
receptor complex on cells, the NLS mutation specifically abolished the ability IFNy to 
initiate STATl a nuclear translocation. 
Thus far, nothing is known about IL-5/IL-5R-associated proteins into the nucleus, but it 
is possible that JAK2 or Lyn, tyrosine kinases associated with the IL-5 receptor a 
subunit (Stafford et al., 2002), can be targeted to the nucleus in association with the 
IL-5 receptor complex. 
Novel techniques such as chromatin immunoprecipitation-·(CHIP) assay as well as 
cyclic amplification and selection of targets (CASTing) as used for the elucidation of 
the nuclear role of the EGF receptor (Lin et al., 2001) will be most helpful in identifying 
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putative DNA sequences recognized by specifically IL-5/IL-SR complexes in 
association with additional unknown factors subsequent to nuclear localization in vivo. 
The determination of potential interactions between IL-5, IL-SR and DNA binding 
proteins will undoubtedly assist in the elucidating the role of IL-5 in IL-5-specific gene 
activation. Electrophoretic mobility shift assays (EMSA), using biotinylated IL-5 and 
nuclear extracts of IL-5 receptor expressing cell lines may yield the first experimental 
evidence for the existence of such interactions. Another powerful approach for 
screening potential binding partners could be to perform yeast two-hybrid screening, 
utilizing a full-length, single-chain IL-5 open reading frame (ORF) as a Gal4-DNA 
binding domain (DBD) fusion protein as a bait. Additionally, immunoprecipitation 
studies in conjunction with subcellular fractionation, involving antibodies directed 
against proteins known to be associated with the IL-5 receptor system, with subsequent 
2-dimensional gel electrophoresis and mass spectroscopical identification of potentially 
interacting proteins should shed light on this intriguing question. 
6.5 Evolution of polypeptide ligand nuclear transport 
Pederson ( 1998) argues that there is rarely anything to lose from thinking in the context 
of evolution. Growth factors most likely arose with the advent of metazoan life, 
possibly evolving from ancient chemoattracting ligands in step with co-emerging cell 
surface receptors. Conceivably, some of today's secreted polypeptide ligands and 
growth factors may have originated in the course of evolution from proteins that were 
once capable of triggering cellular responses like growth, adhesion or movement from 
within (Pederson, 1998). Possibly_ one of the best examples of such a transition is the 
FGF ligand family, with its high molecular weight forms still acting in an intracrine 
manner, while the low molecular weight form is secreted and acts predominantly on the 
cell surface of FGF-receptor bearing cells. 
In the single cell predecessors of metazoans, it is likely that intracellular signal proteins 
had the function of targeting growth-promoting genes within the genome. Whilst the 
present day growth factors have largely converted to be signalling molecules primarily 
fun_ctioning on the cell surf ace by binding to their respective cell surf ace receptor 
systems, some of them may simultaneously retain the ability to mediate ligand-specific 
pathways by direct action in the nucleus (Pederson, 1998). 
~ ----
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The presence of polypeptide growth factors and cytokines in the nucleus/nucleolus 
currently represents an intellectual way station, neither an established piece of 
orthodoxy on the one hand nor necessarily an opaque box on the other (Pederson, 1998), 
but with the elucidation of the direct role of the EGFR as a transcription factor involved 
in regulation of proliferation the field of nuclear import of polypeptide growth factors 
has gained new experimental support. Importantly, the work with EGFR provides a 
plausible mechanism for nuclear action by EGF. 
Comparable evidence is being accumulated at the moment for a range of polypeptide 
hormones and their receptors. It remains to be seen whether IL-5 will prove to be 
another example of a polypeptide ligand exhibiting nuclear transport to achieve full 
signalling activity, although this seems to be likely, based on the work presented here 
and elsewhere (Jans et al., 1997ab; Calanni, 1997; Tavernier, 2000). If it does, this 
should further contribute to the growing idea that polypeptide ligand/receptor nuclear 
import is a key means of activating specific growth factor and cytokine signalling in the 
physiological context of the multiple receptors, kinase signalling cascades, and 
transcription factors shared by a myriad of different cytokines and growth factors within 
a cell. 
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